Viral infections pose a potential threat to the health of laboratory and zoological colonies of nonhuman primates as well as the personnel involved in their care. This chapter discusses those viral diseases of importance to nonhuman primates and their caregivers by taxonomic family to which the causative agent is classified. A doctrine of comparative virology is that infection of the immunocompetent, appropriate host often is associated with minimal disease, whereas infection of the inadvertent susceptible host can have devastating consequences. The likelihood of such transmission is increased when changes in the environment place different species in close proximity. Similarly, transmission of viral agents from nonprimate host to primate host may result in severe disease. Perhaps of equal importance is the realization that experimental manipulations may inadvertently expose animals to unrecognized pathogens with lethal consequences. For instance, a number of minimally pathogenic viruses may cause severe disease in animals immunosuppressed from pharmacologic manipulation or immunodeficient from concurrent infection with viruses that target the immune system. Numerous examples of each of these scenarios are documented within this chapter.

Introduction {#s0010}
============

Viral infections pose a potential threat to the health of (1) laboratory and zoological colonies of nonhuman primates and (2) the personnel involved in their care. This is particularly true at facilities where there is frequent turnover or movement of animals or where animals recently imported from natural habitats are introduced into colonies of highly susceptible colony-born animals.

This chapter discusses those viral diseases of importance to captive primates or to the health of personnel involved in their care by taxonomic family to which the causative agent is classified. The rationale for this is that there is considerable overlap in the clinical and pathologic expression of diseases caused by viruses in the same taxonomic family regardless of the species affected. Obvious exceptions exist, but these will be noted.

A doctrine of comparative virology is that infection of the immunocompetent appropriate host often is associated with minimal disease, whereas infection of the inadvertent susceptible host can have devastating consequences. The likelihood of such transmission is increased when changes in the environment, either natural or imposed by humans, place different species in close proximity. An early example of this phenomenon comes from the family Herpesviridae in which infection of the natural reservoir host usually results in minimal clinical disease, whereas infection of other closely related species may result in an acutely lethal cytolytic or neoplastic process.

Because interspecies transmission of viruses may have such devastating consequences, direct contact between different nonhuman primate species should be prevented. Although isolation of primate species is the norm in well-managed modern facilities, such may not be the case with recently imported animals. Substandard separation of species, coupled with the stress of capture and movement, puts these animals at increased risk. Similarly, transmission of viral agents from nonprimate host to primate host may result in severe disease. Examples include transmission of lymphocytic choriomeningitis virus from rodents to callitrichids and the transmission of various orthopoxviruses such as monkeypox or cowpox from rodent vectors to nonhuman primates. Increasingly zoological collections have adapted multiple species exhibits and more naturalist settings. While such exhibits have many benefits, it should be remembered that they may promote inadvertent cross-species transmission of infectious agents.

Perhaps of equal importance is the realization that experimental manipulations may inadvertently expose animals to unrecognized pathogens with lethal consequences. Tissue homogenates and cell culture derivatives have transmitted simian immunodeficiency virus (SIV) and simian virus 40 in this fashion ([@bib241], [@bib446]). Moreover, the use of xenografts in both experimental and clinical settings is a potential route by which existing or novel pathogens may be introduced to a new population ([@bib667]).

While infection of the natural host is often associated with minimal disease due to extensive host pathogen co-evolution, such may not be the case if the host is immunocompromised ([@bib757]). A number of minimally pathogenic viruses may cause severe disease in animals immunosuppressed from pharmacologic manipulation or immunodeficient from concurrent infection with viruses that target the immune system. Examples of opportunistic infections that may cause disease in these circumstances include simian virus 40, cytomegaloviruses, and lymphocryptoviruses.

Finally, it should be recognized that outbred populations of nonhuman primates differ substantially from inbred rodent lines. Nonhuman primate populations have evolved with a spectrum of infectious agents for millions of years, and host adaptations have likely occurred to minimize the effects of these agents. Removal of ubiquitous, largely nonpathogenic infections from these populations may have unintended consequences.

Enveloped DNA Viruses {#s0015}
=====================

Poxviridae {#s0020}
----------

Poxviruses are large (220--450 × 140--260 nm), brick- to ovoid-shaped enveloped viruses that replicate exclusively in the cytoplasm of infected cells. Their envelope is composed of lipid and tubular or globular protein structures that surround one or two lateral bodies and a dumbbell-shaped core containing a single molecule of double-stranded DNA. Virions have large genomes encoding approximately 200 polypeptides, at least one of which has homology with epidermal growth factor. This latter peptide acts to stimulate mitosis in neighboring cells and likely accounts for the proliferative epidermal and/or dermal lesions that characterize most poxvirus infections. The ability to induce cellular actin polymerization enhances cell-to-cell spread of virus. Poxviruses demonstrate independence from host cell transcriptional machinery due to the presence of virally encoded enzymes that are involved in transcription and modification of nucleic acids and proteins.

Five members of the poxvirus family belonging to *Orthopoxvirus*, *Yatapoxvirus*, and *Molluscipoxvirus* genera have been associated with naturally occurring epizootics in nonhuman primates ([Table 1.1](#t0010){ref-type="table"} ). Variola and vaccina infections of nonhuman primates represent significant experimental models.TABLE 1.1PoxviridaeGenusVirus*AvipoxvirusCapripoxvirusCervidpoxvirusLeporipoxvirusMolluscipoxvirus*Molluscum contagiosum*Orthopoxvirus*MonkeypoxVariola (smallpox)VacciniaCowpox*ParapoxvirusSuipoxvirusYatapoxvirus*Yaba monkey tumor virusYaba-like disease virus

### Monkeypox {#s0025}

#### Introduction {#s0030}

The first reported outbreaks of monkeypox in nonhuman primates occurred in June 1958 at the Statens Seruminstitut in Copenhagen, Denmark, and shortly thereafter at the Biological Development and Control Laboratories of Merck Sharp and Dohme in West Point, Pennsylvania ([@bib756], [@bib567], [@bib627]). At that time, both institutes were importing large numbers of macaque monkeys for use in polio vaccine production. In both outbreaks, cynomolgus monkeys (*Macaca fascicularis*) were primarily affected, but at Merck a small number of rhesus monkeys (*Macaca mulatta*) also exhibited signs of the disease. Since then, there have been several additional outbreaks of monkeypox infection involving both New and Old World monkeys ([@bib21], [@bib22]).

#### Etiology {#s0035}

Monkeypox virus is a member of the family Poxviridae, subfamily Chordopoxvirinae, and genus *Orthopoxvirus*. This genus includes variola (smallpox virus), vaccinia (smallpox vaccine virus), cowpox virus, and several other mammalian poxviruses. Immunologically, there is a close antigenic relationship among monkeypox virus, variola, and vaccinia. Monkeypox isolates are classified in two clades with distinct differences in virulence: the West African clade and the Congo Basin clade originating in Central Africa ([@bib194], [@bib424]).

#### Epizootiology {#s0040}

Unlike many other poxviruses, monkeypox virus has a wide range of permissive host species. This virus exists naturally in the tropical rain forests of western and central Africa ([@bib77], [@bib511]), where it causes subclinical endemic infections in several nonhuman primate species and a serious, sometimes fatal, smallpox-like disease in young people in these regions.

Ironically, despite the fact that the original outbreaks of monkeypox were in macaques imported from Malaysia, a subsequent serologic survey of 481 Malaysian monkeys failed to reveal a single animal seropositive to monkeypox virus ([@bib20]). While rodents, particularly African squirrels, are thought to serve as the major viral reservoir, African green monkeys (*Chlorocebus aethiops*) have a high prevalence of antibodies to monkeypox virus with no evidence of clinical disease ([@bib237], [@bib365]). It is likely that the macaques involved in the original outbreaks may have been incidentally exposed to infected African green monkeys during shipment from Asia. Monkeypox virus has a relatively broad natural host range that includes humans, anthropoid apes, and Old and New World monkeys. Primates in which monkeypox infections have been shown to occur include cotton-top tamarins (*Saguinus oedipus*), squirrel monkeys (*Saimiri sciureus*), African green monkeys, owl-faced monkeys (C*ercopithecus hamlyni*), rhesus monkeys, cynomolgus monkeys, hanuman langurs (*Semnopithecus entellus*), white-handed gibbons (*Hylobates lar*), orangutans (*Pongo pygmaeus*), gorillas (*Gorilla gorilla*), chimpanzees (*Pan troglodytes*), and human beings (*Homo sapiens*) ([@bib756], [@bib561], [@bib472], [@bib449]). In addition, a variety of rodent species, anteaters, pangolins, and birds from endemic areas of Africa have been shown to have antibodies to the virus.

#### Pathogenesis and Pathology {#s0045}

In the reported epizootics of monkeypox, transmission was thought to have occurred via aerosols, although the disease may more commonly be spread by direct contact and by biting insects ([@bib511]). Viremia develops 3--4 days following experimental infection, at which time the virus disseminates to multiple sites, including skin, lung, mucous membranes, spleen, and gastrointestinal tract ([@bib804]). Lesions within the skin initially appear as papules consisting of proliferative acanthocytes and progress to vesicles. Intracytoplasmic eosinophilic inclusions are apparent within acanthocytes. Vesiculation is followed by umbilication to form the classic pock lesion. Progressive dermal changes take place over a 4- to 14-day period. Lesions within the lung are similar, consisting of irregular foci of hemorrhagic necrosis. These may be responsible for more serious clinical sequelae and transmission of the virus by the aerosolized route. Paralleling epidemiologic observations in humans, experimental infections in cynomolgus macaques have demonstrated that isolates from the Congo Basin clade are associated with increased lesion severity, elevated levels of virus, and greater mortality relative to isolates from the West African clade ([@bib110], [@bib617]).

#### Clinical Findings {#s0050}

Clinical manifestations of monkeypox vary with the species affected. In general, a vesicular exanthema appears 6--7 days following experimental inoculation. Lesions are more often seen on the hands, feet, and face. The skin rash may be accompanied by constitutional signs and, in severe cases with respiratory tract involvement, the disease may be fatal.

#### Treatment {#s0055}

There is no specific treatment for monkeypox, but supportive therapy may prevent the death of animals with severe systemic disease. Most cases recover spontaneously after several weeks and animals are immune to subsequent infection by the same or related viruses.

#### Prevention {#s0060}

Vaccination against smallpox confers immunity to monkeypox infection in most cases ([@bib472]).

#### Zoonotic Potential {#s0065}

Human beings are susceptible to infection by monkeypox ([@bib23]). The disease is seen sporadically in Africa and is usually not associated with direct nonhuman primate contact ([@bib315], [@bib483]). The well-publicized 2003 outbreak in the Midwestern United States was the first documentation of human monkeypox in the western hemisphere ([@bib103], [@bib578]). Viral transmission in these cases was from contact with ill prairie dogs comingled with rodents imported from West Africa for the pet trade. In general, a febrile prodrome precedes development of lympadenopathy and characteristic pock lesions that disseminate over the entire body in a centrifugal pattern. Human-to-human transmission is inefficient with reintroduction of virus from animal reservoirs required to sustain infection ([@bib211], [@bib315]). Fatalities have been reported, and are more common in children.

#### Animal Models {#s0070}

Monkeypox has been used as a model organism in cynomolgus and rhesus macaques to support development of therapeutics and vaccines targeting variola ([@bib295], [@bib180], [@bib691], [@bib690], [@bib173], [@bib451]). Studies have included the use of SIV-inoculated macaques as a model of response to orthopoxvirus vaccination in the face of immunosuppression ([@bib181], [@bib179]).

### Variola {#s0075}

Variola is the prototypic *Orthopoxvirus*. Intensive vaccination programs resulted in eradication of the virus in the late 1970s although potential for use as a biological weapon has prompted continued research and classification of this virus, along with monkeypox, as a Department of Health and Human Services (HHS) select agent. To satisfy requirements for drug and vaccine licensure, nonhuman primate models of variola infection have been described. In a study by Jahrling et al., intravenous administration of high-dose virus to cynomolgus macaques resulted in an acutely lethal infection resembling hemorrhagic smallpox in man ([@bib325]). Symptoms included fever, anorexia, cough, and viral exanthema followed by development of a severe hemorrhagic diathesis, multisystem organ failure, and death within 6 days of inoculation. Clinicopathologic findings included leukocytosis, thrombocytopenia, increased D-dimers, and elevated serum creatinine. Dermal lesions were characterized by erythema and hemorrhage with progression to typical vesiculopustlar lesions. Virus was disseminated systemically via a monocytic cell-associated viremia to lymphoid, gastrointestinal, hepatic, and renal tissues. Additional findings included significant cytokine elaboration and depletion of T-cell dependent regions of lymphoid tissue.

### Vaccinia {#s0080}

Vaccinia is the live attenuated *Orthopoxvirus* used in the smallpox vaccine. Attenuated strains, such as modified vaccinia virus Ankara, have been widely used in nonhuman primate animal models as vectors for recombinant vaccines designed to prevent diseases such as human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), influenza, and viral encephalitides. While attenuated, ocular exposure in laboratory workers can lead to severe keratoconjunctivitis and vision loss and appropriate personal protective equipment should be worn. Following intradermal injection a localized proliferative dermatitis develops and the host remains infectious until the crust is lost in 14--28 days ([Figure 1.1](#f0010){ref-type="fig"} ).FIGURE 1.1Poxviridae infections.Intradermal inoculation of vaccinia virus produces a typical pox lesion in the skin (A) which heals within 21 days (B). Histologically eosinophilic intracytoplasmic inclusions are typical of pox virus infections (C). Ultrastructurally viral particles have a "dumbbell" appearance by electron microscopy (D).

### Cowpox {#s0085}

Cowpox is an *Orthopoxvirus* reported in both New and Old World primates ([@bib455], [@bib459]). The first report in common marmosets (*Callithrix jacchus*) may actually be a 1982 epizootic originally attributed to a *Yatapoxvirus.* Clinical disease was characterized by the appearance of erythematous papules progressing through vesiculation and umbilication over a 4- to 6-week course ([@bib242]). Lesions were concentrated on the face, scrotum, and palmar or plantar surfaces. Identification of the etiologic agent was based on ultrastructural examination. A more recent report describes development of hemorrhagic dermal lesions with an identical distribution in a colony of marmosets and *Saguinus* species ([@bib459]). Viral etiology was determined using molecular techniques to be a poxvirus with close homology to cowpox. Skin lesions from both reports were characterized by acanthosis with epidermal necrosis, ulceration, and typical pox-like intracytoplasmic inclusions. Disease may be fatal in New World monkeys. Transmission occurs via contact with rodent vectors which have a geographic distribution over much of Europe, Asia, and Africa but are not present in North America. Cowpox is considered a zoonotic disease resulting in localized, self-limiting infection in immunocompetent individuals.

### Yaba Monkey Tumor Virus {#s0090}

#### Introduction {#s0095}

In 1957 an outbreak of subcutaneous tumors was observed in a group of captive macaques housed in Yaba, Nigeria ([@bib47]). A viral etiology was subsequently demonstrated and confirmed as a poxvirus. Yaba monkey tumor virus (YMTV) has been shown to naturally infect macaques (*M. mulatta*, *M*. *fascicularis*, and *M*. *arctoides*) and baboons (*Papio anubis*) ([@bib164]). Experimentally, the pig-tailed macaque (*M*. *nemestrina*), stump-tailed macaque (*M*. *arctoides*), African green monkey, sooty mangabey (*Cerocebus atys*), and the Patas monkey (*Erythrocebus patas*) are susceptible ([@bib387]). Accidental and experimental human infection have been demonstrated. New World primates are resistant.

#### Etiology {#s0100}

YMTV is included in the genus *Yatapoxvirus* with tanapoxvirus and Yaba-like disease virus.

#### Epizootiology {#s0105}

Relatively few naturally occurring episodes have been documented. Captive-born African monkeys appear susceptible to experimental infection, whereas wild-caught animals are resistant, suggesting that widespread infection with YMTV or closely related virus(es) occurs in the wild, conferring life-long immunity to those individuals at an early age. The method of transmission is unknown, but arthropod vectors, tattoo needles, and trauma have been suggested as possible mechanisms.

#### Clinical Findings {#s0110}

The original outbreak of YMTV disease in rhesus macaques was characterized by multiple subcutaneous masses, often on the hands and feet, varying in size from small papules to nodules several centimeters in diameter. Larger masses would occasionally ulcerate and all masses invariably regressed by 6 weeks. Animals often developed new lesions as old lesions regressed. Subsequent cases and outbreaks have had a similar clinical course ([@bib83], [@bib758], [@bib778], [@bib631]). Oral masses have been described in baboons ([@bib83]). Intravenous inoculation may produce lesions in many organs, including lung, muscle, heart, and pleura. Because masses spontaneously regress, they are often called "pseudotumors." Aerosol transmission of YMTV has been demonstrated experimentally in rhesus and cynomolgus macaques ([@bib786]). Inoculated animals developed nasal, pulmonary, and pleural tumors but did not transmit the virus horizontally to cagemates.

#### Pathogenesis and Pathology {#s0115}

The characteristic histopathologic lesion consists of large pleomorphic histiocytic cells forming a nonencapsulated and infiltrative mass. These cells have hyperchromatic nuclei and prominent nucleoli. Mitotic figures are frequent. Large eosinophilic intracytoplasmic inclusion bodies may be evident. Regression is associated with erosion, ulceration, and formation of multinucleated cells.

#### Zoonotic Potential {#s0120}

Both experimentally induced and spontaneous diseases have been recognized in humans. In spontaneous human cases, lesions were most often noted on hands and feet and were associated with lymphadenopathy and fever. As in nonhuman primates, regression occurred within weeks.

### Yaba-Like Disease Virus {#s0125}

#### Introduction {#s0130}

In 1967 an outbreak of a contagious skin disease of macaques and human handlers was observed at three primate facilities in Oregon, Texas, and California (Or-Te-Ca) and was traced to a single primate importer ([@bib263], [@bib132], [@bib167]). Affected species in the original outbreak were rhesus macaques, pig-tailed macaques, Japanese macaques (*M*. *fuscata*), and Sulawesi-black macaques (*Macaca nigra*).

#### Etiology {#s0135}

Yaba-like disease virus (YLDV) is classified in the genus *Yatapoxvirus*. This virus was initially thought to be tanapox, a relatively benign cutaneous infection of humans responsible for periodic outbreaks of illness in East Africa ([@bib327]). It has been documented that these viruses have 98.6% identity of genomic sequences. Current understanding is that these are two different strains of the same virus with tanapox representing the human virus and YLDV representing the nonhuman primate virus ([@bib84]). Or-te-ca poxvirus and benign epidermal monkeypox (BEMP) are also names used historically to denote this virus.

#### Epizootiology {#s0140}

The unique circumstances responsible for the initial outbreak of YLDV infection in macaques are unrecognized. Serologic surveys indicate natural infection of African but not New World primates ([@bib164], [@bib166]).

#### Pathogenesis and Pathology {#s0145}

Histologically, papules are composed of focally extensive regions of epidermal proliferation and ballooning degeneration and arise after a 4- to 6-day incubation period ([@bib94], [@bib165]). Hair follicles and sebaceous glands may be involved. Eosinophilic, intracytoplasmic viral inclusions may be present. Nuclei are variably distended by large eosinophilic cytoplasmic invaginations. Ultrastructurally mature viral particles are 370 × 150 μm in size and have an outer coat consisting of seven distinct layers and an inner dumbbell-shaped core. Morphologically, these are indistinguishable from YMTV ([@bib94]). Resolution is characterized by necrosis, ulceration, and infiltration of the dermis by a variety of inflammatory cells.

#### Clinical Findings {#s0150}

Following a 4- to 5-day incubation period, small red papules form and progress by 14 days to circular, firm raised foci up to 1 cm in diameter. These lesions may ulcerate and become umbilicated before resolving in 3--4 weeks and are often surrounded by a hyperemic border.

#### Treatment {#s0155}

No treatment is available.

#### Prevention {#s0160}

Previous infection with YLDV is protective against subsequent challenge. Vaccination with vaccinia does not produce protective immunity.

#### Zoonotic Potential {#s0165}

The related human virus, tanapox, occurs naturally in regions of Kenya and Congo. The initial outbreaks in 1957 were associated with flooding of the Congo River. The definitive host and vector(s) involved in these epidemics are unknown. Transmission of YLDV from infected monkeys to humans has been documented. In humans, infection is characterized by a short febrile illness accompanied by constitutional signs. As these signs abate, small nodules and papules arise eventually, forming the classic pock lesion.

### Molluscum Contagiosum {#s0170}

Molluscum contagiosum is a chronic, mildly contagious skin disease of humans characterized by multiple small, pinkish skin nodules from which a waxy material may be extruded. Although it is caused by a pox virus, it is difficult to culture in vitro, and attempts at experimental infection of a variety of nonhuman primates have been unsuccessful. Histologically, the lesion is composed of a flask-shaped proliferative nodule of epidermal cells in which centrally enlarged acanthocytes contain homogeneous, intracytoplasmic, eosinophilic viral inclusions. These molluscum bodies are shed along with keratin debris through a central pore. A single outbreak with similar clinical and histopathologic findings has been described in chimpanzees ([@bib163]). It is unknown whether this represented a similar or identical viral agent to that seen in the human disease.

Herpesviridae {#s0175}
-------------

The family Herpesviridae is divided into three distinct subfamilies: Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae ([Table 1.2](#t0015){ref-type="table"} ). Specific viruses will be discussed herein according to their subfamily grouping. Additionally, there are a number of herpesviruses that have yet to be assigned to a subfamily. The classification of herpesviruses has been recently updated by the International Committee of the Taxonomy of Viruses (ICTV) resulting in a number of name changes ([@bib146]). Names for the nonhuman primate herpesvirus species are based on the host genus with the name ending in *--ine* (i.e. *Macacine herpesvirus 1* replaces *Cercopithicine herpesvirus 1*). Current taxonomic designations with the former and common names are presented in [Table 1.2](#t0015){ref-type="table"}. Although the viral subfamilies are distinctly different, as a group the herpesviruses do share certain genetic and biologic properties. These include (1) a complex double-stranded DNA genome encoding a number of enzymes involved in protein processing, DNA synthesis, and nucleic acid metabolism; (2) DNA synthesis and capsid formation in the nucleus; (3) requisite destruction of the host cell to complete the viral replicative process; and (4) viral persistence in a latent form within the host.TABLE 1.2HerpesviridaeClassificationFormer NameCommon NameSubfamily: *Alphaherpesvirinae*Genus: Simplexvirus *Ateline herpesvirus 1*Spider monkey herpesvirus *Cercopithicine herpesvirus 2*SA8 *Human herpesvirus 1, 2*Herpes simplex 1, 2 *Macacine herpesvirus 1*Cercopithicine herpesvirus 1Herpes simiae; B virus *Papiine herpesvirus 2*Cercopithicine herpesvirus 16Herpesvirus papio 2 *Saimirine herpesvirus 1*Herpesvirus tamarinusHerpes TGenus: Varicellovirus *Cercopithicine herpesvirus 9*Cercopithicine herpesvirus 6,7,9Simian varicellovirus *Human herpesvirus 3*Varicella-zoster virusSubfamily: *Betaherpesvirinae*Genus: Cytomegalovirus *Cercopithicine herpesvirus 5*African green monkey CMV *Human herpesvirus 5*Human cytomegalovirus *Macacine herpesvirus 3*Cercopithicine herpesvirus 8Rhesus monkey CMV *Panine herpesvirus 2*Pongine herpesvirus 4Chimpanzee CMV *Aotine herpesvirus 1, 3*[∗](#tbltblfn50fnlowast){ref-type="table-fn"}Herpesvirus aotus types 1, 3Subfamily: *Gammaherpesvirinae*Genus: Lymphocryptovirus *Callitrichine herpesvirus 3*Marmoset lymphocryptovirus *Cercopithicine herpesvirus 14*African green monkey EBV-like virus *Gorilline herpesvirus 1*Pongine herpesvirus 3Gorilla herpesvirus *Human herpesvirus 4*Epstein-Barr virus *Macacine herpesvirus 4*Cercopithicine herpesvirus 15Rhesus lymphocryptovirus *Panine herpesvirus 1*Pongine herpesvirus 1Chimpanzee herpesvirus *Papiine herpesvirus 1*Cercopithicine herpesvirus 12Herpesvirus papio *Pongine herpesvirus 2*Orangutan herpesvirusGenus: Rhadinovirus *Ateline herpesvirus 2, 3*Herpesvirus ateles *Human herpesvirus 8*Kaposi's sarcoma-assoc. herpesvirus *Macacine herpesvirus 5*Cercopithecine herpesvirus 17Rhesus rhadinovirus *Saimirine herpesvirus 2*Herpesvirus saimiriUnassigned Species in Subfamily *Saguinine herpesvirus 1*Callitrichine herpesvirus 1Herpesvirus saguinusUnassigned Viruses in Family *Callitrichine herpesvirus 2*Marmoset CMV *Cebine herpesvirus 1*Capuchin herpesvirus (AL-5) *Cebine herpesvirus 2*Capuchin herpesvirus (AL- 18) *Cercopithicine herpesvirus 3*SA-6 *Cercopithicine herpesvirus 4*SA-15 *Macacine herpesvirus 6*Cercopithicine herpesvirus 10Rhesus leukocyte-assoc. herpesvirus *Macacine herpesvirus 7*Cercopithicine herpesvirus 13Herpesvirus cyclopis[^1]

Alphaherpesvirinae {#s0180}
------------------

### *Macacine Herpesvirus 1*: Herpes B Virus {#s0185}

#### Introduction {#s0190}

Herpes B virus occurs as a common, latent, and usually asymptomatic infection of Asian macaques and has been demonstrated by viral isolation or serology to occur in rhesus macaques, bonnet macaques (*M*. *radiata*), Japanese macaques, stump-tailed macaques, Formosan rock macaques (*M*. *cyclopis*), pig-tailed macaques, lion-tailed (*M. silenus*), and cynomolgus macaques ([@bib308], [@bib14], [@bib715]). Although rarely responsible for disease in the natural host, inadvertent infection of humans results in a disseminated viral infection characterized by ascending paralysis and a high case fatality rate. The increased incidence of human cases in the late 1980s and early 1990s combined with the 1997 death of a primate center research assistant has spurred continued interest in the prevention and treatment of this disease. Infection of non-macaque species, including the Patas monkey, black and white colobus (*Colobus abyssinicus*), DeBrazza's monkey *(Cercopithecus neglectus),* capuchin monkey (*Cebus apella*), and common marmoset, has reportedly produced fatal disease ([@bib232], [@bib434], [@bib783], [@bib715]). Persistent and asymptomatic B virus infection in a colony of capuchin monkeys housed near but not in direct contact with rhesus macaques has been reported and indicates that safe practices should be employed when working with all nonhuman primate species ([@bib128]).

#### Etiology {#s0195}

Herpes B virus is a member of the subfamily *Alphaherpesvirinae* and genus *Simplexvirus*. The 157-kb-long viral genome encodes approximately 70 proteins. Homologs of all of these genes occur in related viruses of humans, such as *Human herpesvirus 1* and *2* (HHV1 and HHV2; Herpes simplex virus 1 and 2), and of primates, such as *Papiine herpesvirus 2* (Herpesvirus papio 2) and *Cercopithecine herpesvirus 2* ([@bib528], [@bib529], [@bib559]). Notably, herpes B virus lacks a homolog of the HHV neurovirulence gene γ~1~34.5 suggesting alternate strategies to promote replication of B virus within neurons ([@bib559]). The viral envelope contains at least nine glycoproteins that are targets of the immune response and help to define cellular tropism. Glycoproteins B and D have 80% and 56% identity with the respective HHV1 glycoproteins, while glycoproteins G and C demonstrate significant sequence variation ([@bib528], [@bib560]). Genomic sequencing and restriction fragment length polymorphism analysis have demonstrated that distinct genotypes of herpes B virus occur in different species of macaques including rhesus, cynomolgus, pig-tailed, lion-tailed, and Japanese macaques ([@bib662], [@bib715], [@bib530]). The parallel arrangement of phylogenic trees for B virus isolates and mitochondrial DNA sequences from the respective macaque species indicates probable co-speciation. Viral replication occurs rapidly, with enveloped capsids present 8--10 h after infection. In cell culture, syncytial cells and Cowdry-type A intranuclear inclusions are readily apparent.

#### Epizootiology {#s0200}

The incidence of infection in immature rhesus macaques is low and increases rapidly with sexual maturity, approaching 80--90% in some colonies by 3--4 years of age ([@bib764], [@bib15], [@bib624]). The percentage of animals with active oral lesions is much less and in one large study of 14 400 macaques was found to be 2.3% ([@bib356]). The virus is transmitted through sexual or biting behavior and by fomites. In overcrowded or unsanitary conditions, animals may become infected at an earlier age and the seropositive rate may be higher. Animals remain infected for life and may periodically shed the virus in oral and genital secretions. The greatest risk of primary infection occurs during the breeding season in sexually adolescent animals 2--3 years of age ([@bib765], [@bib764]).

#### Pathogenesis and Pathology {#s0205}

The pathogenesis of herpes B infection in macaques is similar to HHV1 infection in humans. Primary infection results in an initial round of replication at the site of inoculation. Histologically, this is characterized by the ballooning degeneration of keratinocytes with progression to vesiculation. Multinucleated, syncytial cells and eosinophilic to basophilic, intranuclear viral inclusions may be prominent. Immunohistochemistry utilizing antibodies against HHV1 can be used to demonstrate viral antigen in equivocal lesions. Inflammatory cells may be found within vesicles, epidermis, and subjacent dermis. Endothelial cell necrosis with intranuclear viral inclusions may be seen. In disseminated disease, there is widespread, hemorrhagic necrosis within the liver, lung, brain, adrenal gland, and lymphoid organs ([@bib193], [@bib653], [@bib14], [@bib91]). Herpes B virus should be included in the list of viral agents responsible for multifocal, necrotizing hepatitis in macaques.

Seroconversion occurs soon after primary infection and is associated with the resolution of clinical signs. These antibodies may be detected by enzyme-linked immunosorbent assay (ELISA) and western blot methods ([@bib760], [@bib761]). False-negative tests and latently infected immunologically unreactive individuals complicate the interpretation of results on single samples. Various strategies have been explored to increase the sensitivity and specificity of serodiagnosis and improve biosafety including assays based on recombinant glycoproteins and surrogate antigens such as HHV1, *Papiine herpesvirus 2*, and *Cercopithicine herpesvirus 2* ([@bib531], [@bib704], [@bib796]). The variable antigenic cross-reactivity of certain glycoprotein epitopes may also allow for discrimination of antibodies to closely related alphaherpesviruses ([@bib560], [@bib557], [@bib223]). A number of strategies for virus speciation via polymerase chain reaction technology have also been described ([@bib284], [@bib558], [@bib544], [@bib488]). PCR detection has decreased sensitivity and utility due to the infrequency of virus shedding.

Following initial viral replication, the virus (virion or capsid) is transported by retrograde axonal flow to the sensory ganglion where a latent infection is established for the life of the animal. Centrifugal spread may contribute to the enlargement of lesions or generalization during primary infection. Factors contributing to recrudescence are poorly understood, but stress, fever, ultraviolet light, tissue or nerve damage, and immunosuppression have been identified clinically as contributing factors in the reactivation of HHV in humans and may play a similar role with B virus in macaques. It is generally thought that stress related to changing social dynamics, transportation, or relocation can result in reactivation of herpes B virus ([@bib490], [@bib186]). Detection of shedding, although uncommon, appears to be most strongly associated with the breeding season ([@bib764], [@bib304]). Other studies have shown that viral shedding in seropositive macaques was not commonly associated with common laboratory procedures or occurrences such as quarantine, parturition, and chair restraint ([@bib767], [@bib304]). Reactivation of oral lesions has been described in macaques treated with immunosuppressive agents and with solid organ transplantation drug regimens ([@bib109]). Interestingly, reactivation is not commonly recognized in macaques experimentally inoculated with SIV and dying with acquired immunodeficiency syndrome (AIDS) ([@bib653]) ([Figure 1.2](#f0015){ref-type="fig"} ).FIGURE 1.2Macacine herpesvirus 1 (B virus (BV)).BV infection of mucosal surfaces may be observed with primary infection or reactivation and often appear first as small vesicles (A). In severe cases these may spread to adjacent haired skin (B) and disseminate to the gastrointestinal tract (esophagus, C). The virus may be sexually transmitted and lesions appear on the penile (D) and vaginal mucosa.(Photographs courtesy of Drs. Dan Anderson and Sherry Klumpp, Yerkes National Primate Research Center, with permission.)

#### Clinical Findings {#s0210}

Infection of Asian macaques is usually mild and self-limiting. Characteristic vesicular lesions occur on oral and genital mucosae, which progress to ulceration and resolve within 10--14 days. Disseminated infection in macaques is rare, but when it occurs, it is usually fatal. Viral dissemination to the lung, liver, spleen, bone marrow, and adrenal cortex has been documented ([@bib783], [@bib653]). In these instances, the clinical course may vary from peracute to slowly progressive, and B virus is often not suspected as an underlying etiologic agent, thereby increasing the risk of human exposure. A respiratory form has been recognized in bonnet macaques ([@bib193], [@bib629]). During the 1973 epizootic, animals exhibited coryza, rhinorrhea, cough, and conjunctivitis. Both morbidity and mortality were high, and hemorrhagic interstitial pneumonia and hepatic necrosis were described at necropsy.

#### Treatment {#s0215}

Animals actively infected and shedding virus should not be treated as this entails considerable risk to the attending personnel. Recommendations for postexposure prophylaxis and treatment of clinical disease in humans have been reviewed and published ([@bib291], [@bib125]) ([Figure 1.3](#f0020){ref-type="fig"} ).FIGURE 1.3Macacine herpesvirus 1 (B virus (BV)).Viral infection may disseminate and cause multifocal hepatic necrosis (A and B). It may also be carried and shed asymptomatically from mucosal surfaces such as the tonsilar epithelium (C and D). Immunohistochemistry may be used for viral localization (B and D). Histologically multinucleated syncytial cells with intranuclear inclusions may be evident in epithelial cells (insert C).

#### Prevention {#s0220}

Guidelines used to establish B virus specific pathogen-free (SPF) colonies have been published ([@bib760], [@bib282]). Animals are initially screened by titration ELISA and western blot. Negative animals should be kept in single cage housing or in small groups and be periodically tested by a modified ELISA for at least one year. Animals that are repeatedly negative by these criteria can then be moved to larger groups. Once in these breeding groups, animals should be periodically tested for seroconversion. Repeated testing during the quarantine period is required because animals may be (1) chronically infected and immunologically unreactive or (2) in the early stages of disease prior to seroconversion. Serologic testing on an annual or semi-annual basis should be continued as a component of colony management as seropositive macaques have been detected as late as 7 years post establishment of a SPF program ([@bib282]). Because the positive predictive value of screening tests decreases concomitantly with the reduced prevalence of disease, false-positive test results are more likely during the maintenance phase and require pursuit of confirmatory testing. While antibody testing is useful for colony management, the value of a single test in an individual animal is limited.

Breaks in the SPF barrier status may occur from introduction of new animals, contact with contaminated fomites, or reactivation of latent infection in seronegative animals. Ideally, SPF colonies should be self-sustaining and not require introduction of new animals. When animals are introduced, appropriate testing and quarantine are required. If non-SPF animals are housed in the same facility, precautions should be taken to prevent transmission of the virus via fomites.

In smaller facilities, the acquisition of seronegative young animals and the subsequent individual housing of those animals have been shown to greatly reduce the occurrence of primary active infections ([@bib162], [@bib534]). Although inappropriate for large colonies, this method may be adequate for small numbers of animals that are kept for short periods.

Implementation of SPF programs appears to be effective at reducing the risk of B virus exposure. Examination of 4 years of data from six SPF colonies indicated a greater than 20-fold reduction in probability of non-negative serologic results ([@bib282]). It must be remembered that all macaque species should be treated as if they may be infected with herpes B virus regardless of the source and that this is only one of many potentially dangerous zoonotic agents that macaques may harbor.

#### Zoonotic Potential {#s0225}

Despite the widespread use of macaques and the common occurrence of B virus infection in these animals, fewer than 50 documented human cases have been described ([@bib291]). Evidence from recent outbreaks indicates that previous infection with HHV is not protective. The majority of human cases have developed following macaque-induced injury. Rarely has human-to-human contact, respiratory spread, needle stick injury, laboratory exposure, or unknown exposure been recorded as the means of transmission ([@bib292], [@bib763]). The most recent fatality was due to an ocular splash with biologic material from a rhesus macaque prompting guidance on mechanisms of ocular protection ([@bib102]). Herpes B virus is listed as a HHS select agent.

In humans, a vesicular dermatitis at the site of inoculation develops as soon as 3--5 days or as late as 24 days post-exposure, which is followed by lymphangitis and secondary lymphadenopathy. Pruritus may be intense at the site of inoculation. Neurologic signs appear 3--7 days after the initial cutaneous lesion and are characterized by an ascending myelitis. Fever, paresthesia, muscle weakness, and conjunctivitis may precede these findings. In some cases, premonitory signs and a clinical history of exposure have not been recognized. The case fatality rate in humans is approximately 70--80%, with death ensuing within 10--14 days. Although less frequent, asymptomatic infection and infections characterized by recurrent vesicular rash and respiratory signs have been identified in humans. Evidence suggests that asymptomatic infection is rare ([@bib221]). Early recognition of clinical signs is critical as the administration of nucleoside analogs (acyclovir, valacyclovir, ganciclovir, or famciclovir) may be beneficial during the initial stages of infection.

Recommendations for the prevention and treatment of injuries inflicted by macaques have been published ([@bib125]). Education of animal care and laboratory personnel on the prevention and risks of herpes B virus infection is critical. An epidemiologic investigation following cases of human herpes B virus infection at a single animal research facility revealed that only 41% of the employees with at least weekly contact with macaques had prior knowledge of herpes B virus ([@bib144]). Advanced preparation of bite/wound kits and detailed standard operating procedures should be available at all institutions housing macaques and handling their tissues. Following exposure, thorough and vigorous cleansing of the wound with detergent and water for at least 15 min should be initiated, followed by risk assessment by an infectious disease specialist. Close clinical follow-up is warranted. Post-exposure prophylaxis with valacyclovir may also be warranted with high-risk exposures.

Although herpes B virus infection of man is rare, protection from and prevention of this zoonosis is of paramount importance. All facilities that house macaque species should implement a comprehensive B virus prevention and control plan. The basic elements of this program should include: (1) standard operating procedures for handling macaques and their tissues; (2) education and training of all personnel having potential contact with macaques; (3) the presence of supplies for immediate patient first aid; (4) maintenance of nonhuman primate-related injury database; (5) the required use of appropriate personal protective equipment; (6) access to medical care staff with expertise in herpes B virus risk assessment, diagnosis, treatment, and follow up; (7) periodic review of existing procedures and policies to ensure employee safety and compliance.

### *Cercopithecine Herpesvirus 2*: Simian Agent 8 {#s0230}

*Cercopithecine herpesvirus 2* (SA8) is a *simplexvirus* of the subfamily *Alphaherpesvirinae*. It was originally isolated from neural tissue of an African green monkey and is found indigenously in this species. The viral genome is organized similarly to other simplexviruses, and all identified genes are homologous and collinear with those of herpes B virus ([@bib734]). Due to the close antigenic similarities, SA8 has been proposed as a surrogate antigen for diagnosis of B virus seropositivity ([@bib441], [@bib704])**.** SA8 is also closely related to *Papiine herpesvirus 2* (previously Herpesvirus papio 2, HVP2) ([@bib177]). Although these are two distinct viruses, the original HVP2 isolates were identified as SA8 leading to some confusion in early publications. Infection in African green monkeys is usually subclinical. The virus has no known zoonotic potential.

### *Papiine Herpesvirus 2*: Herpesvirus Papio-2 {#s0235}

#### Introduction {#s0240}

*Papiine herpesvirus 2 (HVP2)* is a common infection of baboons. This virus is a member of the simplexvirus genus of the subfamily *Alphaherpesvirinae*. Genomic organization is identical to other simplexviruses ([@bib56], [@bib735]). HVP2 is most closely related to SA8 and demonstrates an 85% homology to the SA8 genome. Two regions of the genome, the UL41--44 genes and the UL36 gene, demonstrate closer homology to herpes B virus, suggesting a recombination event between an SA8-like progenitor and a virus closely related to herpes B virus ([@bib735]). Like B virus and SA8, the HVP2 genome lacks the γ34.5 HHV neurovirulence gene ([@bib734], [@bib735]). Antigenic similarities to herpes B virus have allowed HVP2 to be used as a surrogate antigen for diagnosis of B virus seroconversion. Study of HVP2 in a murine model has identified two HVP2 clades, one classified as apathogenic and the other classified as neurovirulent ([@bib602], [@bib603]).

#### Epizootiology {#s0245}

Seropositivity in both captive and wild-caught adult baboons nears 100% ([@bib175]; Payton et al., 2004). Although virus can be spread venerally in adult baboons, oral infection prior to sexual maturity is the predominant mode of transmission ([@bib417], [@bib176]; Payton et al., 2004). As with other alphaherpesvirus infections, the virus may persist latently within sensory ganglia ([@bib351]). Recrudescence may occur periodically. With reactivation, the virus is shed in oral and genital secretions, although it is detected in less than 5% of animals sampled ([@bib176]).

#### Pathogenesis and Pathology {#s0250}

The pathogenesis of HVP2 is most similar to HHV-1 and -2 and recapitulates many aspects of B virus pathogenesis in macaques. Gross lesions include vesicular eruptions in the oral cavity or on genitalia. Vesicles or pustules coalesce, ulcerate, and resolve within 2 weeks of appearance ([@bib604]). Lesions may occasionally spread to adjacent skin. Genital lesions are occasionally severe, involving the vulvar, penile, or perineal tissues. Secondary bacterial infections and fibrosis may contribute to vaginal or urethral obstruction ([@bib657], [@bib456]). Disseminated disease has not been described in adult baboons and inoculation of juveniles with neurovirulent strains does not result in clinical disease ([@bib604]). Severe disease is possible in infant baboons. Experimental inoculation of infantile baboons (though described as an SA8 inoculation, the original inoculum was isolated from an infant baboon) produced a fibrinonecrotic pulmonary alveolitis that was accompanied by multifocal hepatic necrosis. Intranuclear inclusions were noted ([@bib185]). A similar case of severe necrotizing pneumonia secondary to natural transmission of HVP2 from a dam to an infant baboon was recently described by Wolf and colleagues ([@bib785]).

#### Clinical Findings {#s0255}

Many animals carry the virus asymptomatically. During primary infection or recrudescence, small vesicles and pustules may be found on the genital and oral mucous membranes ([@bib417], [@bib456]). There has been one report of natural transmission to a non-host species that has resulted in severe disease ([@bib727]). In this case, a black and white colobus monkey (*Colobus guereza*) from a zoological park demonstrated ataxia and death. Multifocal necrosis and hemorrhage of the central nervous system and adrenal gland were identified on gross and histological examination. Virus was identified using molecular techniques. Transmission via enrichment items shared with an adjacently housed troop of baboons was suspected.

#### Zoonotic Potential {#s0260}

Despite its close relatedness to herpes B virus, zoonotic transmission of HVP2 has not been reported. There is ongoing study of the comparative pathology of HHV, herpes B virus, HVP2, and SA8 in rodent models and cell culture systems with the goal to elucidate the molecular basis of alphaherpesviral neurovirulence ([@bib591], [@bib592], [@bib603]).

### *Saimiriine Herpesvirus 1*: SaHV1, *Herpevirus Tamarinus* {#s0265}

#### Introduction {#s0270}

*Saimiriine herpesvirus 1* (SaHV1; previously named *Herpesvirus tamarinus* or Herpes T) infection has many similarities with human herpesvirus infection of New World primates. The virus is carried asymptomatically by squirrel monkeys (*S. sciureus*) but induces an acutely lethal disease in owl monkeys (*Aotus* spp.) and several species of marmosets and tamarins ([@bib290], [@bib481], [@bib312], [@bib370], [@bib502]).

#### Epizootiology {#s0275}

Squirrel monkeys become infected at an early age and harbor the virus asymptomatically. Viral persistence within sensory ganglia has been documented. Periodic reactivation and shedding of the virus in oral secretions represent the primary reservoir and source of infection. Antibodies to SaHV1 have been detected in asymptomatic spider monkeys (*Ateles* spp.), capuchin monkeys, and woolly monkeys (*Lagothrix* spp.), and these animals may represent additional natural reservoir hosts or, more likely, carry antigenically related simplexviruses ([@bib307], [@bib504]). Initial infection of tamarins, owl monkeys, and marmosets occurs through inadvertent exposure to carrier species. Once established, intraspecies transmission results in an epizootic with high mortality. Surviving animals may continue to shed virus and represent a continued source of infection ([@bib507]) ([Figure 1.4](#f0025){ref-type="fig"} ).FIGURE 1.4Saimiriine herpesvirus 1 (SaHV-1) or herpesvirus tamarinus.SaHV-1 rarely causes disease in the squirrel monkeys (the natural host) but may be associated with stomatitis (A) or glossitis. Transmission to callitrichids or owl monkeys results in severe disseminated disease associated with necrotizing ulcers at mucosal surfaces (B, stomatitis) and multifocal hepatic necrosis (C).

#### Pathogenesis and Pathology {#s0280}

Following a 7- to 10-day incubation period, viral infection causes a disseminated necrotizing process involving the skin, oral mucosa, and numerous parenchymal organs. In sections of skin and mucosa, intraepithelial vesicles progress to full-thickness epidermal necrosis. Within these regions a few viable epithelial cells may remain beneath a mass of degenerate eosinophilic material admixed with pyknotic debris. Sebaceous glands, hair follicles, and apocrine glands are relatively spared. There is mild parakeratosis and intercellular edema within the adjacent epidermis, and scattered multinucleated giant cells may be present, often containing intranuclear viral inclusions. Because of the acutely lethal nature of this process, inflammatory reactions within the dermis may be minimal, consisting only of scattered neutrophils.

Foci of full-thickness necrosis similar to that present within the skin are found in the mucosa of the oral cavity and in the small and large intestine. Large sections of oral mucosa may develop necrotic plaques and slough. Multifocal necrosis is noted in the liver, spleen, lung, kidney, and adrenal gland. Hepatic lesions occur multifocally and randomly and are composed of acute hepatocellular necrosis ranging in size from small clusters of two to five cells to large coalescent foci 2--3 mm in diameter. Large numbers of Cowdry-type A intranuclear inclusions may be present in these regions. If present, encephalitis is minimal. The lesions are essentially identical to herpes simplex infection in these species, and viral isolation or molecular techniques are required to distinguish them.

#### Clinical Findings {#s0285}

In carrier species, infection is usually not associated with clinical signs and only rarely are oral vesicles and ulcers present ([@bib370]). In susceptible species (tamarins, owl monkeys, and marmosets), inadvertent infection results in an epizootic of high mortality with variable oral, labial, and dermal lesions. Clinical signs include pruritus, anorexia, and depression. Progression to death occurs within 24--48 h.

#### Treatment and Prevention {#s0290}

Contact between susceptible and carrier species should be prevented. A live vaccine that reduces natural infection in owl monkeys has been developed; however, infrequent episodes of vaccine-induced disease have occurred, which have been characterized by a rapidly progressive disseminated infection similar to that caused by natural disease ([@bib139]).

#### Zoonotic Potential {#s0295}

There are no published reports of zoonotic transmission. A murine model of SaHV1 infection has been established to study comparative aspects of alphaherpesvirus neuropathogenesis ([@bib78]).

### *Human Herpesvirus 1 and 2:* HHV1 and HHV2, Herpes Simplex Virus 1 and 2 {#s0300}

#### Introduction {#s0305}

*Human herpesvirus 1* (HHV1) is a common infection of humans. Inadvertent infection of gibbons, gorillas, tree shrews (*Tupaia glis*), orangutans*,* and chimpanzees has been described ([@bib672], [@bib189], [@bib469], [@bib448], [@bib470], [@bib367]). In these species, infection usually results in mild, self-limiting oral vesicular lesions. Conversely, infection of New World species, including owl monkeys, callitrichids, and one report in a group of white-faced saki monkeys (*Pithecia pithecia pithecia*), results in a lethal disseminated disease similar to that caused by SaHV1 from which it must be distinguished ([@bib312], [@bib478], [@bib303], [@bib460], [@bib636], [@bib407]). Disseminated disease is also reported secondary to experimental intravaginal inoculation of tamarins (*Saguinus oedipus* and *S*. *fuscicollis*) with HHV2 ([@bib202]). Experimental inoculation of capuchin monkeys produced localized disease ([@bib513], [@bib203]).

#### Etiology {#s0310}

HHV1 and HHV2 are members of the alphaherpesvirus subfamily. HHV1 is most often responsible for oral lesions and encephalitis in adults, whereas HHV2 is responsible for a sexually transmitted disease causing a genital infection in adults and a disseminated infection in infants. Both types are equally pathogenic in New World species and no difference in clinical outcomes has been noted with experimental infections. Serologic evidence of an alphaherpesvirus related to HHV2 has been demonstrated in healthy, free-ranging mountain gorillas (*Gorilla gorilla beringei*) ([@bib178], [@bib174]).

#### Epizootiology {#s0315}

Nonhuman primates are not naturally infected with HHV in the wild and likely acquire the infection through human contact. Once established within New World primate colonies, the virus spreads rapidly and results in high morbidity and mortality ([@bib460], [@bib636], [@bib407]). A natural epizootic in a research colony of gibbons was characterized by a more limited spread ([@bib672]).

#### Pathogenesis and Pathology {#s0320}

The pathogenesis of human herpesviruses in owl monkeys and callitrichids is essentially identical to that caused by SaHV1 with the exception that encephalitis may be a more frequent sequela. A multifocal necrotizing and vesicular dermatitis is often most severe on facial skin and is accompanied by blepharitis and stomatitis. In gibbons, a multifocal acute meningoencephalitis may be evident in the pons and cerebral cortex. These changes may be accompanied by necrosis, reactive gliosis, and typical Cowdry-type A inclusions ([Figure 1.5](#f0030){ref-type="fig"} ).FIGURE 1.5Herpesvirus simplex1 (HSV1).HSV commonly disseminates to the CNS in neotropical primates and may occur without mucosal lesions. Within the CNS multifocal necrotizing encephalitis (A) is characteristic with perivascular infiltrates (insert A left) and intranuclear inclusions (insert A right). Immunohistochemistry often reveals more infected cells than evident with routine stains (B and C).

#### Clinical Findings {#s0325}

In gorillas, chimpanzees, and gibbons, infection is usually self-limiting with clinical signs restricted to vesiculation and ulceration of mucosal surfaces including the oral cavity, genitalia, and conjunctiva. In gibbons, viral encephalitis may occur rarely as a result of recrudescence ([@bib399]). Generalized disease in susceptible species is identical to that induced by SaHV1. Posterior synechia and dyscoria has been reported in owl monkeys with an alphaherpesvirus infection suspected to be HHV due to a history of close human contact ([@bib244]) ([Figure 1.6](#f0035){ref-type="fig"} ).FIGURE 1.6Herpesvirus simplex 1 (HSV1).HSV1 may be transmitted to callitrichids and owl monkeys resulting in a severe disseminated viral infection. Common clinical signs include anisocoria (A), conjunctivitis (B), multifocal hepatic necrosis (C) with hepatocytes containing intranuclear inclusions (D), and stomatitis and glossitis (E and F). Multinucleated viral syncytial cells are often evident within mucosal vesicles (insert F).

#### Treatment and Prevention {#s0330}

Protective clothing and face masks should be worn by animal care personnel. A modified live vaccine was developed and found to be protective in owl monkeys ([@bib138]).

### *Cercopithecine Herpesvirus 9*: SVV, Simian Varicella Virus {#s0335}

#### Introduction {#s0340}

*Cercopithecine herpesvirus 9* (simian varicella virus, SVV) is a member of the Alphaherpesvirinae in the genus *Varicellovirus*. This virus causes a highly contagious infection of a variety of Old World nonhuman primates that can result in significant morbidity and mortality. SVV has a high degree of antigenic relatedness to *human herpesvirus 3* (varicella-zoster virus, VZV), the etiologic agent of chickenpox. The SVV genome is 124 kb in length with 69 open reading frames, each of which shares homology with the corresponding VZV gene for an overall 70--75% homology and collinear arrangement ([@bib776], [@bib253]). Experimental infection with SVV has been used as a surrogate model to investigate aspects of VZV pathogenesis, latency, and therapy.

#### Etiology {#s0345}

Original isolates were named for the facilities in which epizootics occurred and included Liverpool vervet virus, Patas herpesvirus, Medical Lake macaque virus, and Delta herpesvirus. These viruses were found to be antigenically related, and each caused a similar exanthematous viral disease. Subsequent investigation of restriction endonuclease patterns indicated that epizootics were associated with differing species of the same virus ([@bib252]). Infection of African green monkeys, Patas monkeys, pig-tailed macaques, Japanese macaques, cynomolgus macaques, and Formosan rock macaques has been demonstrated. SVV antibodies have also been detected in baboons with a 40% seroprevalence although clinical disease has not been reported in this species (Payton et al., 2004).

A VZV-like herpesvirus has been isolated from chimpanzees, gorillas, and orangutans with mild, self-limiting vesicular dermatitides ([@bib280], [@bib468], [@bib775], [@bib512]). Antigenically, this virus is more closely related to VZV than to SVV ([@bib270]). Although not definitively confirmed with genomic sequencing, restriction endonuclease examination of viral DNA from one case suggests identity to VZV ([@bib512]).

#### Epizootiology {#s0350}

Between 1966 and 1970, epizootics of SVV occurred at the Liverpool School of Tropical Medicine in African green monkeys (Liverpool vervet virus), at the Delta Regional Primate Research Center in Patas monkeys (Delta herpesvirus), and at the Medical Lake field station of the Washington Regional Primate Research Center in cynomolgus, Japanese, and pig-tailed macaques (Medical Lake macaque virus) ([@bib124], [@bib60], [@bib204], [@bib769]). The epizootiology and origin of these early outbreaks is poorly understood. In several instances they occurred in recently imported animals. Serologic evidence suggests that the Medical Lake macaque virus originated in Malaysia. Transmission from an unidentified reservoir host to aberrant primate hosts may be one factor related to the establishment of epizootics. The natural host of SVV has not been identified. Because disease is less severe in Asian macaque species and neutralizing antibodies have been detected in asymptomatic stump-tailed macaques, it is possible that macaque species may play a role in transmitting the virus to more susceptible species. Reactivation from a latent carrier state also plays an important role in transmission of the virus ([@bib678], [@bib437]). Recent cases of SVV in animals undergoing total body irradiation or other forms of experimental immunosuppression are thought to be associated with recrudescence in clinically affected animals or their contacts ([@bib379], [@bib635], [@bib305]). Reactivation may also occur secondary to stress of shipment or movement within a facility**.** Once established within a colony, the virus may spread rapidly via the respiratory route. Transmission via direct contact with skin lesions is also possible.

#### Clinical Findings {#s0355}

Clinical signs recorded in natural outbreaks and in experimental disease are similar, varying only in the extent of lesions and associated mortality. The disease in macaques may be slightly less severe than in African green monkeys and Patas monkeys. The clinical course in natural outbreaks is characterized by the eruption of a disseminated, hemorrhagic vesicular exanthema accompanied by fever and, in severe cases, progression to pneumonia and hepatitis. Vesicular eruption is often observed first in the inguinal region and spares the palms and soles. Animals may demonstrate spontaneous resolution of disease or a subclinical course while, in other instances, the case fatality rate may be high. The incubation period is 7--14 days ([Figure 1.7](#f0040){ref-type="fig"} ).FIGURE 1.7Simian varicella virus (SVV).SVV causes a cutaneous exanthema characterized by vesicles (A and B) which may appear hemorrhagic (left insert A) and be associated with a necrotizing vasculitis (A insert right). Intranuclear inclusions and multinucleated syncytial cells (B insert). The disease may disseminate causing widespread lymphoid necrosis in spleen (C) and lymph nodes as well as multifocal hepatic necrosis (D). Intranuclear inclusions are often found along the margins of necrosis (insert D).

#### Pathogenesis and Pathology {#s0360}

Experimental infections of African green monkeys have provided insight into disease progression ([@bib597], [@bib169], [@bib250], [@bib251]). A transient viremia occurs by day 3 post-inoculation with cell-associated virus likely transported in B and T cells ([@bib777], [@bib250]). A vesicular dermatitis appears by day 10 post-inoculation and is often hemorrhagic in appearance. Lesions progress from papule to vesicle to crust and appear as successive crops such that lesions of all stages may be present. Cutaneous lesions are characterized histologically by the formation of multiple vesicles within the epidermis that contain cell debris, erythrocytes, and rarely syncytial cells. Hyperplasia of the basal cell layer is associated with these vesicles. Characteristic eosinophilic, Cowdry-type A, intranuclear inclusions may be found in cells adjacent to the vesicle. A necrotizing vasculitis often exists within the subjacent dermis with viral inclusions evident in endothelial and adjacent cells.

Viral antigen is found widely disseminated by 8 days and may be localized in the liver, lungs, spleen, adrenal gland, kidney, lymph node, skin, and trigeminal ganglion. Within the liver, there is multifocal to coalescing hepatocellular necrosis. Cowdry-type A inclusions may be found within hepatocytes bordering foci of necrosis. Similar necrotizing lesions may be found in the lung and throughout the gastrointestinal tract. Hepatic and pulmonary lesions may be the most severe lesions in affected animals. Neuropathological changes are not associated with SVV infections. Latency is established within neural ganglia. Competing hypotheses suggest hematogenous versus transaxonal transport to ganglia ([@bib438], [@bib359]). Investigation of genomic transcription during latency has gathered much interest and is thought to have some similarity to VZV ([@bib543], [@bib482]).

#### Laboratory Findings {#s0365}

Following experimental inoculation, there is marked neutrophilic leukocytosis accompanied by a decrease in platelet numbers, and elevations in alanine aminotransferase, aspartate aminotransferase, and blood urea nitrogen (BUN) levels.

#### Treatment {#s0370}

Treatment has not been attempted in natural outbreaks. Acyclovir and interferon have shown some efficacy in experimental models ([@bib24], [@bib676]). Because SVV is less sensitive to acyclovir, higher doses may be required ([@bib568], [@bib649]). Identification of latently infected monkeys and strict species separation may prevent epizootics. Immunization with VZV has been shown to be protective in experimental infections ([@bib205], [@bib677]).

#### Zoonotic Potential {#s0375}

Transmission of SVV to human beings has not been documented.

Betaherpesvirinae {#s0380}
-----------------

### Cytomegalovirus {#s0385}

#### Introduction {#s0390}

Cytomegalovirus (CMV) is a common asymptomatic infection of humans and many nonhuman primates. The rhesus cytomegalovirus (RhCMV), recently renamed *Macacine herpesvirus 3*, is the most thoroughly characterized of the simian cytomegaloviruses. In addition to a variety of macaque species, CMV infection has been demonstrated in capuchin monkeys, woolly monkeys, squirrel monkeys, chimpanzees, baboons, drill monkeys (*Mandrillus leucophaeus*), saddleback tamarins (*Saguinus fuscicollis*), and African green monkeys ([@bib519], [@bib572], [@bib65], [@bib64];)*.* A notable exception is the Gibraltar population of Barbary macaques (*M. sylvanus*) which shows no evidence of CMV infection based on serosurvey ([@bib190]). Viruses within this group are generally believed to have a narrow host range although interspecies transmission does occur. Current names of ICTV classified simian cytomegaloviruses are presented in [Table 1.2](#t0015){ref-type="table"}.

#### Etiology {#s0395}

Cytomegaloviruses resemble other herpesviruses ultrastructurally, but differ from alphaherpesviruses in several aspects. They are slowly cytolytic and tend to cause enlargement of the nucleus and cytoplasm (cytomegaly) of infected cells both in vivo and in vitro. During viral replication, enveloped virions accumulate in large cytoplasmic vacuoles instead of being readily released into intercellular spaces. This feature accounts for their relative cell-associated nature and explains the fact that cytoplasmic inclusion bodies can also be found in infected cells. Unlike many of the cytolytic herpesviruses, cytomegaloviruses also tend to be restricted in terms of their host range with each viral species thought to have coevolved with its host. Finally, latent infections tend to persist in glandular tissue, lymphoreticular cells, and kidneys rather than in neurons.

The RhCMV genome is 221 kb in length and contains approximately 230 open reading frames ([@bib268]). The virus encodes a variety of proteins important for immune evasion including peptides that prevent host MHC-1 expression and a viral homolog of IL-10 that may limit inflammatory responses ([@bib681], [@bib566]).

#### Epizootiology {#s0400}

Cytomegalovirus infection is common with seroprevalence in adult macaques approaching 100% in most colonies. Infection is usually not associated with disease. The virus is spread horizontally in a variety of body secretions, including saliva, blood, urine, milk, and semen ([@bib25]). In contrast to herpes B, virus may be shed for extended periods and can be detected in a large number of animals at any given time ([@bib304]). Macaques become infected within the first year of life ([@bib755]). Prior immunity also does not prevent re-infection, and animals can be infected with multiple genetic variants. For instance, rhesus macaques naturally infected with RhCMV are susceptible to infection by an antigenically distinct African green monkey CMV and commonly become infected with both strains during captivity ([@bib699]).

#### Clinical Findings {#s0405}

Infection of immunocompetent animals is usually asymptomatic although a transient leukocytosis has been demonstrated in healthy animals following experimental infections ([@bib431]). Immunosuppressed animals may experience reactivation, dissemination of the virus, and evidence of disease. In these individuals, clinical signs relate to the anatomic site(s) involved and may include dyspnea, diarrhea, melena, and neurologic signs.

#### Pathogenesis and Pathology {#s0410}

Cytomegalovirus persists as a latent infection and may periodically be shed in body secretions. In immunosuppressed macaques, reactivation of the virus may be associated with disseminated lesions in the brain, lymph nodes, liver, spleen, kidney, small intestine, nervous system, and arteries. Disseminated CMV may be initiated by a variety of immunosuppressive events, including viral infection (SIV or type D retrovirus) and drug therapy (cyclophosphamide, cortisone, and antithymocyte globulin).

In SIV-infected macaques, reactivation typically occurs as a terminal opportunistic infection associated with suppression of both humoral and cellular CMV-specific immune responses ([@bib353], [@bib354]). Disease is manifest by a necrotizing enteritis, encephalitis, lymphadenitis, and/or pneumonitis ([@bib36]). Pulmonary lesions are common and consist of a multifocal to coalescent interstitial pneumonia. The alveolar septa are thickened and lined by hypertrophied type II pneumocytes. Alveolar spaces contain fibrin, alveolar macrophages, and neutrophils. Cytomegaly and large, intranuclear Cowdry-type A inclusion bodies may be evident in alveolar septa and septal lining cells. Similar lesions may be found in the liver, spleen, kidney, and testes. In situ hybridization often reveals many more cells to be infected than would be anticipated on routine stains and may be useful for diagnosis when only equivocal changes (i.e., mild cytomegaly) are present. Smaller amphophilic, intracytoplasmic inclusions are less frequent.

Central nervous system (CNS) lesions are multifocal, involve primarily the leptomeninges and subjacent neuropil, and are characterized by neutrophilic infiltrates with necrosis and fibrinous exudates. These findings are accompanied by characteristic viral inclusions and often by a nonsuppurative, perivascular meningoencephalitis. In the gastrointestinal tract, hemorrhage, particularly neutrophilic infiltrates, may be prominent. In all locations, these findings may be accompanied by a necrotizing and proliferative vasculitis. The pathogenesis of CMV infection in SIV-inoculated macaques shares many similarities with the disease in human patients with AIDS.

Intrauterine CMV infection of the human fetus may occur if primary infection of the mother coincides with pregnancy. This is most frequently observed when maternal infection coincides with conception or occurs during first trimester. In contrast, vertical transmission of CMV has not been demonstrated in the rhesus macaque ([@bib801]). The high prevalence of exposure and preexisting immunity in animals of breeding age likely contributes to the lack of congenital infection in this species. Intrauterine infection has been reproduced experimentally in rhesus macaques and squirrel monkeys ([@bib433], [@bib537], [@bib33]).

Association between CMV and accelerated graft vs. host rejection of heart and kidney transplants in humans is well established ([@bib694]). More controversial is the role of the virus in producing arteriosclerosis in the human population at large ([@bib686]). Long-standing immune upregulation associated with persistent CMV infection is also thought to contribute to immune senescence in aging populations ([@bib377]) ([Figure 1.8](#f0045){ref-type="fig"} ).FIGURE 1.8Cytomegalovirus (CMV).Histologically CMV produces both intranuclear and intracytoplasmic inclusions accompanied by neutrophilic infiltrates (A and B). The virus may target multiple sites including the lung, gastrointestinal tract, vessels, lymphoid tissue, central nervous system and peripheral nervous system (PNS). Targeting of nerves in the PNS (D, lingual nerve) may be associated with necrosis of the overlying epithelium (C, tongue). Viral antigen may be demonstrated in infected cells with immunohistochemistry (E).

#### Treatment {#s0415}

Certain immunosuppressive regimens are associated with reactivation of latent CMV and must be coupled with prophylactic therapy to prevent severe and often fatal disease. CMV is susceptible to ganciclovir, foscarnet, and benzimidazole nucleosides ([@bib523], [@bib801]). Strategies for derivation of RhCMV and baboon CMV SPF breeding colonies have been published ([@bib785], [@bib34]).

#### Zoonotic Potential {#s0420}

NHP and human CMV genomes are similar in size and organization, however disease associated with simian CMV infection of humans has not been reported. Transient detection of baboon CMV has been reported in a human xenograft recipient ([@bib485]).

Gammaherpesvirinae {#s0425}
------------------

### *Macacine Herpesvirus 4*: RhLCV, Rhesus Lymphocryptovirus {#s0430}

#### Introduction {#s0435}

*Macacine herpesvirus 4* (rhesus lymphocryptovirus, RhLCV) is a member of the *Lymphocryptovirus* genus. This genus contains more than 50 distinct simian lymphocryptoviruses isolated from a host of Old World and New World primate species suggesting significant co-speciation ([@bib183]). Most of these viral species have not been formally recognized by the ICTV and are catalogued in a recent publication by Lacoste and colleagues ([@bib394]). Viruses recognized by the ICTV include those of chimpanzees, orangutans, gorillas, baboons, macaques, African green monkeys, and marmosets ([Table 1.2](#t0015){ref-type="table"}) ([@bib418], [@bib198], [@bib236], [@bib235], [@bib569], [@bib553]). *Human herpesvirus 4* (Epstein-Barr virus, EBV) is the type species in the genus. In humans, infection with EBV is usually asymptomatic but may cause infectious mononucleosis when primary infections occur after puberty. This illness is characterized by lymphadenopathy, fever, pharyngitis, and circulating atypical lymphocytes in adolescents and young adults. EBV has been associated with Burkitt's lymphoma, hemophagocytic syndrome, T cell lymphomas, and nasopharyngeal carcinoma in immunocompetent persons and oral hairy leukoplakia, non-Hodgkins lymphoma, and post-transplantation lymphoproliferative disorders in immunocompromised patients.

#### Etiology {#s0440}

Lymphocryptoviruses have a complex genome consisting of approximately 170 kb. The RhLCV genome has been completely sequenced and contains 80 open reading frames, an identical repertoire of lytic and latent genes found in EBV, and an overall nucleotide sequence homology to EBV of approximately 65% ([@bib596]). While the lytic genes are well conserved, the latent genes demonstrate a modest homology of 27--50% with the corresponding EBV genes. Despite this, the genes maintain remarkable similarity of function. Like EBV, two distinct lineages of RhLCV (RhLCV1 and RhLCV2) have been identified based on significant genomic heterogeneity of the EBNA genes ([@bib116]). Each of the variants is isolated with similar frequencies, and animals may harbor both simultaneously. Lineage specific pathology has not been recognized.

#### Epizootiology {#s0445}

Epizootiology in Old World primates closely parallels that in human populations. Infection occurs primarily in the young through contact with infected oral secretions and is usually not associated with clinical signs. Maternal immunity disappears at approximately 4--6 months of age after which juvenile macaques seroconvert at 6--12 months of age. By 2 years of age virtually all animals harbor the virus ([@bib224]). The nearly 100% prevalence in macaque colonies reflects the 85--95% prevalence of EBV in humans. The virus infects B lymphocytes and persists for life, usually in a latent form. Critical to the regulation of the latent state is the expression of EBV-encoded RNAs (EBER-1, and -2, EBERs), EBV-encoded nuclear antigens (EBNA-1, -2, -3a, -3b, -3c, and -LP), and latent membrane proteins (LMP 1, -2a, and -2b). Reactivation and transition to a lytic cycle of viral replication occurs periodically during which animals may shed virus.

#### Pathogenesis and Pathology {#s0450}

Lymphocryptovirus infection of Old World species is common and usually not associated with disease. Following experimental RhLCV infection macaques demonstrate a self-limiting lymphadenopathy and atypical lymphocytosis characterized by activated B lymphocytes ([@bib494]). These animals resolve the acute viremia, seroconvert within 45--60 days, and remain persistently seropositive. In contrast, SIV-inoculated animals with simian AIDS fail to develop a RhLCV-specific humoral response and demonstrate greater RhLCV viral loads indicating the importance of the CD4+ T cell response to control of acute viremia ([@bib594]).

RhLCV has been associated with proliferative squamous epithelial lesions resembling oral hairy leukoplakia in SIV-inoculated rhesus macaques succumbing to AIDS ([@bib41], [@bib388]). Lesions occur on the tongue, esophagus, penis, hand, and thorax and are usually not visible grossly. Histologically, focal regions of hyperkeratotic parakeratosis with or without acanthosis or pseudoepitheliomatous hyperplasia are noted. Epithelial cells demonstrate ballooning degeneration. Basophilic intranuclear viral inclusions are present in most cases and are composed of typical herpesvirus virions as observed by electron microscopy. Detection of the small viral capsid antigen (sVCA) and BZLF1 protein suggests an active lytic infection.

Development of RhLCV-associated non-Hodgkin lymphomas (NHL) in SIV-inoculated macaques has also been described ([@bib38], [@bib62], [@bib450]). The disease course and pathologic characteristics parallel those observed in HIV-infected persons in whom the development of NHL represents an AIDS-defining illness. SIV-infected rhesus macaques have an incidence of NHL ranging from 4--19% while SIV-infected cynomologus macaques have an incidence of up to 40% ([@bib584], [@bib261], [@bib461]). Lymphocryptovirus transcripts are frequently detected in tumor cells while SIV transcripts or proteins are not. These neoplasms usually develop in extranodal locations including the nasal cavity, periorbital tissues, gastrointestinal tract, urogenital tract, myocardium, and central nervous system and are classified as centroblastic, immunoblastic, large cell, or Burkitt-like lymphomas ([@bib38]). Tumors are comprised of clonal expansions of CD-20-positive B cells and express a full spectrum of latent gene products ([@bib62]). While NHL typically develops in conjunction with progression to AIDS/SAIDS, T cell depletion is not sufficient for pathogenesis ([@bib594]). The ability of lymphocryptoviruses to immortalize B cells may allow for increased risk of mutation and subsequent lymphomagenesis. Variable expression of the oncogenes *p53*, *p21*, *cMyc*, and *bcl2* in neoplastic tissue has been described ([@bib343]). There is one report of a mycosis fungoides-like cutaneous T cell lymphoma consisting of CD3--/CD8+ lymphocyte and characteristic Pautier microabcesses in a pig-tailed macaque. The lymphocryptovirus isolated from tumor material was designated as Macaca nemistrina herpesvirus (MneLCV1) and appears to have a unique T cell tropism ([@bib593]).

A B cell lymphoproliferative disorder has also been observed in association with latent lymphocryptovirus infection in macaques assigned to solid organ transplantation protocols ([@bib634]). This post-transplant lymphoproliferative disorder (PTLD) reflects the condition observed in human transplant patients. An atypical and polymorphic lymphocyte population consisting of EBER-positive CD20+ B cells infiltrates lymph nodes and effaces normal architecture. Cell populations may also be observed in extranodal sites including the liver, lung, heart, spleen, and renal allograft or native kidney.

Diagnosis of RhLCV may be accomplished via a number of techniques. Antibody detection of sVCA by ELISA allows demonstration of seropositivity while PCR detection of EBERs in peripheral blood cells demonstrates persistent infection. Immunohistochemistry utilizing cross-reactive antibodies directed at EBV proteins including the lytic protein BZLF, sVCA, and EBNA-2 allows detection of viral infection in nonhuman primate tissue. In situ hybridization using an RNA probe directed against RhLCV EBER is an additional technique that has increased sensitivity for detection ([@bib93]) ([Figure 1.9](#f0050){ref-type="fig"} ).FIGURE 1.9Lymphocryptovirus (LCV).LCV is a gammaherpesvirus that may cause epithelial or lymphoproliferative disorders in immunocompromised hosts. Leukoplakia (A) is an epithelial proliferative disorder that may be observed in the oral, esophageal or genital mucosa as well as the haired skin. It is characterized by multifocal epithelial cell hyperplasia with hydropic degeneration. Intranuclear inclusions are evident and the virus may be demonstrated by immunohistochemistry for the latent antigen EBNA2 (B) or lytic antigen BZLF1. Post transplantation lymphoproliferative disorder (PTLD) is seen in animals on immunosuppressive therapy and is often extranodal invading sites such as the liver (C). Neoplastic cells first appear in the hepatic sinusoids (D) and are EBNA2-positive (E).

#### Zoonotic Potential {#s0455}

Infection of humans with simian EBV-like agents has not been reported. Due to many strong similarities, the RhLCV-infected macaque has been proposed as a model to examine aspects of EBV transmission, pathogenesis, and prevention. In support of this model a number of institutions have developed SPF macaque populations that have excluded this virus ([@bib93]).

### *Callitrichine Herpesvirus 3*: CalHV3, Marmoset Lymphocryptovirus {#s0460}

Many early reports suggest that lymphocryptoviruses have a host spectrum restricted to Old World primates and humans. In 2000, an investigation of B cell lymphomas observed in common marmosets housed at the Wisconsin National Primate Research Center led to the discovery of *Callitrichine herpesvirus 3* (CalHV3) ([@bib571]). Marmosets demonstrated weight loss, anorexia, diarrhea, and palpable enlargement of mesenteric lymph nodes. Histologically, the masses were comprised of sheets of CD20+ neoplastic round cells effacing lymph node architecture and infiltrating the large and small intestine, liver, kidney, and lung. CalHV3 was detected in tumor material and circulating peripheral blood mononuclear cells using molecular techniques. The virus was subsequently isolated ([@bib115]). Seroprevalence of CalHV3 in wild-caught and captive marmosets from various colonies ranges from 35--65% ([@bib215]). Despite similar levels of seroprevalence, not all colonies observe a high frequency of B cell lymphomagenesis suggesting that additional factors are involved in the pathogenesis. Infection in the majority of marmosets is asymptomatic.

The CalHV3 genome has been completely sequenced and demonstrates an overall homology with the EBV genome of 43% ([@bib595]). The genome contains at least seven open reading frames with no homology to known viral or cellular genes ([@bib595], [@bib215]). These genes appear to be precursors to EBV latency genes due to their similar position within the genome and predicted protein structure. The CalHV3 genome is also missing 14 genes found in EBV and RhLCV. The absence of these genes may contribute to inefficient viral transmission and the lower seroprevalence of CalHV3 observed in marmoset colonies. These genetic differences suggest that CalHV3 may be more closely related to a primitive lymphocryptovirus from which it, EBV, and the other the Old World lymphocryptoviruses evolved ([@bib595], [@bib215], [@bib394]). Lymphocryptoviruses have since been detected in various New World primate species including the squirrel monkey, white-faced saki, white-fronted capuchin (*Cebus albifrons*), black spider monkey (*Ateles paniscus*), golden handed tamarin (*Saguinus midas*), and black-pencilled marmoset (*C. pencillata*) ([@bib115], [@bib149], [@bib182]).

### *Human Herpesvirus 4*: EBV, Epstein-Barr Virus {#s0465}

Because EBV is the first identified human virus to demonstrate oncogenic properties there has been much interest in developing animal models with which to study aspects of pathogenesis including mechanisms of lymphogenesis and latency programs. In addition to the natural model of RhLCV infection in macaques, a number of induced models have been described in the literature. Rhesus macaques seronegative to RhLCV are susceptible to experimental inoculation with EBV and develop a resolving atypical lymphcytosis and lymphadenopathy. Cotton-top tamarins are susceptible to experimental infection with human EBV and develop malignant B-cell lymphomas ([@bib647], [@bib486], [@bib517]). Common marmosets develop an antibody response and persistent infection but do not consistently develop lymphoma ([@bib188]). Macaques coinfected with SIV and EBV have been proposed as a model of AIDS-associated Burkitt's lymphoma ([@bib201]).

### *Macacine Herpevirus 5*: RRV, Rhesus Rhadinovirus {#s0470}

#### Introduction {#s0475}

*Macacine herpesvirus 5* (Rhesus Rhadinovirus, RRV) is a member of the *Rhadinovirus* genus. Species in this genus are closely related to Kaposi's sarcoma herpesvirus (KSHV, *human herpesvirus 8*). Rhadinoviruses are thought to be species specific and have been reported in rhesus and other macaque species as well as in African green monkeys, baboons, mandrills, drills, gibbons, chimpanzees, and gorillas ([@bib256], [@bib257], [@bib395], [@bib397], [@bib396], [@bib772], [@bib172], [@bib82]). Rhadinoviruses are also well characterized in spider monkeys and squirrel monkeys. The ICTV-recognized Rhadinovirus species are presented in [Table 1.2](#t0015){ref-type="table"}, and additional identified species are cataloged elsewhere ([@bib394]). Members of this genus are classified into two distinct lineages; the Rhadinovirus-1 lineage containing KSHV and the primate Retroperitoneal Fibromatosis Herpesvirus (RFHV) and the Rhadinovirus-2 lineage which includes rhesus Rhadinovirus (RRV) ([@bib157], [@bib606], [@bib639]). The RV-1 lineage will be discussed separately below.

#### Etiology {#s0480}

RRV isolates were identified independently at the New England (strain H26-95) and Oregon (strain 17795) primate research centers ([@bib157], [@bib789]). Closely related viruses have been recognized in cynomolgus (CRV) and pig-tailed (PRV) macaques. The RRV genome is 130 kb in length and encodes 84 open reading frames ([@bib9], [@bib641]). The genome is collinear with the KSHV genome and most KSHV open reading frames have representative homologs in the RRV genome, and vice versa ([@bib394]). Rhadinoviruses, including RRV, encode several homologs of cellular cytokines including a viral IL-6 that has proinflammatory activity and may contribute to pathogenesis ([@bib345]). The ORF73 gene encodes the latency-associated nuclear antigen (LANA) which is essential for maintaining the viral DNA episome tethered to mitotic host cell chromosomes, allowing the virus to cosegregate with daughter cells during cell division ([@bib768]). This protein is also thought to suppress lytic viral replication ([@bib158]).

#### Epizootiology {#s0485}

Transmission likely occurs via oral secretions. Seropositivity rates for RRV approach 90% by 1 year of age and 98% by 2 years of age ([@bib157]). RRV-like sequences have been identified in recently imported Indonesian macaques suggesting that the virus circulates in wild populations as well ([@bib693]). Seroconversion can readily be detected by ELISA, and PCR can be performed on blood and tissue specimens. These viruses demonstrate two phases of infection; a latent or non-productive phase and a lytic or productive phase. RRV demonstrates a tropism for CD20+ B-lymphocytes with these cells likely serving as the primary site of RRV latency ([@bib51]). While animals may cycle between both phases of infection, natural infections are generally asymptomatic. The factors associated with a change from latent infection to reactivation remain unclear.

#### Clinical Findings {#s0490}

RRV infections are generally asymptomatic. Experimental RRV inoculation of immunocompetent animals produced a mild febrile response, antibody production, mild B cell lymphocytosis, and self-limiting peripheral lymphadenopathy ([@bib447]). In contrast, animals coinfected with SIV developed a marked B cell lymphocytosis with an activated phenotype. Virus-specific antibody responses to both RRV and SIV were attenuated ([@bib789]).

#### Pathogenesis and Pathology {#s0495}

Experimental RRV inoculation has been associated with a lymphoproliferative disorder with characteristics resembling multicentric Castleman's disease (MCD) ([@bib447]). Depending on the strain, lesions may resemble either the hyaline vascular variant or the plasma cell variant of MCD. In the hyaline vascular variant, changes in lymph nodes are initially characterized by paracortical lymphocytic hyperplasia and a vascular proliferation characterized by hypertrophied and hyperplastic endothelial cells. Upon regression of lymphadenopathy, lymph nodes acquire features typical of MCD including hyalinized follicles surrounded by layers of loosely concentric lymphocytes. The plasma cell variant is characterized by infiltration of lymphoid tissue with sheets of CD20+ B-lymphocytes. There is one report in the literature demonstrating an association between RRV and NHL in SIV-inoculated macaques ([@bib538]).

#### Zoonotic Potential {#s0500}

While the level of zoonotic risk is thought to be low, RRV is closely related to KSHV, the causative agent of Kaposi's sarcoma. Kaposi's sarcoma is a highly vascularized neoplasm derived from cells of endothelial origin that is diagnosed in both immunocompetent and immunocompromised individuals. KSHV is also involved in the pathogenesis of the lymphoproliferative disorders multicentric Castleman's disease and pleural effusion lymphoma seen most commonly in AIDS patients. The ability to readily propagate RRV in culture enables its use as a model for the study of the transcription, virus structure and assembly, and protein interactions of gammaherpesviruses. Recapitulation of aspects of human disease upon inoculation of macaques makes RRV a suitable in vivo model for the study of KSHV pathogenesis.

### Retroperitoneal Fibromatosis Herpesvirus: RFHV {#s0505}

#### Etiology {#s0510}

RFHV was identified in 1997 in rhesus (RFHVmmu) and pig-tailed (RFHVmne) macaque retroperitoneal fibromatosis (RF) specimens using degenerate PCR primers directed at the herpesviral DNA polymerase gene ([@bib606]). While the virus has been difficult to isolate and propagate in culture, investigators have been able to sequence 7.7 kb of the viral genome ([@bib605]). This virus has a high degree of colinearity and sequence homology (\~85%) with KSHV, placing it in the RV1 lineage. Additional members of the RV1 lineage have been identified in a number of Old World primates and apes ([@bib394]).

#### Epizootiology {#s0515}

To date serologic assays have not been developed, limiting epidemiologic investigations of the prevalence of this virus in macaque colonies. PCR analysis of blood samples can be performed and has allowed determination of a 44% prevalence of infection in one large macaque breeding colony ([@bib774]). Interestingly, RFHV was only detected in animals co-infected with RRV in this colony.

#### Pathogenesis and Pathology {#s0520}

Retroperitoneal fibromatosis is a multinodular to coalescent infiltrative process originating from the ileocecal junction and involving the root of the mesentery, mesenteric lymph nodes, and gastrointestinal tract. Prior to the identification of RFHV, RF was most frequently associated with Simian Retrovirus 2 (SRV2). While the detection of RFHV sequences is most often observed in SRV2 co-infected macaques, there are limited reports of SRV-negative/SIV-positive RFHV-associated mesenchymoproliferative lesions ([@bib55], [@bib81]). The RF lesion rarely infiltrates parenchymal organs but may produce small nodules or plaques disseminated across mesothelial surfaces. In severe cases, the entire gastrointestinal tract may be encased in a large fibrotic mass. Sclerotic and proliferative patterns of fibromatosis have been recognized and may coexist within the same animal. Histologically, the proliferative lesion is composed of spindle-shaped cells arranged in intersecting fascicles that infiltrate along serosal surfaces and surround normal structures. IHC using a cross-reactive anti-HHV8 LANA antibody demonstrates immunoreactivity within nuclei and large numbers of RFHV-infected cells in RF tissue ([@bib81], [@bib86]). A variable lymphoplasmacytic inflammatory reaction is usually present. The tissue is highly vascular and cells are embedded within a stromal network composed of collagen and reticulin. Absence of nuclear anaplasia and mitotic figures distinguish the lesion from fibrosarcoma. These cells are vimentin, desmin, and smooth muscle α-actin-positive and reveal variable positivity for the factor VIII-related antigen ([@bib730]). An origin from vascular smooth muscle (pericyte) is favored. RF lesions have not been recognized in all large macaque colonies suggesting that RFHV is required but not sufficient for RF pathogenesis and that additional cofactors are required. Recognition of RF cases has declined in recent years and may be associated with elimination of SRV2 from SPF colonies ([Figure 1.10](#f0055){ref-type="fig"} ).FIGURE 1.10Retroperitoneal fibromatosis-associated herpesvirus (RFHV).RFHV is a gammaherpesvirus that has been associated with mesenchymal proliferative disorders including retroperitoneal fibromatosis (RF) (A and insert), subcutaneous fibromatosis and intestinal stroma cell tumors. RF is found in association with simian retrovirus type 2 and often originates near the ileal--cecal lymph node and colonic mesentery (B). It is composed of pleomorphic spindle cells (C) and RFHV LANA can be identified by immunohistochemistry showing a characteristic punctuate staining pattern (D).

#### Zoonotic Potential {#s0525}

There are similarities in the histologic appearance and pathogenesis of RF and Kaposi's sarcoma lesions suggesting that RFHV may be a model system with which to study aspects of pathogenesis. The inability to propagate the virus in culture limits the utility of such a model. There is no known zoonotic risk associated with RFHV.

### *Ateline Herpesvirus 2 and 3* and *Saimiriine Herpesvirus 2* {#s0530}

#### Introduction {#s0535}

*Saimiriine herpesvirus 2* (Herpesvirus saimiri, HVS) and *Ateline herpesviruses 2* and *3* (AtHV; AtHV2, AtHV3) are members of the Gammaherpesvirinae subfamily and the genus *Rhadinovirus*. Although a common asymptomatic infection of their natural hosts, inoculation of other species of primates results in the rapid development of malignant lymphoma or leukemia. Evidence of the ability of these viruses to induce disease in naturally infected hosts is more limited ([@bib311]).

#### Etiology {#s0540}

Like other Rhadinoviruses, HVS is an enveloped, double-stranded DNA virus with a 155-kb genome having approximately 75 open reading frames ([@bib6], [@bib192]). The genes encoding the "saimiri transformation-associated protein" (STP) and the "tyrosine kinase interacting protein" (Tip) have been extensively studied due to their roles in oncogenicity and cell transformation ([@bib341], [@bib339]).

#### Epizootiology {#s0545}

A large percentage of wild squirrel monkeys are infected with HVS and nearly all animals are seropositive by 1.5--2 years of age. Likewise, approximately 50% of spider monkeys are seropositive for AtHV strains. Although squirrel and spider monkeys represent the natural reservoir host for their respective viruses, little is known about the natural history and epidemiologic factors that govern transmission in these species.

#### Clinical Findings {#s0550}

Infection of the natural host is not associated with clinical signs. Experimental inoculation of HVS into owl monkeys, several species of tamarins and marmosets (*Saguinus oedipus, S*. *fuscicollis, S*. *nigricollis, S*. *mystax,* and *Callithrix jacchus*), howler monkeys (*Alouatta caraya*), and spider monkeys results in lymphoma or lymphocytic leukemia. Following inoculation, the time to development of lymphoma is variable but may be as short as 3 weeks. Generally one of three patterns occurs: (1) survival less than 40 days with development of disseminated lymphoma often associated with extensive necrosis and replacement of vital organs; (2) survival from 50--150 days with a less aggressive form of lymphocytic lymphoma involving multiple organs and associated with lymphocytic leukemia; and (3) survival over 150 days with localized, well-differentiated lymphocytic lymphoma. Limited studies indicate that certain HVS strains may be oncogenic in African green monkeys and macaques ([@bib479], [@bib375]).

Experimental inoculation of AtHV into tamarins, marmosets, and owl monkeys induces lymphoma and leukemia. Although the virus has not been studied as extensively, the oncogenic properties of AtHV are similar to HVS.

#### Pathogenesis and Pathology {#s0555}

Microscopically, cells comprising the neoplastic infiltrate vary considerably in their degree of differentiation. In the most aggressive form the neoplastic cells are large, pleomorphic, and resemble reticulum cells or histiocytes. Many are polygonal to stellate and have a moderate amount of granular cytoplasm. In less aggressive forms the cells are more differentiated, resembling lymphocytes. Neoplastic cells are polyclonal and are of T lymphocyte origin. Ultrastructurally, bizarre convoluted nuclei are seen and viral particles are not visible. Virus may be recovered in cell culture from tumor explants.

Three different subtypes of HVS are recognized (A, B, and C) based on homology within the left end of the L-DNA ([@bib342]). A and C types are highly oncogenic and transform peripheral blood lymphocytes of the common marmoset in vitro. The STP is encoded in the left terminus of the L-DNA of A and C strains and confers oncogenicity on individual isolates ([@bib340], [@bib341]). It does not share sequence homology with other known viral oncogenes or cellular protooncogenes.

#### Treatment and Prevention {#s0560}

Natural infection of callitrichids with HVS has been reported infrequently. Exposure to tissue or blood products is probably necessary to produce infection in the inappropriate host.

#### Zoonotic Potential {#s0565}

HVS induces malignant lymphoma when inoculated into a variety of New World primate species and rabbits ([@bib479]). Its oncogenicity in other species has not been fully explored. HVS will infect and transform human T lymphocytes in vitro. These T cells have a mature, activated phenotype and maintain the antigen-specific reactivity of the parental cell. The transformed cells have cytotoxic capabilities and can continue to provide B cell help. Due to these capabilities, HVS transformed T cell lines have been investigated as a potential means to confer adoptive T-cell-mediated immunotherapy targeting diseases such as HIV/AIDS ([@bib477], [@bib386]). The ability of HVS to persist as a high copy number episome and provide sustained gene expression has also prompted study of the virus as a potential gene vector ([@bib259]).

Hepadnaviridae {#s0570}
--------------

### Hepatitis B Virus {#s0575}

#### Introduction {#s0580}

Hepadnavirus B (hepatitis B virus, HBV) belongs to the genus *Orthohepadnavirus* of the family *Hepadnaviridae* and is an important cause of viral hepatitis in humans worldwide. Other important viruses within this family are woodchuck hepatitis B virus, duck hepatitis virus, and ground squirrel hepatitis B virus. Strains of HBV that are distinct from human strains have been described in both captive and wild populations of chimpanzees, gibbons, orangutans, and gorillas ([@bib463], [@bib811], [@bib717], [@bib428], [@bib522], [@bib750]). A HBV strain has also been described in one New World species, the woolly monkey (*Lagothrix lagotricha*) ([@bib401]). While most surveys have not been able to demonstrate infection in Cercopithecidae, there is one report of HBV seropositivity associated with clinical disease in cynomolgus macaques ([@bib382]).

#### Etiology {#s0585}

Hepatitis B viruses are small (42 nm) enveloped DNA viruses with an icosahedral nucleocapsid containing 180 capsomeres. The genome is 3200 kb in length and consists of a single strand of circular DNA encoding the complete genome with a shorter incomplete complementary strand. The core consists of a DNA polymerase, the hepatitis B-core antigen (HBcAg), and the hepatitis B e-antigen (HBeAg). Additional proteins encoded include the surface antigen (HBsAg) and regulatory X protein. Detection of these antigens in the peripheral blood of infected human patients occurs in a predictable and sequential fashion and may be used in the diagnosis and staging of clinical disease.

There are eight human HBV genotypes described (A--H) and two additional, tentative genotypes (I and J) ([@bib599], [@bib725], [@bib709]). These genotypes are based on a greater than 8% divergence from one another and are found to cluster based on geographic region. Phylogenetic analyses of ape HBV genomes indicate that these viruses are genetically distinct from human HBV. As seen with human strains, genomic variants isolated from orangutans, chimpanzees, and gibbons cluster based on the geographic origin of the animals ([@bib258], [@bib299], [@bib750], [@bib685]). The woolly monkey strain is the most divergent of the HBV viruses identified. These phylogenetic relationships are of great interest to researchers interested in determining the origins of human HBV infection.

#### Epizootiology {#s0590}

Transmission of HBV among humans occurs through intimate contact, blood-borne contamination, or vertical transfer. Vertical transmission from mother to child may represent the most significant route of exposure. The epizootiology of nonhuman primate transmission is poorly understood; however, as in humans, mother to infant transmission may play a critical role. Prolonged incubation and a chronic carrier state may be important in propagating the virus in nonhuman primate populations. Seroprevalence in gibbons and orangutans is estimated to range between 40--75% with approximately 15--25% of animals demonstrating a chronic carrier state ([@bib521], [@bib620], [@bib614]).

#### Pathogenesis and Pathology {#s0595}

In humans, a self-limiting hepatitis, fulminant hepatitis, and chronic carrier state are recognized. Chronic HBV infection is associated with a significant increased risk for the development of chronic active hepatitis and hepatocellular carcinoma. The histopathology of naturally occurring and experimental HBV infection of chimpanzees has been described ([@bib161]). The pathology is similar to that described in humans with the exception that chronic active hepatitis and hepatocellular carcinoma have not been recognized as sequelae. Findings vary from essentially normal liver to the occurrence of moderate nonsuppurative inflammatory cell infiltrates centered within portal tracts and extending variably into the hepatic parenchyma. These latter findings are compatible with so-called "chronic persistent infection" of humans and in such specimens the typical "ground glass" hepatocytes containing viral antigen and scattered hepatocellular necrosis may be evident ([@bib161]). The reported lesions described in cynomolgus monkeys were similar but qualitatively more severe and were accompanied by hepatocellular fatty change and Ito cell proliferation ([@bib382]).

#### Clinical Findings {#s0600}

Infection of chimpanzees and gorillas demonstrated by serology is often asymptomatic. Experimental infection of chimpanzees produces mild anorexia, lethargy, and jaundice.

#### Laboratory Findings {#s0605}

Alterations in alanine aminotransferase and the presence of hepatitis B virus surface antigen (HBVsAg), anti-HBVsAg, and anti-HBVcAg have been described following experimental inoculation of chimpanzees ([@bib161]). In these animals, HBVsAg peaked 3 months following infection and coincided with initial elevations in alanine aminotransferase. It was at this time that the initial histopathologic alterations were seen, which generally resolved with the apparent rise in anti-HBVc between 8 and 12 months.

#### Zoonotic Potential {#s0610}

Transmission of ape HBV strains to humans has not been documented. However, chimpanzees can be infected with human HBV strains and spider monkeys are susceptible to experimental infection with the woolly monkey strain ([@bib400]). These findings combined with the common occurrence of experimental and inadvertent exposure of chimpanzees to human HBV suggest that the risk of infection should not be underestimated. Bite wounds and needle stick injuries represent possible routes of transmission.

Nonenveloped DNA-Containing Viruses {#s0615}
===================================

Adenoviridae {#s0620}
------------

###  {#s0625}

#### Introduction {#s0630}

The family Adenoviridae encompasses a large number of ubiquitous viruses that affect a wide range of species worldwide. The family is divided into five genera. The genus *Mastadenovirus* contains the human and nonhuman primate isolates. The family name is derived from the fact that the original isolates were obtained from adenoids (diffuse lymphoid tissue of the nasopharynx) and tonsils of military recruits suffering from acute upper respiratory tract infection and conjunctivitis. Greater than 50 serotypes of adenoviruses have been isolated from nonhuman primate species, including macaques, African green monkeys, baboons, chimpanzees, gorillas, orangutans, squirrel monkeys, owl monkeys, and cotton-topped tamarins ([@bib85], [@bib369], [@bib196], [@bib648], [@bib145], [@bib609]). Although adenoviruses have been confirmed as causing a mild to moderately severe respiratory or enteric disease of monkeys and apes, many isolates have been obtained from oral or anal swabs or from cell cultures derived from clinically healthy animals, suggesting that subclinical and possibly persistent infections of these species are common. A more severe disease has been described in animals whose immune systems are compromised either by immunosuppressive drugs or by concomitant infections, such as SIV and *Betaretrovirus* infections.

#### Etiology {#s0635}

Adenoviruses are nonenveloped, iscosahedral viruses, 70--90 nm in diameter with a capsid composed of 252 capsomeres. At the vertices of the icosahedron there are 12 capsomeres that are pentagonal in cross-section (pentons) and have filamentous glycoprotein projections with knobbly ends that protrude from their surfaces. The remaining 240 capsomeres are hexagonal in cross-section and are referred to as hexons. The adenovirus genome consists of a single linear molecule of double-stranded DNA that ranges from 26--45 kbp in length. Human adenoviruses are classified into six established species, A--F, and a recently identified seventh species, G ([@bib338]). While genetic data on nonhuman primate adenoviruses are forthcoming, current evidence suggests that ape viruses group with human species B and E while those isolated from Old World monkeys group with human species A and F ([@bib366], [@bib384], [@bib608]). Included in the early region of the genome designated E1 are two genes, E1A and E1B, that encode proteins capable of transforming cells in vitro and causing neoplasms in hamsters and rats in vivo. These proteins have been shown to bind to and presumably inactivate the two well-known tumor suppressor genes, *p53* and *Rb*, thereby causing malignant transformation. Despite the well-recognized ability of certain adenoviruses to experimentally transform cells in vitro and in vivo, these same agents have not been incriminated as the cause of naturally occurring neoplasia in any species.

#### Epizootiology {#s0640}

Adenoviruses occur worldwide where they cause sporadic and epidemic forms of disease in human beings and animals. In general, adenoviruses tend to be rather species specific, but, in some cases, closely related species may be infected. Initial infections are generally transmitted through aerosols generated by sneezing and coughing or through pharyngeal secretions of infected individuals. The fecal--oral route is also a significant route of transmission due to the persistence of infection in tonsilar tissue and intestinal epithelium long after the clinical illness has subsided. Healthy apes and macaques shed large amounts of virus in the stool with virus detected in 36--90% of nonhuman primates maintained in captivity depending on the species and facility type ([@bib609]). Housing individuals under crowded conditions clearly promotes the spread of infection. Children and neonatal nonhuman primates are more susceptible to clinically apparent adenovirus infections than adults. The severity of infection varies widely depending on the serotype of the virus, the age and immune status of the patient, and the host species. As mentioned previously, many such infections remain clinically inapparent even though the patient is shedding large amounts of virus.

#### Pathogenesis and Pathology {#s0645}

Adenoviruses bind to specific receptors on susceptible cells by the filamentous projections that protrude from the penton capsomeres and are taken into the cell by endocytosis. In endosomes, the filament-bearing penton capsomeres are stripped from the particle, the pH within the endosome drops, and the endosome ruptures, spilling the partially degraded virion into the cytoplasm. These free particles bind to microtubules and are transported to the nuclear pores where the viral DNA is discharged into the nucleus, leaving the capsid in the cytoplasm. During the course of viral replication, cellular DNA and protein synthesis is severely disrupted, as is the normal processing of host messenger RNAs. These processes are incompatible with cell survival. Nuclei of cells containing actively replicating adenovirus develop large, amphophilic to basophilic inclusion bodies that either completely fill the nucleus or are surrounded by a prominent halo. Using electron microscopy, these inclusion bodies show prominent crystalline arrays of virions as well as unassembled viral capsid proteins and unencapsidated viral DNA.

The respiratory airways and lungs are common sites of adenovirus infection ([@bib70], [@bib736]). Grossly, the affected portions of the lungs have patchy areas of firmness and gray--white or red discoloration that do not collapse on opening the thorax. Microscopically, epithelial cells of the trachea, bronchi, bronchioles, and alveoli are variably necrotic and contain basophilic, intranuclear inclusion bodies. These areas of necrosis and associated alveolar spaces typically are infiltrated by variable numbers of neutrophils and macrophages.

The conjunctiva and cornea may also be affected and appear edematous and congested with variable amounts of conjunctival exudate. Microscopically, the conjunctival epithelium contains areas of necrosis and intranuclear inclusion body formation.

The gastrointestinal tract is the second most common organ system affected by adenoviruses. Infection may be associated with diarrhea. Grossly, the mucosa of the stomach and small intestine may appear normal or somewhat congested and edematous. Microscopically, the mucosa contains focal and confluent areas of erosions or ulcerations in which necrotic enterocytes contain typical adenovirus inclusions ([@bib42]). There are also several reports of adenovirus pancreatitis in various macaque species ([@bib106], [@bib467], [@bib452]). It would appear from the literature that this lesion occurs most often in young macaques that have been severely immunocompromised by naturally occurring or experimentally induced infections including, SRV-1, SRV-2, and SIV ([@bib107]). The pancreas of affected individuals contains either white or red foci that correspond to areas of necrosis and hemorrhage microscopically. Histologically, this chronic active pancreatitis is characterized by lobular fibrosis and extensive necrosis often centered on intralobular ducts and infiltrated by large numbers of neutrophils. These foci are often dispersed among more normal-appearing lobules. The acinar and ductal epithelial cells may contain adenovirus inclusions.

Less commonly recognized forms of disease include necrotizing hepatitis and hemorrhagic cystitis and tubulointerstitial nephritis ([@bib145], [@bib809]). Intranuclear inclusions must be differentiated from those present in CMV, B virus, SV40, and measles virus infections. As with both CMV and SV40, some strains of adenovirus can be associated with significant nucleomegaly and cytomegaly ([Figure 1.11](#f0060){ref-type="fig"} ).FIGURE 1.11Simian adenoviruses.Simian adenovirus infections are generally asymptomatic but may target pancreas (A and B), intestine (D and E) and liver (F) in immunocompromised hosts. Lesions are necrotizing (C, pancreas) and intranuclear inclusions are evident (C, D, and F). Immunohistochemistry may be used to demonstrate viral antigen in hepatocytes (E).

#### Clinical Findings {#s0650}

Monkeys and apes with primary adenovirus infections may appear clinically healthy and asymptomatic or may exhibit a variety of clinical signs, depending on the tropism of the virus. Clinically apparent infections of the respiratory tract are characterized by cough and hyperpnea and, when severe, by dyspnea and cyanosis. There may be an associated keratoconjunctivitis. Most animals, but especially adults, recover within a week to 10 days. Except in neonates, mortality is generally low and is often the result of secondary bacterial infection. Other animals may experience diarrhea as the result of viral replication in the enterocytes of the small intestine. As with the respiratory tract, recovery generally occurs within 2 weeks, but virus may continue to be shed in the feces for many weeks after the animal becomes asymptomatic. This persistent shedding of virus in the feces serves as the source of infection for other susceptible individuals. In rare cases, immunocompromised macaques may experience a severe necrotizing pancreatitis that may be associated with diarrhea and death.

#### Laboratory Findings {#s0655}

Virus may be detected using molecular techniques. Serological tests exist but detect only specific serotypes of adenovirus. Ultrastructural microscopy, immunohistochemistry, or in situ hybridization techniques may be used to demonstrate virus in tissue samples. Viral isolation may be performed on a variety of cell lines, including A549 (human lung carcinoma), Hep-2, HeLa, and KB (epidermoid carcinoma) cells. Clinically healthy animals may yield as many positive samples as animals that are clinically ill.

#### Treatment {#s0660}

There are no specific antiviral drugs commercially available for adenovirus infection. Consequently, treatment regimens are focused on preventing secondary bacterial infections and dehydration in the case of diarrheal illness. Supportive therapy to maintain caloric intake in animals that are severely anorexic is also beneficial ([Figure 1.12](#f0065){ref-type="fig"} ).FIGURE 1.12Adenovirus.Enterocyte with intranuclear virions, rhesus macaque.

#### Prevention {#s0665}

Vaccines do not exist for specific serotypes of nonhuman primate adenoviruses. Accordingly, preventive measures to control or eliminate adenovirus infection in nonhuman primate colonies must be directed toward minimizing the exposure of susceptible populations to potentially infected aerosols or feces. Mixing of animals from different sources during the quarantine period should be avoided so as to reduce the risk of exposure of noninfected animals to those that may have been infected at their previous location. Minimizing overcrowding also reduces the risk of exposure by minimizing the concentration of virus in the environment. Measures to prevent cross-contamination of cages by feces that may contain infectious virus should also be in place.

#### Zoonotic Potential {#s0670}

Recombinant strains of human adenovirus are of interest as vectors for gene therapy and vaccines. Recombinant vaccines based on human serotype 5 generate robust cellular and humoral immunity although prior natural infection, and presence of neutralizing antibodies may lead to reduced vaccine efficacy ([@bib646], [@bib623]). Because of this limitation, there has been interest in the use of engineered simian strains as vectors ([@bib610], [@bib710]). Recent surveys for pre-existing immunity to simian strains have demonstrated presence of antibodies to chimpanzee adenoviruses within human populations from sub-Saharan Africa ([@bib794], [@bib168]). While it is possible that human and chimpanzee antibodies may be cross-reactive, the presence of these antibodies suggests potential for cross-species transmission.

Polyomaviridae {#s0675}
--------------

Viruses within the family polyomaviridae have been of considerable scientific interest because of their oncogenic and transforming effects on mammalian cells and because of their ability to induce disease in immunocompromised hosts. These viruses are small (45 nm) and have a naked icosahedral capsid with 72 capsomeres and 420 structural subunits. Members of the family recognized to infect primates include Simian virus 40 and cynomolgus polyomavirus, baboon polyomavirus 1 (SA-12 or *polyomavirus papionis 1*) and 2 (*polyomavirus papionis 2*) and JC and BK virus in man. Novel and not yet fully characterized viruses have also been recognized in chimpanzees and squirrel monkeys ([@bib330], [@bib748]).

### *Polyomavirus Macacae*: Simian Virus 40 {#s0680}

#### Introduction {#s0685}

Simian virus 40 (SV40) and closely related polyomaviruses are common latent viral infections of feral and captive Asian monkeys, including rhesus, cynomolgus, Japanese, and Formosan rock macaques (*M*. *cyclopis*). Based on limited sequence data Cynomolgus polyomavirus (CPV) is a distinct genotype reported in normal and immunosuppressed cynomolgus macaques ([@bib743]). Considerable genetic heterogeneity has been observed in SV40 isolates from naturally infected animals ([@bib405]). Simian virus 40 was originally isolated from normal rhesus kidney cell cultures and subsequently from cell lines used for the production of killed poliovirus vaccine from 1954 to 1963. Because of its ability to readily transform cells in vitro and to produce malignant neoplasms in vivo, SV40 is one of the most extensively studied nonhuman primate viruses. Although its capacity to induce neoplasms in suckling hamsters is well established, its association with human disease is controversial.

#### Etiology {#s0690}

Simian virus 40 is classified in the polyomavirus genus of the family Polyomaviridae. Its genome consists of double-stranded circular DNA approximately 5000 bp in length, encompassing early- and late-coding regions and a noncoding regulatory region. Two DNA-binding proteins coded within the early region are referred to as the large and small T (tumor) antigens and bind to viral regulatory sequences to facilitate the transcription of late viral genes. These genes have been studied extensively and are used in the construction of transgenic animals due to their transcriptional promoting activity. Evidence from macaques suggests that distinct subtypes of SV40 may exist that differ in their genomic sequence and ability to induce disease. Based on the genetic analysis of the SV40 regulatory region, a protoarchetypal strain of SV40 has been identified in neotropical Goeldi's monkeys (*Callimico goeldii*) suggesting that the host range of viral genotypes may be more extensive than previously recognized ([@bib805]).

#### Epizootiology {#s0695}

Although serologic evidence indicates that infection of captive macaques with SV40 is common, clinical disease is rare and is usually associated with some immunosuppressive disease or immunomodulatory therapy. While common in captive colonies, surveys of wild or feral populations indicate markedly different infection rates. For example examination of Mauritian cynomolgus macaques reveals low seroprevalence rates (8.8%), while serosurveys of rhesus macaques in Nepal reveals that more than 90% of the animals are positive as adults ([@bib336], [@bib749]). The principal mode of transmission has not been investigated but the identification of infected renal epithelial cells in immunologically normal animals suggests that urinary excretion may play a role. Pathology results from reactivation of latent infection or primary infection during periods of immunosuppression. Concurrent natural or experimental infection with SIV has been demonstrated in multiple cases ([@bib296]).

#### Clinical Findings {#s0700}

The vast majority of animals infected with SV40 do not show clinical signs and harbor the virus asymptomatically. The occurrence of clinical disease should prompt a search for an underlying immunosuppressive agent (most likely SIV). When disease does occur, most animals are in the terminal stages of AIDS with severe depletion of CD4+ T lymphocytes. At this time, clinical signs may relate to CNS or renal involvement or to a host of other opportunistic infections often present at death. Due to the slowly progressive nature of the disease in SIV-infected animals, the CNS lesions in the white matter may be advanced before clinical signs are evident ([Figure 1.13](#f0070){ref-type="fig"} ).FIGURE 1.13Simian virus 40 (SV40).SV40 causes progressive multifocal leukoencephalomalacia (PML) (A through D) in SIV-infected macaques characterized by demyelinization and gliosis within white matter tracts. Virus may be demonstrated by in situ hybridization (C) or immunohistochemistry and intranuclear inclusions may be observed in oligodendrocytes (D). SV40 may also cause an interstitial nephritis (E) and pneumonitis.

#### Pathogenesis and Pathology {#s0705}

Lesions are confined to the brain, lung, and kidney. The brain lesion consists of multifocal to confluent regions of demyelination scattered throughout the cerebral white matter and subependymal regions. Demyelination can be confirmed by Luxol fast blue staining and results from direct viral injury to oligodendroglial cells. Large basophilic inclusions fill and enlarge nuclei of oligodendrocytes and astrocytes. As the lesion progresses, gitter cells and astrocytes predominate. These lesions resemble progressive multifocal leukoencephalopathy (PML) of humans with JC virus reactivation. Immunohistochemistry or in situ hybridization can be used to confirm SV40 infection.

Renal lesions are found primarily within the inner cortex and medulla. Collecting tubules are lined by hypertrophic/hyperplastic and occasional dysplastic epithelial cells containing typical viral inclusions. These inclusions are often found in the desquamated epithelial cells present in tubular casts. Their large size and deep basophilic color often make them visible under the lowest magnification. These findings are accompanied by a chronic nonsuppurative tubulointerstitial nephritis, fibrosis and glomerular sclerosis, and atrophy. It is postulated that renal lesions may predominate in macaques acquiring infection during immunosuppression, whereas CNS lesions are more likely to occur following a recrudescence of latent infection ([@bib296]). Disease phenotype may be dependent on viral genotype; for example CPV has been associated exclusively with interstitial nephritis. Pulmonary lesions are seen less frequently and consist of a proliferative interstitial pneumonia with intracellular viral inclusions present within hypertrophied type 2 pneumocytes.

A distinct SV40-induced meningoencephalitis without demyelination has been recognized in SIV-inoculated macaques with AIDS ([@bib654]). In these animals, polyomavirus infection of astrocytes rather than oligodendrocytes predominates. Sequencing data suggest that this manifestation may be the result of a viral strain of SV40 distinct from that which causes PML. A SV40 molecular clone has recently been developed and with a unique tropism for neurons ([@bib137]).

SV40 sequences have been detected in a malignant astrocytoma from an SIV-infected macaque ([@bib313]). However, an etiologic relationship to the neoplasm could not be determined ([Figure 1.14](#f0075){ref-type="fig"} ).FIGURE 1.14Simian virus 40 (SV40).Electron photomicrograph of cytoplasmic and intranuclear viral particles, rhesus macaque.

#### Laboratory Findings {#s0710}

In SIV-infected macaques with renal lesions, clinicopathologic findings included a mild hypochromic microcytic anemia and moderate elevations in BUN and creatinine. Because SV40 is found ubiquitously in macaques, the ability to isolate this virus from tissue is not definitive evidence of its role as a pathogen in an individual animal. The demonstration of polyomavirus virions by electron microscopy or polyomavirus DNA/RNA by in situ hybridization in typical lesions is diagnostic.

#### Treatment and Control {#s0715}

No specific treatment for SV40 is available. Use of seronegative donors and recipients may be required to prevent disease in solid organ transplantation protocols. Specific pathogen-free breeding colonies have been developed.

#### Zoonotic Potential {#s0720}

The zoonotic potential of SV40 is controversial ([@bib52]). Although large numbers of individuals have been exposed to SV40 through contaminated poliovirus vaccine, a clear relationship to any human disease has not been demonstrated ([@bib480]). Moreover, although SV40 has been isolated from human neoplasms, the widespread contamination of cell lines by SV40 has interfered with the interpretation of these results. Serological responses to SV40 have been detected in zoo workers with primate contact consistent with its zoonotic potential ([@bib191]).

### Baboon Polyomavirus 1 (Polyomavirus Papionis-l; SA12) {#s0725}

SA12 is a papovavirus closely related to, but distinct from, the human papovavirus, BK virus. While initially isolated from a vervet monkey, only natural infection of baboons (*Papio* sp.) has been demonstrated ([@bib737]). Serological responses have also been detected in Patas monkeys and macaques ([@bib74]). Like SV40, SA12 transforms cells and has produced neoplasms in hamsters. Complete viral sequences have been described ([@bib89]). While the virus circulates in baboon colonies, natural disease in normal or immunosuppressed animals has not been reported. This virus has not been associated with natural disease and is more closely related to BK virus than to JC virus or SV40 ([@bib134]).

### African Green Monkey Polyomavirus (*Polyomavirus Cercopitheci;* Lymphotropic Papovavirus) {#s0730}

Lymphotropic virus (LPV) is a papovavirus originally isolated from a B-lymphoblastic African green monkey cell line and is unique in its B-cell tropism ([@bib812]). It is related to, but distinct from, other primate polyomaviruses and appears to be most closely related to the recently recognized human Merkel cell tumor virus ([@bib206]). Serological surveys indicate that humans and a variety of nonhuman primates are immunoreactive for LPV or an antigenically related virus ([@bib706]). This virus induces tumors in hamsters but has not been associated with naturally occurring disease in primates.

Recent evidence has demonstrated a zoonotic potential for LPV ([@bib152]). LPV genomic sequences have been detected in the peripheral blood mononuclear cells of both HIV-infected and -noninfected individuals.

### *Polyomavirus Hominis-2* and *Polymomavirus Hominis-1*: JC Virus and BK Virus {#s0735}

Infection of humans with JC virus and BK virus is a common occurrence in childhood and while not associated with clinical disease, the virus persists for life. Recrudescence may occur with immunosuppression, leading to viral tubulointerstitial nephritis in the case of BKV and progressive multifocal leukoencephalopathy in the case of JCV. A closely related virus (SV40) causes a progressive demyelinating disorder in SIV-inoculated macaques with many clinicopathologic similarities to PML. Despite the fact that a variety of nonhuman primates are susceptible to infection with SV40, there is a paucity of information concerning the occurrence of JCV and BKV in these species. Natural infection of nonhuman primates with these viruses reportedly does not occur ([@bib643]). Owl monkeys were susceptible to intracerebral inoculation of JCV and developed primitive neural tumors after a prolonged incubation ([@bib432], [@bib487], [@bib440]).

Papillomaviridae {#s0740}
----------------

###  {#s0745}

#### Introduction {#s0750}

Over 100 different papillomaviruses have been recognized in human beings, many with strict site specificity and different tendencies to promote the malignant transformation of keratinocytes. Fewer, approximately 47 at the time this chapter was written, have been recognized in nonhuman primates. It is likely that more will be identified and that the spectrum of disease with which they are associated will increase. Papillomavirus infection has been demonstrated in the Colobus monkey (*Colobus guerza*), spider monkey, howler monkey (*Alouatta fusca*) rhesus macaque, cynomolgus macaque, chimpanzee, pygmy chimpanzee (*P. paniscus*), and gorilla ([@bib708], [@bib372], [@bib697], [@bib615], [@bib17]). A viral etiology has been suspected in a number of benign and malignant proliferative disorders in a variety of species, including cebus monkeys, baboons, and a squirrel monkey ([@bib696]).

#### Etiology {#s0755}

Papillomaviruses are spherical, double-stranded DNA viruses 50--55 nm in diameter with a capsid composed of 72 capsomeres. This capsid consists of two proteins: the major capsid protein, which comprises approximately 80% of the total viral protein, and a slightly larger minor capsid protein. Their genome is approximately 8 kb in size and encodes ten open reading frames. Research has focused on transregulatory factors (El and E2) and early viral proteins (E6 and E7) and their role in host cell growth dysregulation. Most papillomaviruses identified in nonhuman primates are of the Alphapapillomavirus genus although recently a Betapapillomavirus was identified in cynomolgus macaques ([@bib329]). Papillomaviruses cannot be successfully grown using traditional cell culture methods.

#### Epizootiology {#s0760}

The epizootiology of papillomavirus infection of nonhuman primates is unknown. In other species, initial infection occurs primarily in the young and is thought to require defects in the superficial layers of the dermis. The virus is spread by fomites, by direct contact, or as a sexually transmitted disease. Lesions may be multiple and generally resolve with the mounting of an effective immune response. Not all primate papillomaviruses show strict species specificity with some strains identified in both cynomolgus and rhesus macaques ([@bib791], [@bib114]).

#### Pathogenesis and Pathology {#s0765}

Viral infection of skin or oral mucosa produces an exophytic mass that is often described grossly as "cauliflower like" and may reach 1--2 cm in diameter. Histologically, there is massive hyperplasia of the stratum spinosum and corneum. Basophilic intranuclear inclusions are occasionally found in the stratum spinosum. Acidophilic intracytoplasmic inclusions likely represent keratohyaline granules. The formation of rete ridges that invest the mass with blood vessels and contain scattered inflammatory cells often accompany epidermal proliferation. Infection with some viruses may induce massive fibroblastic proliferation (fibropapilloma) in which viral antigen may be detected.

Specific strains of human papillomavirus (HPV) including HPV 16 and 18 are associated with an increased risk of cervical carcinoma. Viral DNA in these carcinomas and in viral-induced dysplastic lesions is present in an integrated form. If integration disrupts the E2 open reading frame, the normal control of early viral genes (E6/E7 products) is disrupted. These gene products can promote unregulated cell growth by two mechanisms: E7 protein binds to and deactivates the tumor suppressor protein (pRb) and E6 protein facilitates the degradation of another tumor-suppressing protein (p53). HPV types associated with cervical carcinoma apparently contain early viral proteins with high affinity for pRb and p53, whereas HPV types associated with low cancer risk are not. Other genetic and environmental factors likely act in conjunction with HPV infection to complete carcinogenesis. Papillomavirus DNA with similarities to HPV 16 was detected in a penile squamous cell carcinoma with lymph node metastasis in a rhesus macaque ([@bib372], [@bib540]). Female macaques that had mated with this male or were exposed via intermediate sexual contacts demonstrated a 71% incidence of papillomavirus infection that was detected clinically, histologically, or via molecular methods ([@bib541]). Of the females surveyed, one presented with an adenosquamous carcinoma of the endocervix and another with a squamous cell carcinoma of the cervix. These initial reports indicated that genital infection with this genus of viruses may be carcinogenic for nonhuman primates, as is the case in humans. Subsequent surveys by Wood and colleagues demonstrated up to a 19% overall prevalence of cervical intraepithelial neoplasia (CIN) in cynomolgus macaques ([@bib790], [@bib791]). Lesions were highly associated with presence of papillomavirus infection and included benign vaginal papillomas, mild to severe intraepithelial dysplasia, and occasional invasive cervical carcinomas. Key morphologic features included koilocytosis, nuclear atypia, anisokaryosis, expansion of the basal epithelium, and presence of epithelial pearls. Transfer of exfoliated cervicovaginal cells propagated infection and initiated lesion development in a subset of animals ([@bib791]).

Focal epithelial hyperplasia has been described as a distinct entity in chimpanzees (*P. troglodytes* and *P. paniscus*) although a recent report describes a similar pathology in a howler monkey ([@bib288], [@bib708], [@bib745], [@bib238], [@bib615]). Multiple, sessile, well-circumscribed proliferative structures 0.2--0.5 cm in diameter are described within the oral mucosa. These may persist for extended periods and undergo spontaneous regression. Histologically, the most striking feature is marked irregular acanthosis with the formation of anastomosing rete ridges. Typical papillomavirus virions have been demonstrated in some cases.

A recent report describes "butcher's warts" with a flat, verrucous appearance on the hands and feet of a cynomolgus macaque ([@bib329]). These lesions were associated with the first nonhuman primate papillomavirus identified as belonging to the Betapapillomavirus genus (MfPV-1). Viruses of this genus have a predilection toward growth in cutaneous tissue and are often associated with persistent wart-like lesions with potential for malignant transformation in immunosuppressed human patients. Presence or a cause of immune compromise was not identified in the affected animal.

#### Treatment and Prevention {#s0770}

Formalin-inactivated autologous vaccines have been used in the treatment and prevention of papillomavirus infection in cattle and dogs. Their effectiveness is not established.

Parvoviridae {#s0775}
------------

### Simian Parvovirus {#s0780}

#### Introduction {#s0785}

Parvoviridae represent some of the smallest known vertebrate viruses. They are nonenveloped, measuring 18--26 nm in diameter with icosahedral symmetry and a genome consisting of a single strand of DNA. This simple genome is only 5 kb in length and encodes three proteins, a nonstructural protein NS-1 and two structural proteins, VP1 and VP2. In addition to nonhuman primates, parvovirus infections have been recognized in cats, dogs, swine, mink and ferrets, rats, mice, and humans.

#### Etiology {#s0790}

Simian parvovirus (SPV) was first described in cynomolgus macaques concurrently infected with the simian-type D retrovirus ([@bib524]). SPV resides within the erythrovirus genus and shares 65% homology at the DNA level with human B19 parvovirus within the major capsid protein. Subsequently, similar parvoviruses have been recognized in several other species of macaques including rhesus and pig-tailed macaques. Systematic surveys of other nonhuman primate species have not been conducted.

#### Epizootiology {#s0795}

Infection of a cohort of five cynomolgus monkeys and two additional contacts was demonstrated in an initial report ([@bib524]). Serological surveys indicate that SPV and related erythroviruses may be common and yet unrecognized infections in captive macaque colonies. As in human patients with parvovirus B19, it is suspected that infection with SPV is usually asymptomatic and clinical disease is rarely seen. The mode of natural transmission is unknown, although it appears direct contact may not be required. Intranasal inoculation does result in experimental transmission ([@bib525]).

#### Pathogenesis and Pathology {#s0800}

Human infection with parvovirus B19 has been associated with a variety of clinical syndromes, including profound anemia, polyarteritis, fetal loss, and erythema infectiosum ([@bib552]). The pathogenesis of these disorders is poorly understood; however, a propensity for the virus to infect rapidly dividing cells likely contributes to clinical manifestations.

Infected macaques have a variety of gross and microscopic lesions, some of which may have been attributable to an underlying immunosuppressive process. Bone marrow reveals marked dyserythropoiesis with a loss of mature erythroid elements and increased numbers of atypical erythroid precursors (pronormoblasts). Large intranuclear inclusion bodies are evident and typical 24-nm-diameter viral particles are observed ultrastructurally. While initially described in SRV-infected cynomolgus macaques, disease has now been reported in animals on solid organ transplantation studies receiving immunosuppressive therapy and in SHIV/SIV-infected macaques ([@bib216], [@bib254], [@bib637], [@bib652]).

Experimental inoculation of cynomolgus macaques with SPV by the intravenous or intranasal route results in a transient subclinical anemia with reticulocytopenia ([@bib525]). In these immunologically normal animals these alterations rapidly resolved ([Figure 1.15](#f0080){ref-type="fig"} ).FIGURE 1.15Simian parvovirus (SPV).SPV may be associated with anemia and in the bone marrow dyserythropoiesis (A). Brightly eosinophilic intranuclear inclusions may be observed (B) and infection confirmed by in situ hybridization (C).

#### Clinical Findings {#s0805}

Clinical signs in infected macaques are varied and have included diarrhea, dehydration, and moderate to severe normocytic/normochromic anemia often with reticulocytopenia. Animals may present in acute anemic crisis or may have periods of anemia that may appear to resolve spontaneously.

#### Laboratory Findings {#s0810}

Affected macaques may have a severe normocytic normochromic anemia which may appear regenerative or nonregenerative. In initial reports, parvoviral DNA was demonstrated in the serum of affected animals by dot-blot hybridization using radiolabeled B19 human parvovirus genomic probes. PCR and serological assays have been developed and work in cynomolgus macaques suggests that both antibody-positive nonviremic and antibody-negative viremic states may occur. Definitive diagnosis may require both serological assays and PCR to determine the true viral status. Typical 24-nm parvovirus particles could also be found by electron microscopy within bone marrow and histologic findings can be confirmed by in situ hybridization.

#### Treatment {#s0815}

No antiviral treatment is available. Use of corticosteroids may help alleviate signs associated with acute hemolytic crisis. If animals are to be used in transplantation studies, screening by serology and PCR to assure that animals are free of SPV may be beneficial.

#### Zoonotic Potential {#s0820}

SPV can replicate in human bone marrow stromal cells and serological responses to SPV have been detected in individuals with and without primate contact ([@bib80]). The zoonotic potential of SPV remains controversial as the specificity of serological assays and ability to distinguish SPV from B19 infection in man is uncertain ([@bib652]).

Enveloped RNA-Containing Viruses {#s0825}
================================

Rhabdoviridae {#s0830}
-------------

The family Rhabdoviridae encompasses a diverse group of over 100 viruses that infect a number of mammals, plants, reptiles, fish, and crustaceans. They are linked by a common rod-shaped (*Rhabdo*) ultrastructural appearance. Genera *Lyssavirus* and *Vesiculovirus*, respectively, contain the agents of rabies and vesicular stomatitis, the viruses of importance to nonhuman primates.

### Rabies Virus {#s0835}

#### Introduction {#s0840}

Rabies has been reported in whitelipped tamarins, golden lion tamarins (*Leontopithecus rosalia*), common marmosets, squirrel monkeys, capuchin monkeys, cynomolgus macaques, rhesus macaques, and chimpanzees ([@bib207], [@bib586], [@bib200]). Given the wide host range of this virus, its occurrence in other nonhuman primate species would not be unexpected.

#### Etiology {#s0845}

The occurrence of rabies in captive-bred nonhuman primates is extraordinarily rare, and present-day housing practices do not facilitate exposure to carrier species. Nonetheless, potential exposures do occur ([@bib673]) and the serious zoonotic potential of this agent dictates that it be considered in sporadic cases of encephalitis. In regions of the world where rabies is endemic, populations of wild nonhuman primates may represent important vectors in the transmission of the virus to domestic species and humans. A report from the state of Ceará, Brazil attributed at least eight cases of human rabies deaths to transmission by rabid common marmosets ([@bib200]). Viral isolates did not correspond to previously identified variants of rabies virus and were suggested to represent a unique strain. The tendency in this region to capture and raise marmosets as pets as well as the close proximity of marmoset habitats to urban centers are factors thought to contribute to the emergence of this cycle.

#### Epizootiology {#s0850}

Although nonhuman primates obviously become infected by contact with reservoir or inadvertent host species, the viral strains, vectors, and factors governing this transmission are unknown. Evidence suggests that several New World species and baboons may become infected when vaccinated with attenuated strains ([@bib57], [@bib565]).

#### Pathogenesis and Pathology {#s0855}

Following experimental infection of rhesus macaques, furious rabies develops in 15--35 days, whereas in the dumb or paralytic form this period may extend to 105 days. The incubation in natural cases is unknown. Evidence in humans suggests that the incubation period may be as long as 6 years or more in unusual cases ([@bib670]).

Following exposure, initial replication of the virus occurs within myocytes at the site of inoculation and the virus is transported through peripheral nerves to the CNS where it spreads rapidly and exclusively infects neurons. Transmission between cells is mediated by the passage of ribonucleoprotein across synaptic junctions and exocytosis of complete virions. Centrifugal spread to peripheral organs occurs near the time of the onset of clinical signs, resulting in widespread dissemination of the virus at the death.

Microscopically, lesions vary from few recognized changes to marked formation of glial nodules, perivascular, nonsuppurative encephalitis, and neuronal degeneration. Negri bodies, which may consist of prominent, eosinophilic intracytoplasmic inclusions within nerve bodies, likely represent the defective assembly of precursor proteins. The changes are qualitatively similar to those seen in other species. Fluorescent antibody testing may be used to confirm the diagnosis on frozen neural tissue ([Figure 1.16](#f0085){ref-type="fig"} ).FIGURE 1.16Rabies virus (RV).RV intracytoplasmic inclusions (Negri body).

#### Clinical Findings {#s0860}

Both the furious and the paralytic forms of rabies have been recognized in nonhuman primates. Reported clinical signs include self-mutilation, irritability, and paralysis of pharyngeal and pelvic muscles ([@bib69], [@bib207]). These findings are often not suggestive of the diagnosis.

#### Prevention {#s0865}

Facilities that house nonhuman primates in indoor/outdoor configurations may include rabies vaccination as a component of preventative health care regimens ([@bib518]). Vaccination with killed vaccines induces a neutralizing antibody response although the efficacy of such vaccination for preventing transmission in nonhuman primates is unknown. The use of attenuated vaccines is contraindicated as they have been implicated in the occurrence of vaccine-induced disease. An inactivated hamster diploid cell vaccine has been used for post exposure prophylaxis in white-handed gibbons potentially exposed to a rabid bat ([@bib673]). A killed vaccine combined with human rabies immune globulin has also been used prophylactically in capuchin monkeys exposed under similar circumstances ([@bib360]). Similar protocols might be considered in valuable animals if proper quarantine facilities exist and with the realization that the natural incubation period in primate species is unknown. Nonhuman primates are frequently utilized as animal models for the development and efficacy testing of novel vaccines and vaccine regimens for the prevention of rabies ([@bib104], [@bib218]).

#### Zoonotic Potential {#s0870}

Rabies is a significant zoonotic threat, and nonhuman primate to human transmission has been documented.

### Vesicular Stomatitis Virus {#s0875}

Antibodies to vesicular stomatitis virus have been identified in Geoffroy's marmoset (*Saguinus geoffroyi*) in Panama ([@bib683]). No clinical signs were associated with seropositivity. Phlebotomine sandflies may carry the virus, which causes vesicular lesions in the oral mucosa of a variety of mammalian species. The role of New World primates in the arborial cycle of this virus is unknown.

Recombinant vesicular stomatitis virus has shown considerable promise as a vaccine vector for expression of recombinant proteins of HIV, Ebola virus, Lassa fever virus, and other viruses ([@bib123]). Replication competent vaccines must undergo stringent safety testing including assessments of neurovirulence. Intranasal or intramuscular inoculation has not been associated with adverse effects. However, depending on the strain, intrathalamic inoculation in cynomolgus macaques may result in moderate to severe necrotizing menigoencephalitis ([@bib333]). This has created recent interest in strategies to further attenuate vaccine strains of this virus.

Vesicular stomatitis virus infection in cattle can result in significant morbidity and is clinically indistinguishable from foot-and-mouth disease. Because of the significant impact to agriculture, it is included in the list of select agents compiled by the United States Department of Agriculture. Vesicular stomatitis virus is transmissible to humans and may present as a flu-like illness ([@bib73]).

Filoviridae {#s0880}
-----------

### Filoviruses {#s0885}

#### Introduction {#s0890}

In 1967, an outbreak of hemorrhagic fever was identified in Marburg and Frankfurt, Germany, and in Belgrade, Yugoslavia ([@bib666]). The disease was seen in laboratory workers preparing cell lines derived from African green monkey tissue. Twenty-five primary cases with seven deaths were recorded. In addition, the agent spread to an additional six contacts. Reportedly the shipment of African green monkeys from which tissue had been obtained was normal and the source of infection in these animals remains unknown. An interesting account of the management practices concerning the procurement of these animals has been given and suggests that animals were infected in Uganda prior to shipment ([@bib671]). The first filovirus, Marburg virus, was isolated and characterized from this outbreak. Since that time, isolated and small clusters of cases caused by an antigenically identical virus were identified in Zimbabwe, Kenya, and Uganda. In 2005 a more extensive outbreak occurred in Angola with over 200 infection-associated fatalities ([@bib781]).

The first members of a second group of closely related viruses (Ebola subtype Zaire and Ebola subtype Sudan) were identified in 1976 as the etiologic agent of an epidemic of hemorrhagic fever in Zaire (present day Democratic Republic of the Congo (DRC)) and Sudan, respectively. During these simultaneous outbreaks, 500 human cases with over 430 deaths were recognized. The virus was named Ebola virus after the Ebola river in northwest DRC. As with the Marburg virus, secondary and tertiary cases occurred in contacts. In these contact cases, lower mortality suggested attenuation of the virus. A distinct viral strain, Ebola Côte-d'Ivoire, was isolated from a 34-year-old female patient with a dengue-like syndrome after she necropsied a chimpanzee ([@bib260]). Ebola hemorrhagic fever resulted in over 250 deaths during 1995 in Kikwit, DRC, due to Ebola Zaire and over 200 deaths in Gulu, Uganda, due to Ebola Sudan in 2000 ([@bib100], [@bib780]). Since 1995 smaller outbreaks have also occurred in Central and Western Africa. The most recent outbreak in 2007 in Uganda was associated with an Ebola virus distantly related to Ebola Côte-d'Ivoire that was tentatively designated Ebola Bundibugyo ([@bib722]).

A distinct filovirus subtype (Ebola Reston) was identified in 1989 and 1990 during an outbreak of hemorrhagic fever in newly imported Asian macaques. The animals originated from the Philippines and were housed at primate quarantine facilities in Virginia, Pennsylvania, and Texas. The virus caused a contagious, hemorrhagic fever with high mortality in cynomolgus monkeys. Although no clinical signs or deaths were recorded in human contacts, inadvertent infection of animal handlers in both United States and Philippine facilities did occur ([@bib96], [@bib97]). In 1992, a similar virus was identified in Siena, Italy, in macaques obtained from the same Philippine source ([@bib779]). The virus resurfaced again in Texas in 1996 after which the Philippine facility was depopulated and permanently closed ([@bib101]).

#### Etiology {#s0895}

The family Filoviridae contains one genus (*Filovirus*) with two distinct viruses: Marburg and Ebola. Four species of Ebola virus are currently recognized by the ICTV (Zaire, Sudan, Reston, and Côte-d'Ivoire). One species of Marburg virus is recognized (Lake Victoria) although this species is comprised of at least nine genetically distinct strains with up to 21% divergence at the nucleotide level ([@bib44], [@bib721]). These viruses have a single-stranded antisense RNA genome 12.7 kb in size. Morphologically, the virus forms distinctive filamentous, sometimes branching, structures 800--1000 nm in length and 80 nm in diameter. This structure is surrounded by a closely adherent host membrane in which 10-nm peplomers are found. The virus replicates by budding, and nucleocapsids accumulate in the cytoplasm, forming closely packed arrays of bundled filaments that are visible microscopically as viral inclusions ([@bib508]).

#### Epizootiology {#s0900}

Factors that allow filoviruses to become established in primate hosts are unknown. A reservoir host has not yet been definitively identified although reports implicate fruit bats as a potential reservoir for both Ebola and Marburg viruses ([@bib414], [@bib413], [@bib720]). Viral antibodies to both Marburg and Ebola have been detected in healthy, free-roaming and wild-caught chimpanzees, gorilla, African green monkeys, drills, mandrills, and baboons ([@bib332], [@bib415]) indicating that infection is not always lethal for these species. Seroprevalence is reportedly as high as 12.9% in wild-born chimpanzees and 6.7% in gorillas ([@bib415]). Ongoing outbreaks of Ebola have reportedly resulted in the death of up to 90% of gorillas from certain regions of Western Africa ([@bib53]). Human outbreaks often coincide with outbreaks in ape populations. Once established in the human population, Marburg, Ebola Sudan, and Ebola Zaire viruses were transmitted between close contacts and to medical personnel. The Ebola Reston virus was transmitted between macaques by direct contact, fomites, and aerosolization.

The Reston outbreak was associated with concurrent infection with an arterivirus (simian hemorrhagic fever virus (SHFV)) ([@bib136]). This infection causes a fatal hemorrhagic fever of macaques, but is carried asymptomatically by a number of African primates, principally the Patas monkey. This suggests that while macaques involved in the Reston outbreak were obtained from the Philippines, they may have become infected by inadvertent contact with African species. Inappropriate husbandry procedures such as reuse of needles and failure to organize flow of work may have contributed to the spread of virus within the Philippine facility ([@bib489]). Recently, Reston Ebolavirus has been isolated in the Philippines from pigs in association with a severe outbreak of porcine reproductive and respiratory disease syndrome ([@bib32]). These findings suggest that concurrent arterivirus infection may exacerbate the severity of Reston Ebolavirus disease.

#### Pathogenesis and Pathology {#s0905}

The pathogenicity of filoviruses is dependent on the viral strain and species affected. Generally, the African filovirus, Ebola Zaire, is considered the most pathogenic, followed by Ebola Sudan, Marburg, and Ebola Reston ([@bib212]). Certain strains of Marburg, specifically the Angola strain, may demonstrate increased pathogenicity. Macaques are thought to be more susceptible to filovirus infection than African green monkeys.

The pathophysiology of filovirus infection is most thoroughly elucidated for Ebola virus with many of the pathways determined from study of disease progression in macaque models. Macrophages and monocytes are the initial targets of infection and distribute virus to secondary sites of replication. Mediators released from monocytes and macrophages are thought to recruit additional macrophages thus increasing the number of viral target cells. These mediators additionally may cause endothelial cell activation and breakdown of endothelial integrity contributing to hypovolemic shock. Disseminated intravascular coagulation results in microvascular thrombosis and secondary multi-organ failure. Tissue factor release from infected monocytes is thought to be a key mediator in the induction of DIC in Ebola virus infections ([@bib234]). Upregulation of tissue factor and subsequent fibrin deposition is a less prominent feature of Marburg viral infections ([@bib233]).

Declines in lymphocyte numbers are observed and thought to be due to bystander apoptosis. Experimental infection of cynomolgus macaques with Ebola Zaire resulted in a 60--70% decrease in CD4+ and CD8+ T cell counts with the loss of CD8+ cells most prominent in the natural killer (NK) population ([@bib577]). Loss of these cell populations is thought to contribute to failure to mount an effective immune response. Marburg virus infection of cynomolgus macaques is associated with a more robust but delayed immune response. Loss of circulating CD4+ and CD8+ T cells was not observed in this model and, while NK cell populations in the blood declined, an increase was observed in the spleen suggesting trafficking of this cellular population to tissues ([@bib222]). Both viral infections are associated with a massive cytokine elaboration and abrogation of the host interferon response.

Lesions within the spleen, gastrointestinal tract, lymphoid organs, and kidney are similar to those described in SHFV infection ([@bib136]). There is extensive lymphoid necrosis and deposition of fibrin within splenic white pulp. Depletion of germinal centers is evident in lymphoid tissues. A characteristic lesion present within the liver is scattered hepatocellular necrosis accompanied by a mild, mononuclear inflammatory cell infiltrate. Multifocal necrosis is similarly present within the zona glomerulosa of the adrenal gland. In both locations, large amphophilic to eosinophilic intracytoplasmic inclusions may be evident. Immunohistochemical staining for viral antigen identifies presence of virus within hepatocytes, Kupffer cells, monocytes/macrophages, endothelial cells, and fibroblasts. Hepatocellular necrosis and necrosis within the adrenal cortex serve to distinguish filovirus infection from SHFV infection. An additional finding described in both Marburg and Ebola Reston viruses is the presence of a mild interstitial pneumonia accompanied by more diffuse evidence of disseminated microvascular thrombosis.

Evidence suggests that an epizootic among chimpanzees in the Tai National Forest was responsible for the transmission of Ebola Côte-d'Ivoire to a single human subject ([@bib260]). This troop experienced episodes of increased mortality in November 1992 and 1994. Although many animals were found in a state of advanced decomposition, tissues examined from one chimpanzee revealed lesions compatible with Ebola hemorrhagic fever, including multifocal necrotizing splenitis and hepatitis. Infrequent acidophilic intracytoplasmic inclusions were identified and were immunoreactive for Ebola-specific antigen. The magnitude of the impact of Ebola virus on ape morbidity and mortality in Africa has since been recognized ([Figure 1.17](#f0090){ref-type="fig"} ).FIGURE 1.17Filoviridae.Marburg (A) and Ebola (B) virus infection cause widespread lymphoid necrosis (A), multifocal hepatic necrosis (B), and adrenocortical necrosis. Fibrin deposition is often widespread in the spleen and characteristic intracytoplasmic inclusions are evident in hepatocytes (B insert).

#### Clinical Findings {#s0910}

Following experimental inoculation with Ebola Reston, there is a variable incubation period of 7--14 days. Once clinical signs appear, progression to death is rapid (\<24 h). Animals become anorexic, lethargic, and hypothermic. Cardiovascular collapse is followed by severe depression and coma. Petechiae are noted on the face, chest, and medial aspects of arms and thighs. A separate study of Ebola Zaire in rhesus macaques indicated prolonged partial thromboplastin time, increased fibrinogen degradation products, and normal prothrombin time ([@bib213]).

Interpretations of clinical signs observed during the occurrence of natural disease in Reston were complicated by the concurrent infection with SHFV. This outbreak was associated with a rapidly progressive and fatal disseminated viral infection. Animals would abruptly become anorexic and lethargic and were often found dead in the morning without premonitory clinical signs.

#### Laboratory Fingings {#s0915}

Experimental inoculation with filoviruses was associated with significant increases in lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) ([@bib213]). These values peaked earlier following inoculation with African Ebola viruses than with Asian strains and quickly returned to normal in those animals that survived infection. Hematologic changes included thrombocytopenia, neutrophilia, and lymphopenia. A reactive lymphocytosis was noted in survivors. Filovirus antigen ELISA, PCR, and virus isolation may be utilized for definitive diagnosis although these assays are best outsourced to laboratories with biosafety level 4 capabilities if index of suspicion for disease is high.

#### Treatment and Prevention {#s0920}

Because of the serious zoonotic potential associated with filovirus infection, affected animals should be euthanized. Experimental inoculation of animals requires biosafety level 4 conditions. Animals surviving infection with filoviruses may not be protected against subsequent challenge with a heterotypic virus. Recommendations for biocontainment and management of the various hemorrhagic fever-inducing agents have been published by the Centers for Disease Control and Prevention ([@bib95]). Importation of Ebola Reston to the United States also led to additional guidance and oversight of primate importation and quarantine activities ([@bib153]).

#### Zoonotic Potential {#s0925}

The zoonotic potential with these agents is high. The initial outbreak of Marburg virus infection was associated with the handling of infected African green monkey tissue. Human Ebola Côte-d'Ivoire virus infection resulted from contact with chimpanzee tissue but was nonlethal and did not spread to secondary contacts. Experience with Ebola Reston indicates that while this virus appears less pathogenic in humans, transmission occurred readily to animal handlers ([@bib96], [@bib97]). Both Ebola and Marburg viruses are HHS select agents.

Orthomyxoviridae {#s0930}
----------------

### Influenza Viruses {#s0935}

#### Introduction {#s0940}

Influenza viruses are an important cause of respiratory illness in humans and occasionally infect nonhuman primates. Worldwide pandemics occurred in 1918, 1957, and 1968, and an estimated 20 000 000 humans died as a result of influenza between 1918 and 1919 ([@bib3]). Animal infections (swine and fowl) are believed to have played a critical role in the generation of influenza viral strains responsible for these pandemics. More recently, highly pathogenic avian strains (H5N1) and swine origin strains (H1N1) have emerged as significant public health threats and nonhuman primates have played an important role as biomedical research models of these infections.

#### Etiology {#s0945}

Influenza viruses are 80--120 nm in size with a single-stranded segmented RNA genome encoding 9--10 proteins. Based on soluble (S) internal antigens, three virus types are recognized (A, B, and C). Types B and C infect only humans, have limited antigenic variation, and usually produce only sporadic cases. Type A strains infect a variety of animal species (humans, nonhuman primates, foals, fowl, swine, and seals), are more virulent, and have been responsible for the great pandemics. Two protein subunits within the viral envelope (hemagglutinin (H) antigen and neurominidase (N) antigen) define viral subtypes. The H antigen mediates adhesion of the virion to sialic acid residues on respiratory epithelial cells. The N antigen facilitates viral entrance to the cytosol following fusion and endosome formation.

Infection with a particular strain produces strong immunity, preventing reinfection. Unfortunately, genetic reassortment between genes coding for H and N subunits occurs with striking regularity, producing new subtypes that pre-existing immunity does not protect against. It is the emergence of these new strains that are sufficiently different from previously circulating subtypes and for which pre-existing immunity is not protective that has been associated with widespread human infection. Infection of fowl and/or swine is believed to be critical in the production of many of these strains.

#### Epizootiology {#s0950}

Evidence shows that gorillas, chimpanzees, orangutans, gibbons, macaques, baboons, African green monkeys, marmosets, tamarins, squirrel monkeys, owl monkeys, and capuchin monkeys are susceptible to infection ([@bib349], [@bib348], [@bib506], [@bib347], [@bib580]). The virus is highly contagious by the aerosolized route and nonhuman primates likely become infected through contact with humans or wildlife species. Once established within a cohort, transmission may occur among nonhuman primate members. Evidence cited from an epizootic in gibbons suggests that adaptation of the virus in a naive population may be associated with increased virulence.

#### Pathogenesis and Pathology {#s0955}

In mild cases of upper respiratory tract infection, changes noted grossly may be minimal, consisting of hyperemia of mucous membranes and overproduction of mucoid secretions. Depending on the strain, experimental inoculation of macaque species results in acute bronchointerstitial pneumonia with diffuse alveolar damage characterized by alveolar spaces filled with edema and inflammatory infiltrates ([@bib35], [@bib111], [@bib319]). An exuberant inflammatory response may be an important contributor to the observed pathology ([@bib121]). Most strains replicate efficiently in the lungs with variable replication noted within the trachea, nasal mucosa, oropharynx, and tonsils ([@bib588], [@bib376], [@bib111], [@bib319]). Variation in tropism for Type I versus Type II pneumocytes may significantly impact degree of pathology with the more pathogenic strains preferentially targeting Type II pneumocytes. Resolution of severe pulmonary involvement is characterized by marked septal thickening and hyperplasia of type II pneumocytes. Natural cases may be complicated by secondary bacterial infection and, in these instances, inflammation may be more purulent. Histologically, a desquamative alveolitis with the formation of hyaline membranes and microvascular thrombi is evident.

#### Clinical Findings {#s0960}

Clinical signs are nonspecific and consist of fever, oculonasal discharge, anorexia, lethargy, and gastrointestinal signs. Changes in respiratory rate and pulse oximetry measures may be observed. The incubation period is 1--3 days and the illness may last 3--6 days. Occasionally, nonhuman primate illnesses will coincide with human cases, suggesting a diagnosis.

#### Treatment {#s0965}

No specific treatment is available; however, the prevention of secondary bacterial infections may be beneficial ([@bib331]). Demonstration of seroconversion to the S antigen by the hemagglutination--inhibition test is evidence of recent infection. Nasopharyngeal swabs or lung tissue collected at necropsy may be used for viral isolation on primary monkey kidney cell culture or embryonated chicken eggs. CPE is usually not observed and virus is first demonstrated by hemadsorption techniques. Immunofluorescent staining may be used for viral identification.

Paramyxoviridae {#s0970}
---------------

The family Paramyxoviridae contains two subfamilies: Paramyxovirinae and Pneumovirinae. The former is divided into three genera known to infect nonhuman primates: *Respirovirus*, *Rubulavirus*, and *Morbillivirus*. Pertinent species from each genus are presented in [Table 1.3](#t0020){ref-type="table"} . The subfamily Pneumovirinae contains two genera, *Pneumovirus*, which includes respiratory synctial viruses (chimpanzee coryza agent), and the recently identified *Metapneumovirus*. Specific viruses will be discussed herein according to their subfamily grouping.TABLE 1.3ParamyxoviridaeSubfamilyGenusVirus*ParamyxovirinaeMorbillivirus*Measles virusParamyxovirus saguinus*Respirovirus*Human parainfluenza virus 1Human parainfluenza virus 3Sendai virusSimian virus 10*Rubulavirus*Human parainfluenza virus 2Human parainfluenza virus 4Parainfluenza virus 5 (formerly Simian virus 5)Simian virus 41*PneumovirinaeMetapneumovirus*Human metapneumovirus*Pneumovirus*Human respiratory syncitial virus

Paramyxovirinae {#s0975}
---------------

Members of the subfamily Paramyxovirinae are pleomorphic, occasionally filamentous, enveloped, RNA-containing viruses with a diameter of 150--200 nm. Their genome consists of a single molecule of single-stranded, mostly negative-sense RNA, but some contain a positive strand. Unenveloped nucleocapsids consist of long tubular structures and are assembled in the nucleus. These acquire a fuzzy, protein coat once they are released into the cytoplasm. These coated tubular structures then align themselves beneath the cell membrane through which they bud and acquire an envelope. The envelope consists of host cell membrane lipids with inserted viral-encoded proteins and glycoproteins. The latter protrude from the surface of the virions as 8- to 12-nm projections. Members of the genera *Respirovirus* and *Rubulavirus* contain a hemagglutinin-neuraminidase protein while members of the genus *Morbillivirus* lack neuraminidase. Members of the genus *Pneumovirus*, however, exhibit neither neuraminidase nor hemagglutinin activity. The surface spikes of all Paramyxoviridae members contain two glycosylated proteins that are responsible for the attachment and fusion of the virus to susceptible cells. The hemagglutinin or hemagglutinin-neuraminidase functions as an attachment protein in the case of the Paramyxovirinae subfamily. Within the Pneumovirinae subfamily, the attachment protein is termed protein G. Both subfamilies have a fusion protein (F) that is responsible for membrane fusion. The F protein contributes to fusion of infected cells with noninfected cells and formation of multinucleated syncytial cells.

### Parainfluenza Viruses {#s0980}

#### Epizootiology {#s0985}

Because of the potential for significant impact on nonhuman primate colonies, members of the *Morbillivirus* genus are discussed separately below. Here we will address the members of the *Respirovirus* and *Rubulavirus* genera. The term parainfluenza virus will be used broadly to refer to viruses within these genera. Parainfluenza viruses have a global distribution where they are highly contagious and responsible for upper and lower respiratory ailments of a wide variety of species. Serological surveys indicate that most species of monkeys and apes have been infected with one or more parainfluenza viruses either in their natural habitats, as in the case of newly imported animals, or after being maintained in laboratory colonies. Many of these infections are mild and may go clinically undetected. The principal mode of transmission is by aerosols, although direct contact with infected secretions can also be a mode of transmission. Parainfluenza viruses appear to be less species specific than adenoviruses, as cross-species transmission among nonhuman primates, human beings, rodents, and possibly even dogs and cattle seems likely based on the antigenic relatedness of homologous serotypes isolated from these species. Reinfections with the same or related viruses occur with some frequency.

#### Pathogenesis and Pathology {#s0990}

Once in the respiratory tract, parainfluenza viruses bind to epithelial cells of the respiratory mucosa in the nasal cavity, nasopharynx, trachea, or bronchi and bronchioles. The virus enters susceptible cells by binding to and fusing with the cell membranes. Its negative-strand RNA is transcribed to form multiple molecules of messenger RNA that code for various viral proteins and as an entire transcript of positive-strand RNA that serves as the template for the synthesis of entire molecules of negative-strand viral progeny RNA. During the replicative process, infected cells develop both intranuclear and intracytoplasmic, eosinophilic viral inclusion bodies corresponding to the naked, intranuclear, tubular nucleocapsid and the fuzzy coated cytoplasmic nucleocapsids, respectively. Infected cells, bearing viral-encoded fusion proteins, often fuse with adjacent noninfected cells to form multinucleated syncytial giant cells. Thus, the hallmark of infection by viruses of the family Paramyxoviridae is the presence of single or multinucleated syncytial cells bearing both intranuclear and intracytoplasmic, eosinophilic inclusion bodies. Infected cells undergo virus-induced lysis and desquamate from the mucosa, thereby predisposing the host to secondary bacterial infection. Coinfecting bacterial species include *Klebsiella pneumoniae*, *Streptococcus pneumonia*, and *Pasteurella multocida* ([@bib698], [@bib380], [@bib702]). The disease produced by parainfluenza viruses varies from a mild upper respiratory infection (coryza) to a rhinotracheobronchitis or croup-like illness to frank pneumonia. Most animals recover from these infections unless secondary bacterial infection results in death. Most respirovirus and pneumovirus infections do not result in a viremia.

#### Clinical Findings {#s0995}

Clinical signs associated with parainfluenza infections are not specific for any particular genus of virus. Depending on the portion of the respiratory tract most affected, nonhuman primates with active infection may exhibit no signs of clinical illness or may have nasal discharge and sneezing, wheezing, coughing, and even severe hyperpnea, dyspnea, and cyanosis. Epizootics of parainfluenza type 3 virus have been described in Patas monkeys and gibbons whereas parainfluenza type 1 has resulted in disease in marmosets ([@bib120], [@bib214], [@bib453]). Sendai virus, the murine counterpart to human parainfluenza type 1, replicates at high levels in the upper and lower respiratory tracts of experimentally inoculated African green monkeys and chimpanzees but has not been associated with clinical disease ([@bib660]).

#### Laboratory Findings {#s1000}

Serological tests that demonstrate a rise in antibody titer to a specific viral agent in a convalescent serum are a practical method to determine which, if any, parainfluenza virus is responsible for the respiratory illness. Detection of virus using PCR or IHC techniques is also useful for diagnosis. One must be aware, however, that there are numerous viral agents in addition to members of the paramyxovirinae that can cause respiratory disease.

#### Treatment {#s1005}

As most simians recover naturally from parainfluenza virus infections, treatment is largely supportive in nature and is directed toward minimizing the risk of secondary bacterial infection. Parainfluenza 3 virus infection has been shown to predispose to invasive pneumococcal disease in chimpanzees ([@bib337]).

#### Prevention {#s1010}

Although there are effective vaccines available commercially for canine parainfluenza virus (a host variant of Parainfluenza virus 5) and bovine parainfluenza virus 3, these have not been tested nor are they approved for the prevention of infection by simian isolates of these serotypes. Thus, preventative measures should be similar to those indicated for adenovirus infections, namely the prevention of crowding and minimizing exposure to other species that might harbor similar agents.

### Measles (Rubeola) Virus {#s1015}

#### Introduction {#s1020}

Measles virus infection is a common viral disease with the potential to significantly impact the health and management of nonhuman primate colonies. This virus is a member of the genus *Morbillivirus* which contains many viruses of veterinary importance including canine and phocine distemper viruses, Rinderpest virus, virus of Pestes des petites ruminants, and the recently documented equine morbillivirus. These agents produce illnesses in a diverse group of animals with remarkable clinical and histopathologic similarities.

Measles virus infection has been described previously in rhesus macaques, cynomolgus macaques, bonnet macaques, Formosan rock macaques, silvered leaf monkeys, African green monkeys, squirrel monkeys, colobus monkeys, chimpanzees, marmosets, cotton-top tamarins, white-lipped tamarins, and owl monkeys ([@bib640], [@bib7]). Historically, this disease was once widespread in newly imported macaques and responsible for significant morbidity in animals stressed by importation and quarantine procedures. While largely controlled in the United States and Europe, recent outbreaks have occurred in Southeast Asia and infected animals have been recognized following importation. Measles virus infection should be considered a serious threat to nonhuman primate colonies, and appropriate preventative measures should be taken.

#### Etiology {#s1025}

The measles virus is grouped with the viruses of canine distemper and rinderpest in the genus *Morbillivirus* and family Paramyxoviridae. The virus is spherical to pleomorphic and 120--270 nm in diameter. The core consists of single-stranded negative-sense RNA and virion assembly occurs at the plasma membrane with the formation of spherical particles. Six gene products have been identified: N (nucleoprotein), P (polymerase protein), L (large protein), M (matrix protein), H (hemagglutinin), and F (fusion factor). Neuraminidase, a protein of other Paramyxoviridae, is not present.

#### Epizootiology {#s1030}

Serological evidence indicates that while measles can be a common infection in captive nonhuman primates, it does not occur in their natural habitats. Historically, seroconversion was often observed to occur within weeks of first human contact, leading to endemic infection within groups or, if combined with stress of capture, quarantine, or shipping, to epizootics characterized by high morbidity and mortality. Roberts et al. documented an epizootic with high mortality in a group of immunosuppressed macaques inoculated with SIV ([@bib598]). In a naive population, the disease spreads rapidly by the aerosolized route. With the prohibition of importation of many primate species and the advent of widespread vaccination, serious epizootics have become less frequent. In recent years unfounded concerns over side effects associated with human vaccination have increased the number of unvaccinated individuals in the United States and Europe. Such individuals have been associated with measles cases and pose a risk to nonhuman primate colonies. Measles remains problematic in human populations throughout Southeast Asia and serious epizootics have been recognized in captive macaque populations. Such animals may be infected prior to exportation and pose a significant threat to colonies.

#### Clinical Findings {#s1035}

Clinical signs vary, depending on the species infected. In macaques the disease is usually mild or asymptomatic unless animals are stressed or immunosuppressed. The incubation period varies from 6--10 days and is followed by fever and a maculopapular exanthema. This rash is most pronounced on the ventral body surface and generally spares plantar and palmar surfaces. It then progresses to a dry or scaly desquamative dermatitis and may continue for up to 2--3 weeks ([@bib264]). Animals may be infectious prior to the onset of overt clinical signs.

While considered pathognomonic, Koplik's spots are present inconsistently. These small, white foci are rimmed by a raised red border and are found within the oral mucosa. In some cases, respiratory signs, including cough and conjunctivitis, may be present. Infected animals may be more susceptible to enteric bacterial infections, such as that caused by *Shigella flexneri*, and these animals may present with primarily gastrointestinal signs ([@bib598], [@bib466]). Such concurrent bacterial infections may adversely impact morbidity and mortality. Abortion and neurologic signs may occur in some individuals ([@bib581], [@bib687]).

In marmosets, owl monkeys, and colobines the disease is more severe. In these species the disease is characterized by a rapidly progressive course and a predominance of gastrointestinal signs. The characteristic exanthema may be lacking. Edema of the periorbital region may be pronounced. Mortality may approach 100%, and lesions are centered within the gastrointestinal tract ([Figure 1.18](#f0095){ref-type="fig"} ).FIGURE 1.18Measles virus (MV).MV causes a viral exanthema often appearing first on the face and axilla (A), spreading to the abdomen (B). Multinucleated viral syncytial cells may be present in the epithelium (C) and viral infection may be demonstrated by immunohistochemistry for the measles matrix antigen (C, insert). Intranuclear inclusions composed of viral nucleocapsids (D) may be observed. A bronchointerstitial pneumonia may be observed (E) with antigen-positive cells centered on airways (E, insert right). Multinucleated syncytial cells (E, insert left) are often evident. The virus targets lymphoid tissue causing marked lymphoid depletion (F). Large multinucleated syncytial (Warthin-Finkeldey) cells may be observed in lymph node (F insert).

#### Pathogenesis and Pathology {#s1040}

The pathogenesis of measles virus infection is similar to that of rinderpest and canine distemper viruses. Following infection by the aerosolized route, there is an initial round of replication within the regional lymph nodes. The resulting viremia leads to dissemination of the virus to lymphoreticular organs and epithelial surfaces. It is in the terminal phases of this viremia that the characteristic skin rash appears. This exanthema coincides with rising neutralizing antibodies and may, in part, represent an Arthus-type (antibody--antigen complex) reaction.

Histologically, there is mild erythema and parakeratotic hyperkeratosis of the skin. Multinucleated syncytial cells may occasionally be found ([@bib264]). Lesions are most pronounced within the hair follicles where follicular necrosis is a characteristic change. In more severe cases there is often a proliferative and necrotizing bronchointerstitial pneumonia. Large syncytial cells are often present and careful inspection may reveal intranuclear and intracytoplasmic eosinophilic inclusions present within these cells, as well as type II pneumocytes and histiocytes. A purulent bacterial bronchopneumonia may be superimposed on these findings.

The latter stages of infection may be associated with significant viral-induced immunosuppression, which arises from lymphopenia and the destructive effect of the virus on thymic tissue, and may predispose animals to bacterial infections of the respiratory and gastrointestinal tracts. Morphologically marked depletion of lymphoid tissue in the lymph nodes and spleen may be evident. Viral inhibition of interferon-γ-induced upregulation of MHC class II antigen expression may further compromise immunologic function ([@bib409]). These effects on the immune system of the host may induce hyporesponsiveness to tuberculin antigen, resulting in a false-negative skin test in sensitized animals. Immunodysfunction may be so severe that animals develop opportunistic infections such as disseminated reactivation of CMV and candidiasis. The resolution of infection correlates with the appearance of cytotoxic CD8+ T lymphocytes.

Giant cells lacking viral inclusions (Warthin--Finkeldey cells) may be found within lymphoid tissue. In the most severe cases, typical viral inclusions may be found in a variety of epithelial surfaces. In marmosets, these changes may be accompanied by a necrotizing gastroenteritis. Ultrastructurally, the virus may be identified in tissues in two forms: (1) nucleocapsids that form tangles of filamentous tubules with a diameter of 20 nm and (2) paracrystalline arrays of filamentous rods 20 nm in diameter surrounded by an outer rim of less electron-dense material, giving the structure an overall diameter of 40--50 nm ([@bib570]). These latter structures can occasionally be found subjacent to the cell membrane in various stages of budding. Immunohistochemistry is useful in confirming the etiology of the viral infection.

A well-characterized postinfectious syndrome in human is subacute sclerosing panencephalitis (SSPE), which occurs in a small minority of patients 5--10 years after primary infection, and is characterized by progressive gliosis, demyelination, and neuronal loss ([@bib712]). Intranuclear inclusions composed of viral nucleocapsid are prominent and result from defective viral replication. One or more defects in the M, H, or F antigens prevent the formation of mature virons. Although an acute measles encephalitis in macaques and other species is well recognized ([@bib30]), it is less clear whether reported cases of SSPE in nonhuman primates critically fulfill all diagnostic requirements of SSPE in humans ([@bib368], [@bib8]).

#### Laboratory Findings {#s1045}

Presumptive diagnosis may be made on seroconversion, characteristic clinical, histopathologic, and ultrastructural findings. Further support may be gathered by demonstrating seroconversion. Definitive diagnosis requires viral isolation and identification. Isolation is best performed on human or rhesus monkey kidney cells from nasopharyngeal secretions, whole blood, or buffy coat preparations. Cultures should be maintained for 4--6 weeks with weekly transfers of supernatant to fresh cultures. Characteristic CPE include multinucleated syncytial cells and eosinophilic intracytoplasmic and intranuclear viral inclusions.

#### Treatment {#s1050}

No specific treatment is available. Epizootics in macaques have been controlled by the infusion of exposed animals with human γ-globulin and vaccination with modified live vaccine ([@bib598]). Supportive therapy for dehydration and secondary bacterial infections may be beneficial.

#### Prevention {#s1055}

Infant macaques should be vaccinated at 3 months of age or older with a modified live measles vaccine design for human use. A second dose given no sooner than 6 weeks produces protective antibody levels. Use of a commercial canine distemper measles modified live vaccine has also been reported and protects against wild-type challenge. In recent years availability of these products has been intermittent.

#### Zoonotic Potential {#s1060}

A macaque-to-human transmission has been demonstrated ([@bib598]).

### Paramyxovirus Saguinus {#s1065}

#### Introduction {#s1070}

A single outbreak of infectious gastroenteritis was diagnosed in cotton-topped tamarins, red-chested moustached tamarins (*S*. *labiatus*), black-chested moustached tamarins (*S*. *mystax*), and common marmosets at the New England Primate Research Center in 1977 ([@bib219]).

#### Etiology {#s1075}

A virus isolated from the spleen of a terminally ill tamarin was identified and used to infect four cotton-topped tamarins that later developed characteristic lesions and died. The virus was closely related to, but antigenically distinct from, measles virus. Although the exact relationship to measles virus is unknown, the causative agent likely represents a variant of measles virus ([@bib309]).

#### Epizootiology {#s1080}

The origin of infection in these animals is unknown. Virus was shed in the feces and a fecal--oral route of transmission seems likely.

#### Pathogenesis and Pathology {#s1085}

Pathogenesis likely parallels measles virus infection in nonhuman primates. Affected animals had moderate to severe necrotizing colitis and typhilitis with multinucleated syncytial cells present within crypts. Similar syncytial cells were present in pancreatic acini, renal tubules, and hepatic cords. A striking change was the presence of large syncytial cells containing up to 20--25 nuclei and intracytoplasmic viral inclusions within bile duct epithelium. Lymphoid necrosis within germinal centers was evident. No exanthema was recognized, and in contrast to measles virus infection of macaques, lesions were absent in the lungs and brain.

#### Clinical Findings {#s1090}

Clinically there was acute onset of anorexia, dehydration, and diarrhea, which progressed rapidly to death. Colony mortality of *S*. *oedipus* was approximately 10% and approached 100% in *S*. *mystax* and *S*. *labiatus*.

#### Treatment {#s1095}

No specific treatment is available.

Pneumovirinae {#s1100}
-------------

### Respiratory Syncytial Virus {#s1105}

#### Introduction {#s1110}

Respiratory syncytial virus (RSV) was first isolated from a chimpanzee with coryza in 1956 ([@bib66]). Subsequently, this agent has been shown to be an important cause of mild to severe respiratory disease in children worldwide.

#### Etiology {#s1115}

Respiratory syncytial virus, of the genus *Pneumovirus,* is a single-stranded RNA virus 90--130 nm in diameter. Individual isolates of RSV, in general, have a broad host range.

#### Epizootiology {#s1120}

The virus is highly contagious and is spread through aerosols. Anti-RSV antibodies are widespread in human and nonhuman primate populations ([@bib585]). Nonhuman primates likely become infected through human contact. Naturally occurring infections have almost exclusively been reported in apes, particularly gibbons and chimpanzees, although African green monkeys and owl monkeys have been experimentally infected with demonstrated signs of clinical disease ([@bib378], [@bib344]).

#### Pathogenesis and Pathology {#s1125}

Neutralizing antibodies (IgG) are nonprotective and may predispose individuals to more severe disease through the deposition of immune complexes within pulmonary vessels. Conversely, IgA is protective. The disease is often more severe in children within the first months of life due to the persistence of maternal antibodies (IgG not IgA). Similarly, in a clinical study of children, parenteral inoculation with killed vaccine was found to exacerbate and prolong infection as a consequence of the production of neutralizing antibodies.

In more severe cases, disease is characterized by a necrotizing bronchiolitis to bronchopneumonia. Multinucleated syncytial cells with intracytoplasmic inclusion bodies may be apparent. Lethal episodes are invariably associated with diffuse alveolar damage and microvascular thrombosis, which are characteristic of the acute respiratory distress syndrome (ARDS).

#### Clinical Findings {#s1130}

In nonhuman primates, the disease is often mild and is characterized by nonspecific upper respiratory signs, including coughing, sneezing, and mucopurulent oculonasal discharge. Fatalities have been described in infant or juvenile chimpanzees ([@bib122], [@bib380], [@bib702]). Epizootics in wild populations of apes may be associated with high morbidity of greater than 90% ([@bib380]).

#### Laboratory Findings {#s1135}

Rapid detection of RSV antigen in nasopharyngeal secretions of affected human infants using a direct immunofluorescent test has been described ([@bib117]). Viral isolation may be made on Hep-2 cells or rhesus monkey kidney cells and identified by immunofluorescent staining techniques. CPE is characterized by syncytial formation 1--14 days postinoculation. Molecular diagnostic techniques may also be employed.

#### Prevention {#s1140}

Vaccination by the parenteral route is not recommended because neutralizing antibodies (IgG) may predispose to more severe disease.

### Human Metapneumovirus {#s1145}

Human metapneumovirus was first identified in 2001 as a cause of respiratory disease in children from the Netherlands and is a cause of community-acquired influenza-like illness ([@bib739]). A 61% seroprevalence has been demonstrated in captive-bred chimpanzees with exposure likely to have occurred secondary to contact with human handlers ([@bib659]). Clinical signs following experimental infection of chimpanzees included nasal discharge and decreased appetite. African green monkeys were also able to support a high level of viral replication following experimental infection although there was no evidence of clinical disease ([@bib659]). Human metapneumovirus has been implicated as a cause of respiratory disease in wild populations of chimpanzees ([@bib355], [@bib380]).

Arteriviridae {#s1150}
-------------

The family Arteriviridae contains one genus, Arterivirus, which includes the viral species simian hemorrhagic fever virus, equine arteritis virus, lactate dehydrogenase-elevating virus of mice, and porcine reproductive and respiratory syndrome virus. These viruses are positive-stranded RNA viruses with genomes that vary from 12--15 kb in length.

### Simian Hemorrhagic Fever Virus {#s1155}

#### Introduction {#s1160}

Simian hemorrhagic fever virus (SHFV) is a highly contagious, fatal infectious disease of rhesus macaques. It was first recognized in 1964 simultaneously at the National Institutes of Health (Bethesda, MD) and at the Sukhumi Institute (USSR) ([@bib10], [@bib546], [@bib2]). It must be distinguished from other viruses capable of causing hemorrhagic fevers.

#### Etiology {#s1165}

SHFV is a single-stranded RNA virus 40--45 nm in diameter. It can be propagated in vitro on primary macaque macrophage cultures and on the MA-104 embryonic African green monkey kidney cell line ([@bib711]). Diagnostic ultrastructural changes become apparent after 24--72 h in these cells and include the formation of unique lamellar replicative structures.

#### Epizootiology {#s1170}

SHFV has been shown to naturally infect several African species, including Patas monkeys, African green monkeys, and baboons (*Papio anubis* and *P*. *cynocephalus*). Of these, the Patas monkey represents the most important reservoir and the greatest risk to macaques. In these species, infection is usually asymptomatic and reportedly animals may be viremic and seronegative ([@bib249]). Several strains of SHFV have been identified in Patas monkeys, which vary in their ability to cause clinical disease, persistent infection, and an antibody response ([@bib246]). Interestingly, Patas monkeys persistently infected and unable to mount an antibody response are able to clear infection when inoculated with a more virulent strain capable of inducing acute disease ([@bib247]).

Transmission to Asian macaques results in a fulminant and fatal infection characterized by a bleeding diathesis and rapid progression to death. Initial infection of macaques appears to require parenteral exposure to infected blood or tissue from carrier species. Once established the virus is highly contagious and may then be spread from macaque to macaque by aerosol, direct contact, or fomites ([@bib582]). Mortality may be as high as 100%.

#### Pathogenesis and Pathology {#s1175}

##### Macaques {#s1180}

At necropsy there is striking locally extensive congestion, hemorrhage, and necrosis of the proximal duodenum. Similar foci are found randomly distributed throughout the gastrointestinal tract and in the renal capsule, retrobulbar tissue, subcutis, and lung. The spleen is enlarged two to three times normal, and the white pulp may not be visible grossly.

Microscopically, characteristic lesions are found in lymphoid tissue. Extensive lymphoid necrosis and congestion exist within the spleen. Prominent perifollicular hemorrhages are often separated from the subjacent follicular mantle by a fibrinous exudate ([@bib10]). Sinuses may be distended by fibrin and plasma. Necrosis of germinal centers in other lymphoid tissues is prominent. Complete cortical thymic necrosis with sparing of the medulla is reportedly unique to SHFV infection ([@bib802]). Lesions elsewhere are compatible with those associated with disseminated intravascular coagulation and include deposition of fibrin thrombi within glomeruli, hepatic sinusoids, and lung. Lesions within the small intestine consist of extensive hemorrhage within the lamina propria accompanied by intestinal epithelial cell necrosis. As with other arteriviruses, fetal loss is common. A lymphohistiocytic meningoencephalitis is present in a minority of animals. Macrophages represent the principal target cell of SHFV infection, and the unique sensitivity of macaques to this viral infection relates to the propensity of their macrophages to support viral growth ([@bib248]).

The absence of hepatic and/or adrenal necrosis in conjunction with the previously described findings is highly suggestive of SHFV. Their presence suggests possible infection with Ebola virus, Marburg virus, or Kyasanur Forest disease virus. Additional distinguishing features of Ebola Reston virus are intracytoplasmic inclusion bodies and patchy interstitial pneumonia ([Figure 1.19](#f0100){ref-type="fig"} ).FIGURE 1.19Simian hemorrhagic fever virus (SHFV).In macaques simian hemorrhagic fever targets lymphoid tissue causing widespread lymphoid necrosis and deposition of fibrin.

##### African Monkeys {#s1185}

Simian hemorrhagic fever virus infection of Patas monkeys, African green monkeys, and baboons is generally asymptomatic. In Patas monkeys, the viral strain appears to play a critical role in determining the disease course ([@bib247]). Viral strains LVR and P180, both of which induce lytic infection of Patas monkey peritoneal macrophages, may induce an acute and rarely fatal disease in this species. Animals frequently were febrile and showed anorexia, lethargy, facial edema, and dehydration. Small subcutaneous hemorrhages were noted occasionally. These viral strains induced a strong antibody response and did not result in persistent infection. In contrast, viral strains that did not result in lytic infection of Patas monkey peritoneal macrophages were more likely to result in asymptomatic infection, poor antibody response, and persistent infection.

#### Clinical Findings {#s1190}

Following experimental inoculation of macaques there is an incubation period of 3--7 days. Initially a fever without other clinical signs is recognized followed shortly by a bleeding diathesis (epistaxis, hematuria, melena, ecchymoses and petechiae). In the terminal stages, depression, dehydration, photophobia, and cyanosis are present. The entire clinical course may last from 1--7 days ([@bib546]). An alternative presentation is sudden death without obvious clinical signs.

#### Laboratory Findings {#s1195}

Fibrin degradation products may become elevated as early as 24--48 h postexperimental inoculation ([@bib2]). There is an increase in aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase at the onset of clinical signs. The coagulopathy is characterized by thrombocytopenia and prolonged partial thromboplastin times. Proteinuria and hematuria may be noted on urinalysis.

#### Treatment {#s1200}

No treatment is available. A summary of control measures has been published and should be instituted at the first evidence of an epizootic hemorrhagic disease in macaques ([@bib246], [@bib802]). This multifaceted approach includes (1) elimination of clinically ill and exposed animals, (2) quarantine of remaining animals, (3) disinfection of premises, (4) diagnostic efforts to identify the etiologic agent, (5) notification of appropriate government agencies, and (6) monitoring of human contacts.

#### Prevention {#s1205}

Exposure of macaques to African primates and their blood and tissue products should be prevented. When Patas monkeys and macaques are housed within the same facility, special precautions should be taken to prevent inadvertent exposure. Although ELISA assays have been developed, serology may be of limited value in determining which African primates carry the virus ([@bib239]).

#### Zoonotic Potential {#s1210}

There is no evidence that simian hemorrhagic fever virus is a zoonosis. A major concern is that the clinical signs of this disease in macaques mimic several other diseases (Ebola virus, Marburg virus, yellow fever virus, and Kyasanur Forest virus) that may infect human beings with lethal consequences. As such, all macaques exhibiting these clinical signs should be treated as if infected with a potentially lethal zoonotic agent.

Togaviridae {#s1215}
-----------

Togaviridae are single-stranded, positive-sense RNA viruses that are 70 nm in diameter with a lipid envelope and peplomers composed of a heterodimer of two glycoproteins. The Togaviridae family contains two genera (*Alphavirus* and *Rubivirus*). The Alphavirus genus consists of approximately 30 species of arthropod-borne viruses including the significant human pathogens eastern equine encephalitis, western equine encephalitis, Sindbis virus, Chikungunya virus, and Mayaro virus. These viruses are grouped into seven serocomplexes based on serological data and three phylogenetic clusters. These viruses may also be categorized into Old World and New World viruses based on geographic distribution. Free-roaming populations of both Old and New World nonhuman primates have been proposed as vertebrate hosts and potential reservoirs for Mayaro and Una viruses, prevalent in South America, and Chikungunya virus, distributed in Africa and Asia ([@bib287], [@bib642], [@bib707], [@bib148], [@bib317], [@bib159]). Clinical disease associated with Mayaro and Una virus has not been reported in nonhuman primates.

### Chikungunya Virus {#s1220}

#### Introduction {#s1225}

Chikungunya virus was first isolated in 1952, reemerged in Kenya in 2004, and has since contributed to significant human morbidity in over 18 countries ([@bib607], [@bib684]). Genetic mutations in viral strains have allowed adaptation to more widely distributed mosquito vectors likely contributing to spread of the epidemic ([@bib731]). Disease in humans is characterized by fever, maculopapular rash, myalgia, and arthralgia that may persist in a portion of patients.

#### Epizootiology {#s1230}

Nonhuman primates are susceptible to infection and likely act as a contributor to the viral reservoir in Africa and Asia. Free roaming populations of red tail monkeys (*Cercopithecus ascanius*), African green monkeys, baboons, chimpanzees, and colobus monkeys have demonstrated seropositivity ([@bib473]). Seropositivity rates for IgM and IgG antibodies were 14.8% and 59.3% respectively in wild-caught cynomolgus macaques in the Philippines ([@bib317]). Interestingly, there currently does not appear to be strong evidence to indicate that the large population of cynomolgus macaques residing on the island of Mauritius has contributed to the significant epidemic within this region ([@bib281]).

#### Pathogenesis and Pathology {#s1235}

Naturally occurring disease has not been reported in nonhuman primates, however, experimental infection of cynomolgus macaques recapitulates human symptomatology and pathology ([@bib390]). Depending on dose of inoculum, macaques demonstrated evidence of fever, morbilliform skin rash, increased hepatic transaminases, and detectable levels of circulating virus. Macaques inoculated with a high dose demonstrated evidence of swollen joints, menigoencephalitis, and variable mortality. Histopathological lesions included extensive histiocytic infiltration of spleen and lymph nodes. Infiltrates were present as long as 6 months postinoculation suggesting that macrophages act as the main cellular reservoir for persistent Chikungunya virus.

#### Zoonotic Potential {#s1240}

Zoonotic transmission of Chickungunya virus from animals housed in research settings has not been reported.

Flaviviridae {#s1245}
------------

The family Flaviridae ([Table 1.4](#t0025){ref-type="table"} ) encompasses greater than 70 viruses, many of which are important pathogens of humans and animals. In humans, pathogenic flaviruses characteristically produce meningoencephalitis (e.g., Japanese encephalitis, St. Louis encephalitis, West Nile virus) or a hemorrhagic fever syndrome (e.g., yellow fever, dengue). Although many of these viruses are transmitted by arthropod vectors (ticks and mosquitoes), some may be transmitted directly among mammalian hosts. The Flavivirade family is comprised of three genera including *Flavivirus,* *Hepacivirus*, and *Pestivirus*. Members of the *Flavivirus* genus can be grouped serologically into distinct groups based on differences within the envelope protein, the most significant of which are the Dengue, Japanese encephalitis virus, and yellow fever virus subgroups. The number of identified flaviruses is continually expanding, and the pathogenicity of most for nonhuman primates is unknown.TABLE 1.4FlaviviridaeFamilyGenusVirusFlaviridae*Flavivirus*Dengue virusJapanese encephalitis virusKyasanur Forest disease virusSt. Louis encephalitis virusWest Nile virusYellow fever virusZika virus*PestivirusHepacivirus*Hepatitis C virusGB virus A, B, and C

### Yellow Fever Virus {#s1250}

#### Introduction {#s1255}

Yellow fever, a member of the genus *Flavivirus*, is a devastating viral disease of humans and New World primate species that is transmitted by a variety of mosquito vectors. It is thought that yellow fever virus originated in Africa and was spread to the New World in the 16th and 17th centuries along trans-Atlantic trade routes. Once established in native mosquitoes, its introduction was associated with devastating epidemics and epizootics in humans and indigenous nonhuman primates.

#### Epizootiology {#s1260}

Yellow fever virus infects forest and bush-living mosquitoes, including *Aedes* spp., *Haemagogus* spp., and *Sabethes* spp., with which it commensally exists. In *A*. *aegypti* the virus may persist through the dry season by transovarian transmission. The mosquito represents the reservoir host and largely determines the geographic distribution and persistence of the virus in nature.

Yellow fever virus has been shown to infect a variety of primate species. In African species, infection is associated with viremia but few clinical signs and is eliminated with rising neutralizing antibodies generally within 6 days. Wild hosts that support this sylvatic cycle reportedly include baboons, mangabeys, chimpanzees, red colobus monkeys (*Pilocolobus badius*), African green monkeys, and Patas monkeys. Viremia in these animals serves to propagate the virus in vector species and may initiate the urban cycle when transmission to peridomestic mosquitoes such as *A*. *aegypti* occurs. Once established in mosquito species that feed on humans, epidemics may become established in human populations.

In New World primates, the disease is more severe and epizootics have been described in howler monkeys, spider monkeys, and squirrel monkeys and may coincide with cases in adjacent human populations ([@bib621], [@bib587]). Capuchin monkeys and wooly monkeys may be less susceptible. In tropical South America, human infection generally results from inadvertent exposure of individuals to the sylvatic cycle. Other than a small urban outbreak in Bolivia in 1999, the reduction of *A*. *aegypti* populations has limited the urban cycle within South America ([@bib741]).

#### Pathogenesis and Pathology {#s1265}

Although yellow fever is not found naturally in Asia, experimental inoculation of macaques is associated with a rapidly lethal disease that models many of the features present in fatal human cases. As such, much of what is known about the pathogenesis of yellow fever virus infection has been determined in this experimental setting ([@bib302], [@bib373], [@bib374], [@bib495]).

Following inoculation, initial rounds of replication occur in the regional lymph nodes, with rapid dissemination to multiple organs. While neurotropic and viscerotropic strains are recognized, the viscerotropism of the virus accounts for the cardinal clinical signs. During the initial phase of viremia, virus is visualized first within Kupffer cells and subsequently with hepatocytes. Disseminated intravascular coagulation and depletion of vitamin-K-dependent clotting factors contribute to the recognized bleeding diathesis.

Histologically, lesions in the liver are characterized by multifocal hepatocellular necrosis with the formation of Councilman bodies and Torres bodies ([@bib45], [@bib46]). These changes are invariably accompanied by the fatty degeneration of the remaining hepatocytes. Lymphoid depletion within germinal centers and splenic arterial sheaths may be prominent. Although not a natural disease of macaques, clinical and pathologic findings following experimental inoculation are remarkably similar to syndromes caused by other hemorrhagic fever agents such as simian hemorrhagic fever virus and filoviruses.

#### Clinical Findings {#s1270}

Infection of African species is asymptomatic. Natural infection of New World nonhuman primates is generally recognized by an increased mortality in susceptible species and may accompany human cases in the geographical vicinity.

#### Prevention {#s1275}

Yellow fever is primarily a disease of wild nonhuman primates. Because there is a short incubation period and no carrier state is established, the risk of capture and importation of infected animals is relatively low. Nevertheless it should be considered in the differential diagnosis of hemorrhagic fever in endemic regions and in recently imported primates.

### West Nile Virus {#s1280}

#### Introduction {#s1285}

West Nile virus, first documented in Uganda in 1937, emerged in the United States in 1999, gradually spread across the continent, and is now endemic within North America ([@bib398]). The single-stranded RNA virus of the *Flavivirus* genus is a member of the Japanese encephalitis virus serogroup. The mosquito-borne virus causes clinically evident disease primarily within human, avian, and equine hosts although it can also infect numerous vertebrate species as incidental hosts. Avian species are considered the primary reservoir host. Disease in humans is often a mild, self-limiting febrile illness although meningoencephalitis is a rare complication observed primarily in aged or immunocompromised individuals.

#### Epizootiology {#s1290}

West Nile virus seropositivity has been demonstrated within outdoor-housed nonhuman primates. A survey of baboons, rhesus, and pig-tailed macaques at the Tulane National Primate Research Center demonstrated a 36% overall seroprevalence, while a similar survey at the Yerkes National Primate Research Center demonstrated a lack of seroprevalence within outdoor-housed rhesus macaques and a limited 6.6% seroprevalence within Sooty Mangabeys ([@bib573], [@bib127]). This difference was suspected to be associated with the variability in the abundance of mosquito vectors between the two sites. The short duration and low level of viremia are thought to exclude nonhuman primates as a potential source of transmission of the virus.

#### Pathogenesis and Pathology {#s1295}

The majority of natural and experimental West Nile virus infections in nonhuman primates are subclinical ([@bib574], [@bib306], [@bib784]). Intracerebral inoculation of rhesus macaques and intranasal inoculation of Bonnet macaques reportedly results in a variable incidence of encephalitis ([@bib564], [@bib243]). Naturally acquired and clinically evident disease has been reported in a Barbary macaque housed outdoors within a zoological setting ([@bib533]). Clinical signs observed in this case included ataxia, tremors, cranial nerve deficits, and nystagmus. Histopathology revealed a nonsuppurative meningoencephalitis characterized by gliosis and glial nodules as well as perivascular lymphoplasmacytic cuffing. Mononuclear infiltrates and edema were observed in the meninges. West Nile virus as the etiology was confirmed with IHC and molecular techniques.

#### Prevention {#s1300}

Control of exposure to mosquito vectors may be indicated for outdoor-housed animals.

### Kyasanur Forest Disease Virus {#s1305}

Kyasanur Forest disease, also of the genus *Flavivirus*, was first recognized in March of 1957 as a cause of increased mortality in langurs (*Presbytis entellus*) and bonnet macaques ([@bib321], [@bib322]). Subsequent investigations demonstrated a concurrent illness in adjacent human populations. The virus has been isolated from a variety of ixodid ticks, including *Haemaphysalis spinigera*, *H*. *turturis*, and *loxdes petauristae* ([@bib656]). In addition, the virus has been isolated from rodents and bats from the endemic region.

The disease in nonhuman primates is characterized by multifocal hepatocellular necrosis accompanied by hemorrhages within the adrenal gland, brain, kidney, and lung. There is prominent leukopenia, anemia, and thrombocytopenia ([@bib762]). In humans, the disease may produce mild nonspecific signs or a fulminant hemorrhagic disease with high mortality. This virus is a HHS select agent.

### Dengue Viruses; Serotypes 1--4 {#s1310}

Dengue viruses (DNV) are important causes of human hemorrhagic fever in tropical and subtropical regions worldwide. These viruses are members of the genus *Flavivirus*. There are four serotypes each with approximately three to five genotypes. Free-ranging nonhuman primate populations, including cynomolgus monkeys, Toque macaques (*Macaca sinica*), and brow-ridged langurs (*Trachypithecus* (*Presbytis*) *cristatus* and *T*. *obscura*), may have a high rate of seroreactivity, indicating widespread exposure ([@bib611], [@bib601], [@bib556]). Neutralizing antibodies have been demonstrated in nonhuman primates in association with epidemics in Nigeria, Sri Lanka, and other regions ([@bib147]). As with yellow fever, a sylvatic cycle involving *Aedes* spp. mosquitoes and nonhuman primates and an urban cycle in which the disease is spread among the human population are postulated to occur.

Experimental infection of macaques, African green monkeys, mangabeys *(Cercocebus* spp.), owl monkeys, and baboons produces viremia and antibody response but has been associated with only minimal clinical signs ([@bib265], [@bib630], [@bib454]). This has allowed species such as the rhesus macaque and owl monkey to be useful for evaluation of Dengue vaccination strategies and study of virologic and immunologic responses ([@bib266], [@bib267], [@bib59], [@bib575], [@bib651]). However, the absence of significant clinical disease has limited the utility of such models for the study of the pathogenesis of Dengue hemorrhagic fever and Dengue shock syndrome. A recent publication suggests that high-dose intravenous inoculation with DNV2 was associated with a hemorrhagic phenotype accompanied by modest thrombocytopenia, increased D-dimer, and increased thrombin--antithrombin complexes ([@bib535]). The significance of dengue virus infection of wild nonhuman primates is unknown.

### Hepatitis C Virus (HCV) {#s1315}

#### Introduction {#s1320}

Hepatitis C virus is the most common bloodborne pathogen recognized in the United States and in man causes a persistent viral infection leading to chronic hepatitis and hepatocellular carcinoma. HCV-related deaths are expected to triple in the next decade in this country and currently there are limited treatment options and no effective vaccine. HCV is a member of the tentative genus *Hepacivirus*. Like other members of the flaviridae, HCV is a single-stranded positive sense RNA virus. It was identified in 1989 through work largely made possible through transmission of infectious serum from human patients with non-A non-B hepatitis to chimpanzees ([@bib118]). Like many other RNA viruses, HCV has an error-prone replicase resulting in a high mutation rate that leads to the production of progeny virions exhibiting extensive sequence variation. There are at least six major genotypes and more than 50 serotypes defined. Vaccines and therapeutic strategies must address this diversity to be successful.

#### Etiology {#s1325}

The HCV genome itself is a single-stranded positive-sense RNA of about 9.5 kb in length. Highly conserved non-translated regions flank a single open reading frame encoding a polyprotein of about 3000 amino acids. In the 5'NTR is an internal ribosome entry site (IRES) which functions to initiate translation of the viral protein. This polyprotein is processed by cellular and viral proteases to produce specific viral gene products. Structural proteins including the capsid and envelop proteins are found at the N-terminus of the polyprotein while the nonstructural proteins (the proteases and proteins forming the replicase complex) are found at the C-terminus. The IRES, NS3 protease and RNA-dependent polymerase are under intense investigation as potential therapeutic targets.

#### Epizootiology {#s1330}

HCV is not a natural infection of nonhuman primates and attempted experimental inoculation of a number of species has failed to result in transmission ([@bib1]). Chimpanzees are susceptible to infection and remain an important animal model of this condition ([@bib118]).

#### Pathogenesis and Pathology {#s1335}

According to the World Health Organization there are approximately 170 million individuals chronically infected with HCV worldwide. Only 4 million of these individuals are found in North America with the vast majority located in Asia and Africa. These are areas that also have a high prevalence of HIV, and co-infection of patients with HCV and HIV is increasingly a concern. The natural history of disease is prolonged with average time to the development of chronic hepatitis being 10 years, 20 years for cirrhosis, and 30 years for hepatocellular carcinoma.

Following exposure there are two disease patterns in individuals infected with HCV: one characterized by control and recovery and the other with chronic infection and progression. In the first pattern there is evidence of viral replication and hepatic damage in the first few months following infection. The rise in ALT may be associated with clinical signs; however, the host mounts an effective immune response and the appearance of anti-HCV antibodies is associated with resolution of the viremia and abatement of hepatic disease. In the second pattern primary infection is associated with clinical signs but the immune response is only partially effective in controlling viral replication.

The chimpanzee has been the primary animal model involved in HCV research and was in fact instrumental in the initial recognition of HCV as a distinct clinical entity and molecular characterization of the virus ([@bib703], [@bib118]). Experimental inoculation recapitulates the course of human infection and the model has several advantages including: (1) susceptibility to infection with HCV; (2) similarities in onset of disease, level of viremia and timing of serologic responses and elevations in liver enzymes; and (3) the ability to obtain liver tissue and examine early time points. The model continues to find important uses and recently demonstrated the efficacy of inhibition of miRNA122 in lowering viral load in chronically infected animals ([@bib402]).

### GB Agent Viruses: GBV-A, GBV-B, and GBV-C {#s1340}

#### Introduction {#s1345}

Two novel viruses have been identified using subtractive PCR methodology on tissue samples from tamarins infected with the serially passaged "GB agent" ([@bib632], [@bib655]). This agent was first identified in the mid-1960s when serum from a human patient with acute hepatitis was inoculated into four marmosets that subsequently developed a nonsuppurative portal hepatitis ([@bib151]). At the time, investigators questioned whether the agent identified in marmosets represented a human pathogen or reactivation of an indigenous marmoset virus ([@bib551]).

Subsequent molecular techniques have identified two distinct viruses (designated GBV-A and GBV-B) in tamarins infected with pooled marmoset plasma from the original studies. Furthermore, a third virus (GBV-C) with close homology to GBV-A has been found in human hepatitis patients; however, the relationship of this virus to clinical disease in humans remains to be determined ([@bib810]). Finally, PCR using primers directed against the 5' end of GBV-A has identified GBV-A sequences within tamarins not exposed to the GB agent, suggesting that the virus may be more widespread than originally thought ([@bib633]).

#### Etiology {#s1350}

These GB agents, of the genus *Hepacivirus*, are closely related to hepatitis C virus of humans and share similar genomic organization and replication strategies. They are single-stranded, positive-sense RNA viruses with a 9.5-kb genome encoding a single polyprotein that is cleaved by cellular and viral proteases. Structural proteins are encoded within the N-terminus of the polyprotein and the homologous nonstructural proteins encoded within the C-terminus. GBV-A and -C are unique among the flaviviridae in that they lack a well-defined capsid protein. As with all flaviridae translation of the viral proteins is mediated by an internal ribosome entry site (IRES), a highly structured RNA sequence within the 5' NTR. The IRES binds to the host 40S ribosomal subunit and the eukaryotic initiation factor to precisely position the start codon at the ribosome decoding site. One of the critical elements of the IRES is the IIIc stem loop which is highly conserved not only among HCV genotypes but GBV-B and pestiviruses. Deletion of the IIIc loop results in a significant reduction of IRES-initiated translation and thus has been an attractive target for small molecule inhibitors. The structure and function of the IIIc stem loop have been compared between HCV and GBV-B and have revealed extensive homology suggesting that GBV-B may represent an appropriate model to study such inhibitors.

#### Epizootiology {#s1355}

GBV-A and now additional variants have been identified in a number of New World nonhuman primate species. Distinct GBV-A viral sequences have been detected in moustached tamarins (*Sanguinus labiatus* and *S*. *mystax*), cotton-topped tamarins, owl monkeys (*Aotus trivirgatus*), and common marmosets. The origin and importance of GBV-like agents to wild and captive marmosets is presently unclear. Samples from wild-caught primates in South America have found animals to be naturally infected with these agents and distinct sequence differences have been observed between isolates from captive colonies and those in wild animals. There are significant variations in these isolates with 52% to 72% identity at the nucleotide level among the different strains. Cross-species transmission studies suggest high host specificity. Together this evidence suggests that GBV-A variants circulate in many wild populations of neotropical primates.

The epizootiology of GBV-B infection is less clear and the agent has not been recognized outside of strains derived from passage 11 GB serum. The natural host and associated disease processes are unknown.

#### Pathogenesis and Pathology {#s1360}

No clear disease process has been associated with GBV-A or -C. GBV-C, also known as hepatitis G virus, was initially associated with fulminant hepatitis in humans; however, additional work revealed that if GBV-C caused hepatic disease this was an infrequent occurrence. The initial association with hepatic disease is probably due to the fact that GBV-C is often co-transmitted with HCV as a bloodborne pathogen. GBV-C viremia is common in the US with about 1.5% of normal blood donors infected. The peripheral viremia is cleared with the development of the virus-specific antibody response. Similar viruses have been detected in wild chimpanzee populations ([@bib58]).

GBV-B produces a nonsuppurative hepatitis following intravenous inoculation of tamarins or marmosets and has been proposed as a small primate surrogate model of HCV infection. Tamarins, owl monkeys, and common marmosets appear to be susceptible and develop increases in liver function test values after intravenous inoculation. In marmosets hepatic pathology and peripheral viremia could be quantified biochemically, immunophenotypically and morphologically, and persisted for periods of up to 6 months in some animals ([@bib323]). Hepatitis was characterized by a marked influx of CD3+ CD8+ T lymphocytes and CD20+ B cells within the first 2 months of primary infection. In vitro systems to cultivate the virus in primary marmoset hepatocytes have also been developed ([@bib324]).

Arenaviridae {#s1365}
------------

Arenaviruses are pleomorphic, enveloped viruses 110--130 μm in diameter containing two segments of RNA that encode at least three gene products. A characteristic biological feature of arenaviruses is life-long viral persistence within the definitive rodent host. The persistently infected host sheds the virus in urine and body secretions which then contaminate the environment and play a critical role in the transmission to the inadvertent (primate or human) host. A number of arenaviruses have been identified, with at least 23 species recognized by the ICTV. Viruses are classified according to antigenic properties and genetic differences into two groups: the Tacaribe or New World serocomplex and the Lassa-lymphocytic choriomeningitis (LCM) or Old World serocomplex ([Table 1.5](#t0030){ref-type="table"} ). Other than lymphocytic choriomeningitis virus (LCMV) which has a worldwide distribution, members of the *Arenaviridae* family demonstrate a restricted geographic distribution determined primarily by the range of the reservoir species. Several arenaviruses including Machupo, Junin, Guanarito, Sabia, and Lassa fever viruses cause hemorrhagic fever in humans. These viruses are all HHS select agents.TABLE 1.5ArenaviridaeComplexVirusOld WorldLymphocytic choriomeningitis virusLassa fever virusNew WorldJunin virus (Argentine hemorrhagic fever)Machupo virus (Bolivian hemorrhagic fever)

### Lymphocytic Choriomeningitis Virus {#s1370}

#### Introduction {#s1375}

A rapidly progressive viral hepatitis occurring in zoological collections has been characterized ([@bib498]). Outbreaks have been reported in golden lion tamarins, emperor marmosets (*Saguinus imperator*), pygmy marmosets (*Cebuella pygmaea*), common marmosets, cotton-topped tamarins, white-fronted tamarins (*S*. *nigricollis*), saddle-backed tamarins (*S. fuscicollis*), and Goeldi's monkeys ([@bib565], [@bib496], [@bib26]). Due to the predilection for disease in these species, the original reports termed this virus Callitrichid Hepatis Virus.

#### Etiology {#s1380}

The etiologic agent is LCMV. This arenavirus is pleomorphic and 85--105 nm in diameter. The genome is a two-segmented RNA genome consisting of the S segment that encodes the glycoprotein precursor and nucleoprotein and the L segment that encodes the viral polymerase and small zinc-binding protein. The virus has been identified within cytoplasmic vesicles of affected animals ([@bib496]). Although reports of natural infections in nonhuman primates are limited to the above species, macaques are susceptible to experimental infection with LCMV and therefore wider species susceptibility may be anticipated. LCMV infection in macaques is similar in presentation to and used as a surrogate model for Lassa fever.

#### Epizootiology {#s1385}

Animals become infected through contact with or ingestion of infected rodents. The virus may be introduced to colonies by either wild mice or the intentional feeding of neonatal laboratory mice ("pinkies") ([@bib499]). The incubation period is 1--2 weeks. The incidence and mortality rate may be high. Serologic evidence of infection of captive marmosets without recognized clinical signs has been demonstrated ([@bib565]).

#### Clinical Findings {#s1390}

Clinical signs include dyspnea, anorexia, weakness, and lethargy. Animals may be jaundiced and evidence of coagulopathy may be apparent. In many cases there is sudden death without clinical signs.

#### Pathogenesis and Pathology {#s1395}

At necropsy, hepatosplenomegaly, pleural and pericardial effusions, jaundice, and subcutaneous and intramuscular hemorrhages are characteristic ([@bib496]). Histopathologic lesions within the liver consist of multifocal hepatic necrosis with infiltration by lymphocytes and neutrophils. Acidophilic bodies representing apoptotic hepatocytes are prominent and may be found in hepatic sinusoids or within Kupffer cells ([@bib496]). The LCMV antigen and mRNA have been identified within hepatocytes, suggesting that direct viral infection may be responsible for the observed hepatocellular necrosis ([@bib497]). In addition, necrosis may be evident in the abdominal lymph nodes, adrenal gland, spleen, and gastrointestinal tract ([@bib498]). Lymphoid tissue demonstrates hyperplasia of follicular and parafollicular regions with depletion of germinal centers. Immunohistochemistry for viral antigen demonstrates presence of virus within macrophages and intrafollicular reticular cells although not in lymphocytes. Viral antigen is also present within both epithelial and endothelial cells from pulmonary and renal tissues ([@bib497]) ([Figure 1.20](#f0105){ref-type="fig"} ).FIGURE 1.20Lymphocytic choriomeningitis virus (LCMV).LCMV can be transmitted to callitrichids causing severe hepatitis. Grossly jaundice, hepatomegaly and serosal hemorrhages are observed (A). (Photograph courtesy of Dr. Richard Montali and Smithsonian National Zoological Park.) In the liver brightly eosinophilic apoptotic (Councilman) bodies are evident (B) as well as intracytoplasmic eosinophilic cellular inclusions (C).

#### Laboratory Findings {#s1400}

Elevations in liver enzymes, bilirubin, and serum alkaline phosphatase have been demonstrated.

#### Treatment {#s1405}

Treatment directed at correcting hypovolemia and electrolyte disturbances may be of some benefit. Ribavirin therapy in macaques inoculated with the related Junin, Machupo, and Lassa fever viruses has shown some efficacy ([@bib326]). The pharmacokinetics and safety of these drugs in marmosets are unknown.

#### Prevention {#s1410}

Screening of food source rodent colonies for LCMV and preventing contact with wild rodents should prevent disease transmission. Biologics of murine origin should be screened for the presence of LCMV before use in tamarins or marmosets.

#### Zoonotic Potential {#s1415}

Lymphocytic choriomengingitis virus may cause disease in humans. The most common presentation is a subclinical or a self-resolving influenza-like illness. Severe disease presenting as meningitis or meningoencephalitis may occur. The virus is considered a teratogenic pathogen resulting in fetal loss or developmental defects. Seroconversion of veterinarians in contact with infected marmosets has been demonstrated ([@bib497]).

### Lassa Fever Virus {#s1420}

Lassa fever virus is a member of the Old World Arenaviridae serogroup and is responsible for outbreaks of human disease in western Africa. Manifestation of disease in humans varies from asymptomatic to a fatal hemorrhagic fever. Experimental inoculation of rhesus and cynomolgus macaques results in disease that recapitulates that observed in humans ([@bib87], [@bib29]). Clinical symptoms include fever, anorexia, and an acute respiratory syndrome. On histopathologic examination an interstitial pneumonia and alveolitis may be identified as well as a multifocal, necrotizing hepatitis with minimal to moderate periportal, mononuclear infiltrates. Dendritic cells, macrophages, hepatocytes, and endothelial cells are the cellular targets of infection. Earlier and more robust humoral and cellular immune responses are associated with control of viral replication and survival in the cynomolgus model ([@bib29]). Severe, fatal disease associated with experimental Lassa virus infection in common marmosets has also been described ([@bib92]). Animals developed fever and weight loss accompanied by high levels of viral replication. At necropsy, the characteristic multifocal hepatic necrosis was present in addition to evidence of hepatocyte proliferation as indicated by KI67 immunostaining. Animals demonstrated lymphoid depletion characterized by loss of T and B cells. Depleted regions were replaced with histiocytic infiltration. Such changes were likely associated with impairment of the adaptive immune response and progression of disease.

### Bolivian Hemorrhagic Fever Virus: Machupo Virus {#s1425}

Machupo virus is an arenavirus from the New World serogroup that has contributed to epidemics of hemorrhagic fever in Central and South America. The susceptibility and importance of nonhuman primates in natural disease are unknown. Rhesus macaques, Geoffrey's marmosets, and African green monkeys may be experimentally infected with the Machupo virus. In these species it causes a severe, disseminated infection involving the central nervous system, gastrointestinal tract, and lungs. Hemorrhages are found in the skin, liver, oral cavity, and adrenal cortex. The virus has been isolated from rodents within the Muridae and Cricetidae families.

Retroviridae {#s1430}
------------

The family *Retroviridae* consists of two subfamilies; the *Orthoretrovirinae* containing six genera (including the four that infect nonhuman primates: *Betaretrovirus*, *Deltaretrovirus*, *Gammaretrovirus*, and *Lentivirus*) and the *Spumaretrovirinae* containing one genus; *Spumavirus.* These viruses are single-stranded RNA viruses that possess the enzyme reverse transcriptase (RT) that transcribes RNA into double-stranded DNA and the enzyme integrase that enables the DNA provirus to integrate into the host genome. The retrovirus genome consists of four major genes including *gag* encoding the structural capsid proteins, *pol* encoding the RT and integrase enzymes, *env* encoding the transmembrane and envelope proteins, and *pro* encoding a protease enzyme. Additional genes encoding regulatory proteins vary among specific viruses ([Figure 1.21](#f0110){ref-type="fig"} ). FIGURE 1.21Ultrastructural morphology of simian retroviridae.Simian retrovirus (A), simian immunodeficiency virus (B) and simian foamy virus (C).

Orthoretrovirinae {#s1435}
-----------------

### Simian Retrovirus (SRV) {#s1440}

#### Introduction {#s1445}

During the 1960s and 1970s, several regional primate research centers located in the United States experienced epizootics of malignant lymphoma and immunosuppressive disease ([@bib692], [@bib668], [@bib279], [@bib310], [@bib371]). At the time these epizootics were suspected to be the result of an underlying simian viral infection. The issue remained unresolved until the early 1980s when, spurred by a burgeoning epidemic of immunodeficiency in homosexual men, investigators simultaneously identified two agents capable of inducing immunosuppressive disease in macaques. The first virus, a member of the *Betaretrovirus* genus, was identified and designated simian retrovirus type D (SRV/D) (since designated simian retrovirus \[SRV\]) ([@bib140], [@bib245], [@bib457]). The second, a member of the *Lentivirus* genus, was designated simian immunodeficiency virus of macaques (SIVmac) ([@bib141], [@bib416]). This primate lentivirus is closely related to the etiologic agent of human AIDS and has subsequently been the subject of intensive investigation as an animal model of human immunodeficiency virus infection. Because SRV is more distantly related to the human immunodeficiency viruses than SIV, it has received far less attention than its lentivirus cousin. Although SIV may be of greater scientific interest as an animal model of human AIDS, SRV is clearly of greater significance in the management and care of captive macaques. As experience has shown, not only is SRV more difficult to eliminate from macaque colonies, it is also responsible for most cases of spontaneous viral-induced immunodeficiency in captive members of these species.

#### Etiology {#s1450}

Simian Betaretroviruses (formerly Type D retroviruses) exist as both endogenous and exogenous forms ([Table 1.6](#t0035){ref-type="table"} ). Endogenous virus sequences have been recognized in squirrel monkeys, spectacled langurs, members of the *Cercopithecinae*, and are suspected in several species of colobines ([@bib276], [@bib719], [@bib740]). SRV was originally isolated in 1970 from the mammary neoplasm of a female rhesus macaque and was designated the Mason--Pfizer monkey virus (MPMV) ([@bib119]). Subsequent work indicated that this virus caused a wasting syndrome and thymic atrophy when inoculated into infant rhesus macaques and that approximately 25% of all macaques housed at US regional primate research centers were seroreactive to MPMV or a closely related virus ([@bib209], [@bib208]). Several SRV serotypes have since been reported and include SRV type 1 (SRV-1), type 2 (SRV-2), type 4 (SRV-4), and type 5 (SRV-5). More recently SRV-Tsukuba (SRV-T) was isolated from macaques housed at the Tsukuba Primate Center in Japan while SRV-6 and SRV-7 were identified in free-ranging rhesus macaques and langurs (*Semnopithecus entellus*) from India ([@bib514], [@bib515], [@bib269]). These three novel viruses remain untyped by antibody neutralization assays. Significant genetic variation exists among the serotypes. The prototypic retrovirus, MPMV (SRV-3), is most closely related to SRV-1 and SRV-2, which are the viruses that serve as the major causes of immunosuppressive disease in captive macaques. While SRV-1 is most typically detected in rhesus macaques and SRV-2 more commonly isolated from cynomolgus or pig-tailed macaques, animals housed in research environments may carry any of the serotypes or possibly multiple serotypes ([@bib410], [@bib500]).TABLE 1.6Simian BetaretrovirusesClassificationHostRef.EndogenousSquirrel monkey retrovirus*S*. *saimiri*[@bib276]Langur virus (PO-1-Lu)Presbytis obscurus[@bib719]Simian endogenous retrovirusCercopithecinae[@bib740]ExogenousSimian retrovirus type 1 (SRV-1)*Macaca* sp.Simian retrovirus type 2 (SRV-2)*Macaca* sp.Mason--Pfizer monkey Virus (SRV-3)*Macaca* sp.[@bib119]Simian retrovirus type 4 (SRV-4)M. fascicularisSimian retrovirus type 5 (SRV-5)M. mulattaSimian retrovirus type 6 (SRV-6)Semnopithecus entellus[@bib514]Simian retrovirus type 7 (SRV-7)*M. mulatta* and *S. entellus*[@bib515]Simian retrovirus Tsukuba (SRV-T)[@bib269]

#### Epizootiology {#s1455}

SRV appears to be transmitted readily among captive macaques. SRV-seropositive rates vary widely among colonies and likely relate to husbandry, housing practices, and efforts to eliminate the virus. Investigation of an epizootic of SRV in captive Celebes black macaques (*Macaca nigra*) revealed an increase in the seropositive status from 0% to greater than 90% during an 8-year period following the introduction of several infected animals to the colony ([@bib411], [@bib645]). New World primates appear to be resistant to SRV infection in part due to species-specific variability in the TRIM5α protein that is a major factor in determining host range of retroviral infections ([@bib160]). This protein facilitates premature dissociation of virus cores and subsequent proteasomal degradation.

SRV-1 may be isolated from the saliva of healthy carrier animals, and biting with inoculation of saliva or blood is the most likely method of horizontal transmission ([@bib411]). Wilkinson and colleagues determined that exposure to blood from viremic animals carried a higher risk of infection while blood from non-viremic animals with provirus integrated in circulating mononuclear cells was less likely to transmit infection ([@bib782]). Vertical transmission may play an additional role in the propagation of the virus within macaque colonies. Cesarean-derived infants raised in isolation may be infected ([@bib728]). Moreover, mother-to-infant transmission may occur in the perinatal or postnatal period. Of fundamental importance to the design and implementation of control strategies is the fact that animals may be persistently infected, healthy, and shedding virus while seronegative for antibodies against SRV. It is these seronegative virus-positive individuals that frustrate control strategies. Evidence suggests that in utero infection may be more likely to result in this seronegative, virus-positive status than transmission at other times ([@bib492]). These animals may play a key role in viral persistence within colonies.

#### Pathogenesis and Pathology {#s1460}

Superficially there are many similarities between the immunosuppressive diseases induced in macaques by SRV and simian lentiviruses. There are, however, fundamental differences in their molecular biology and genomic organization that impart differences in the resulting clinical syndrome ([Table 1.7](#t0040){ref-type="table"} ) ([@bib391]). SRV has a wider tissue tropism than simian lentiviruses and readily infects T cells (CD4+ and CD8+), B cells, macrophages, epithelial cells, and cells of the choroid plexus ([@bib462], [@bib392]).TABLE 1.7Characteristic Differences of SIVmac and SRV Infection of MacaquesCharacteristicSIVmacSRVNatural host rangeRelated viruses endemic in several species of African monkeysEndemic in several species of Asian macaquesSignificance as natural\
disease in captive macaquesSerologic surveys indicate low prevalenceMost significant viral agent of acquired immunodeficiency in captive macaquesOccurrence of seronegative, viral positive infectionUncommon in natural\
hostCommonViral tropismCD4^+^ T lymphocytes and macrophagesB and T lymphocytes, macrophages, and epithelial cellsUniquely associated diseasesGiant cell pneumonia and encephalitis; SIV arteriopathy; lymphoma; *Mycobacterium avium*Retroperitoneal and\
subcutaneous fibromatosis in association with RFHV; noma

The mechanism by which SRV produces the severe immunosuppression characteristic of this disease is unknown. Animals may harbor the virus asymptomatically for extended periods with few or no clinical signs. In asymptomatic animals there may be generalized lymphadenopathy characterized by varying proportions of follicular and paracortical lymphocytic hyperplasia consisting of immature CD4+ and CD8+ T lymphocyte subsets. With the onset of severe immunosuppression, eventually the spleen, thymus, and lymph nodes evidence marked lymphoid depletion and complete effacement of normal architecture. In these nodes the paracortex is often depleted of lymphocytes and plasma cells, which are largely replaced by histiocytes and contain small postreactive follicles with hyalinized arterioles ([@bib539]). Hyperplastic or hypoplastic bone marrow may be present and contributes to the frequently observed anemia and granulocytopenia.

The hallmark of the acquired immunodeficiency in macaques induced by both SRV and SIVmac is the occurrence of unusual opportunistic infections. Despite some similarities, there are, for reasons that are presently unclear, differences in the propensity of these viruses to induce disease by specific opportunistic organisms. SRV-infected animals appear to be more susceptible to infection by pyogenic bacteria and less susceptible to infection by *Mycobacterium avium*, *Pneumocystis carinii*, SV40, and adenovirus. Moreover, SIV-specific lesions are lacking and the occurrence of overt lymphoma is uncommon in SRV-infected animals. A rapidly progressive necrotizing gingivitis and stomatitis known as noma (cancrum otis) is most often described in SRV-infected animals while other common opportunistic infections such as disseminated CMV, oral and esophageal candidiasis, intestinal cryptosporidiosis can be observed in either SRV or SIV-infected animals ([@bib435]).

In addition to a syndrome of immunosuppressive disease, a unique fibroproliferative disorder termed retroperitoneal fibromatosis (RF) was recognized in association with SRV infection. In 1997 RFHV was identified in rhesus and pigtail macaque RF specimens. These lesions have not been recognized in all large macaque colonies suggesting that RFHV is required but not sufficient for RF pathogenesis and that additional cofactors, possibly SRV coinfection and associated immunosuppression, are required. This syndrome is discussed in more detail in the section on RFHV. A localized subcutaneous fibromatosis has also been reported characterized by multiple proliferative nodules within the subcutis and oral cavity in pig-tailed macaques ([@bib729]).

#### Clinical Findings {#s1465}

SRV infection of rhesus macaques may be responsible for the induction of several phenotypes, including (1) the occurrence of severe, rapidly progressive disease accompanied by high viremia and no antibody response, (2) the occurrence a low-grade viremia and a transient antibody response with or without disease, and (3) no clinical disease with a high antibody response and transient viremia.

The clinical features and AIDS definition of SRV infection are presented in [Table 1.8](#t0045){ref-type="table"} . Young animals often present for small body stature and failure to thrive. Body weight may be 40--50% of normal cagemates and these animals are often physically traumatized through intraspecies aggression. Intermittent to chronic gastroenterocolitis is common and results from direct viral infection of mucosal cells or damage induced by a variety of opportunistic organisms. Because the occurrence of an antibody-negative viremia is common in these young animals, diagnosis is best achieved through viral isolation or PCR. Alternatively, in cases in which serum or frozen tissue is not available, the virus may be visualized in formalin-fixed, paraffin-embedded tissue through the use of SRV-specific probes and in situ hybridization. In older animals the illness is more insidious and while wasting may be conspicuous, clinical signs often relate to the specific opportunistic infections present.TABLE 1.8Case Definition of Simian Retrovirus-Induced Simian AIDS[a](#tbl8fna){ref-type="table-fn"}Generalized lymphadenopathy and/or splenomegaly accompanied by at least four of the following clinical and laboratory findings:Weight loss (\>10%)Fever (\>103°F)Persistent refractory diarrheaChronic infections unresponsive to therapyOpportunistic infectionsNoma (cancrum oris)Retroperitoneal or subcutaneous fibromatosisHematologic abnormalities Anemia (PCV \<30%) Neutropenia (\<1700) Lymphopenia (\<1600) Thrombocytopenia (\<50,000) PancytopeniaBone marrow hyperplasiaCharacteristic lymph node lesions[^2]

#### Prevention {#s1470}

Because of the potential for SRV to cause clinical and subclinical disease as well as serve as a significant research confounder, efforts to establish SRV-free macaque colonies are paramount to the continued use of these animals in biomedical research. To date these efforts have been very successful despite the difficulties in detecting infection. Because macaques may be seronegative but harbor virus, viral isolation or PCR to confirm virus-free status must be used in conjunction with serological methods of detection ([@bib773]). Successful algorithms used to establish retrovirus-free breeding colonies have been published ([@bib638], [@bib410]). These protocols utilize PCR detection of viral nucleic acid or viral isolation combined with antibody detection (EIA and Western blot) to screen all animals. Once established, colonies should be self-propagating and remain closed with periodic retesting to verify continued virus-free status.

#### Zoonotic Potential {#s1475}

The risk of zoonotic transmission of SRV is not completely elucidated. The most convincing evidence for human SRV infection is presented in a case report describing the isolation of virus and SRV transcripts in lymphoma tissue from an HIV/AIDS patient. This individual was additionally seropositive for antibodies directed against multiple viral proteins although they had no known nonhuman primate exposure ([@bib67]). Serological and molecular techniques were also used to demonstrate possible SRV exposure with a relatively high frequency in healthy individuals from Guinea ([@bib503]). However, a survey of over 200 individuals occupationally exposed to nonhuman primates demonstrated a very low seroprevalence of 0.9% and virus was not able to be detected via viral isolation or molecular techniques ([@bib412]). Based on this evidence zoonotic exposure should be considered a possibility although the risk may be quite low.

### Simian T-Cell Leukemia Virus {#s1480}

#### Introduction {#s1485}

Simian T-cell leukemia virus (STLV), human T-cell leukemia virus (HTLV), and bovine leukemia viruses are species within the Deltaretrovirus genus of the subfamily *Orthoretrovirinae*. The viruses within this genus share a common ancestry, genomic organization, and the propensity to induce lymphoproliferative disease in the host animal. The association between HTLV and various disease processes has raised interest in closely related simian viruses. There are three viral subtypes, numbered 1 through 3, for both STLV and HTLV. Analysis of a STLV-1 isolates obtained from a variety of nonhuman primate species demonstrate high degrees of homology with human isolates. This combined with a clustering by geography rather than by host species strongly suggests cross-species transmission events and a nonhuman primate origin of HTLV-1 ([@bib619], [@bib439], [@bib742], [@bib658]).

HTLV-1 has a worldwide distribution and is endemic in Japan and the Caribbean basin, as well as regions within subSaharan Africa, South America and the Middle East. While usually asymptomatic, in approximately 2--5% of cases infection may be associated with adult T-cell leukemia/lymphoma (ATLL), tropical spastic paresis (TSP), and HTLV-1-associated myelopathy (HAM). As in human patients with HTLV-1, STLV-1 has been associated with lymphoproliferative disease in baboons, gorillas, macaques, and African green monkeys ([@bib406], [@bib465], [@bib723]). Although overt neoplastic disease is an uncommon sequela to infection of some species, STLV-1 agents immortalize T cells in vitro and their presence may complicate the interpretation of experimental protocols.

#### Etiology {#s1490}

Seroreactivity to STLV-1 or STLV-like agents has been demonstrated in at least 33 species of captive and wild African and Asian nonhuman primate species, including *Cercopithecus* spp., macaque species, Patas monkey, olive baboon (*Papio anubis*), mandrill (*Mandrillis sphinx*), gorilla, and siamang (*Symphalangus syndactylus*) ([@bib272], [@bib318], [@bib618]). Restriction patterns of initial STLV-1/HTLV-1 isolates suggested that a number of distinct but related viruses were contained within the STLV grouping. Sequencing data have since confirmed the existence of seven clusters or clades. The C clade contains Asian STLV/HTLVs, whereas the A, B, and D--F clades contain African STLV/HTLV isolates. The seventh clade G is populated by STLV-1 species isolated from *Papio* sp. ([@bib381]). It is postulated that this diversity is due to repeated cross-species transmission within restricted geographic localities. Moreover, it suggests that STLV-1 has been present in nonhuman primate populations longer than HTLV-1 has been in humans and a likely STLV origin of HTLV-1. Differences in the ability of the various isolates to induce lymphoproliferative disease are largely unknown.

#### Epizootiology {#s1495}

Unless steps have been taken to exclude the virus from colonies, serologic surveys may indicate high rates of infection in captive African green monkeys, macaques, sooty mangabeys, and baboons ([@bib724], [@bib624], [@bib135]). Seroprevalence may be high in free-ranging populations. These surveys indicate an increasing prevalence with age and while the mechanism of natural transmission is unknown, parenteral and sexual routes are suspected of being of greater importance than perinatal transmission.

#### Pathogenesis and Pathology {#s1500}

STLV-1 is a cell-associated virus that is spread via breeding, breast feeding, transfusion with infected blood cells, and blood contamination during wounding episodes (d'Offay et al., 2007). The virus has been demonstrated to infect both CD4+ and CD8+ cells with proviral loads significantly higher within CD4+ cells ([@bib680]). Virus replicates within the host via a clonal expansion of infected cells contributing to the low genetic variability of this virus compared to other retroviruses that rely on continuous, error-prone reverse transcription ([@bib228]).

Although STLV-1 is a common and usually asymptomatic infection, it has been associated with lymphoproliferative disease in several nonhuman primate species. This has perhaps been best characterized in baboons ([@bib753], [@bib465], [@bib300]). In this species, STLV-1 infection has been linked to the development of an ATLL-like syndrome characterized by non-Hodgkin's lymphoma and leukemia. Involvement of the lymph nodes, spleen, liver, skin, and especially lung is common. Overt leukemia has been documented in greater than 50% of the cases and is occasionally associated with the presence of circulating multilobulated neoplastic lymphocytes, a clinical feature of ATLL ([@bib465]). Unlike human patients with ATLL, hypercalcemia is uncommon. Within the lung, the earliest changes may be present in a perivascular and/or peribronchiolar distribution. Although a variety of cell types have been recognized, most cases have been of T-cell lineage (CD2+ CD4+). Interestingly, an ATLL-like disease consisting of cells expressing CD8+ was identified in an African green monkey. Spontaneously transformed cell lines from STLV-1 infected African greens also consisted of CD8+ cells suggesting that STLV-1 may preferentially transform CD8+ cells in this species ([@bib5]). Histologically, infiltrates vary from a monomorphic population of neoplastic lymphocytes to a more pleomorphic population accompanied by multinucleated giant cells, necrosis, and inflammatory cells.

Although STLV-1 is clearly associated with lymphoproliferative disease, the mechanism involved is not completely understood. The *tax* gene product stimulates transcription of viral mRNA by acting on the 5′ long terminal repeat (LTR) and is highly conserved among all STLV/HTLV isolates, suggesting a fundamental role in viral replication and disease pathogenesis ([@bib619]). In addition to stimulating the 5′ LTR, *tax* may activate host genes responsible for controlling T-cell proliferation, including c-*fos*, c-*sis*, interleukin-2 (IL-2), IL-2r, and GM-CSF, thereby leading to polyclonal T-cell expansion. It is postulated that secondary events are required for monoclonal neoplastic transformation. Monoclonal integration of STLV-1 has been demonstrated in African green monkeys with non-Hodgkin's lymphoma and preneoplastic lymphoproliferative disease ([@bib733]). Such integration is considered definitive evidence of the etiologic role of PTLV in lymphomagenesis. Coinfection with other viral agents such as SIV or Epstein--Barr-like viruses may promote neoplastic transformation ([@bib753], [@bib723]).

#### Clinical Findings {#s1505}

STLV-1-associated lymphoma/leukemia in baboons is clinically characterized by depression, anorexia, regional or generalized lymph node enlargement, and hepatosplenomegaly. As in humans with ATLL, radiographic and histologic evidences of pulmonary infiltrates are frequent. Cutaneous involvement, hypercalcemia, and effusions may be noted less commonly. Leukocytosis and multilobulated neoplastic cells within peripheral blood smears are present with the majority but not all cases.

#### Prevention {#s1510}

Altered cytokine profiles secondary to STLV-1 infection indicate potential for significant confounding of research protocols prompting efforts to eliminate this virus from breeding colonies ([@bib410]). A two-stage testing algorithm to evaluate macaque sera for the presence of antibodies to STLV-I has been published ([@bib410]). Samples are initially screened by enzyme immunoassay (EIA), and negative results indicate a provisional virus-free status. Positive results are further tested by confirmatory Western blot, and reacting animals are culled or segregated from the colony. Additionally, PCR should be used to test seronegative or seroindeterminant animals. Occasionally there may be long intervals to seroconversion indicating the need for continual monitoring for virus during the establishment of SPF colonies ([@bib410]).

### Other Simian T-Cell Leukemia Viruses {#s1515}

A virus closely related to HTLV-2 and designated STLV-2 has been identified in bonobo chimpanzees (*P. paniscus*) ([@bib738]). HTLV-2 is present within regions of North America, South America, and Africa and shows approximately 75% identity to the STLV-2 sequences. STLV-2 has not been linked to disease in nonhuman primates. A reported STLV-2 isolate from a single spider monkey (*Ateles fusciceps*) has not been confirmed and likely represents a laboratory contaminant ([@bib112]).

HTLV-3 has been identified in human populations although currently there are no known disease associations. Simian counterparts to HTLV-3 have been identified in a variety of nonhuman primate species including red-capped managbys (*Cercocebus torquatus*), Hamadryas baboons (*Papio hamadryas)*, *Cercopithecus* sp., and agile mangabeys (*Cercocebus agilus*) ([@bib476], [@bib131]). Coinfections with STLV-1 and STLV-3 have been documented.

HTLV-4 is rare, having only been identified in a hunter from Cameroon ([@bib788]). A simian counterpart to HTLV-4 is yet to be identified.

### Simian Sarcoma Virus and Gibbon Ape Leukemia Virus {#s1520}

These viruses are members of the genus *Gammaretrovirus*. Simian sarcoma virus was isolated from a spontaneous fibrosarcoma of a pet woolly monkey ([@bib787]). Further investigation revealed the isolate to be composed of two agents; a defective transforming virus (simian sarcoma virus, SSV-1) and a replication competent helper virus (simian sarcoma-associated virus, SSAV-1) ([@bib714], [@bib787]). When injected intracerebrally into newborn marmosets, animals developed gliomas from which virus could be recovered and identified ([@bib334]).

Gibbon ape leukemia virus (GALV) has been isolated from a number of captive gibbons with spontaneous hematopoietic neoplasms. Various isolates have been identified (GALV, GALV-1, GALV-SEATO, GBr-1, and Gbr-3) with differing abilities to induce malignant lymphoma and leukemia. Clinical aspects of a spontaneous epizootic in white-handed gibbons have been reported and are characterized by a prolonged clinical course, a marked elevation in the peripheral granulocyte count, and involvement of bone marrow, liver, lymph nodes, and spleen ([@bib154]). As described above for SRV infection of macaques, gibbons may not seroconvert following persistent infection with this virus.

### Simian Immunodeficiency Virus {#s1525}

#### Introduction {#s1530}

Simian immunodeficiency viruses (SIVs) are a group of closely related viruses within the *Lentivirus* genus of the family Retroviridae, which infect a variety of Old World nonhuman primates. The striking similarity between SIV-induced disease in macaques and HIV-induced disease in humans makes the SIV-infected macaque an extremely valuable model for the study of human HIV infection. Macaques infected with SIV develop many of the same clinical and pathologic abnormalities that occur in AIDS patients and die from the same array of opportunistic infections (OI). Using SIV-infected macaques as a model of human AIDS has produced a volume of research concerning all aspects of lentiviral biology and pathogenesis that cannot begin to be summarized here. The lessons to be reinforced from a standpoint of colony management and conservation are that (1) well-adapted viruses may be carried asymptomatically and silently by one primate species and yet have devastating consequences when introduced into another species and (2) the occurrence of unusual opportunistic infections should spur a vigorous search for an underlying immunosuppressive etiologic agent.

#### Etiology {#s1535}

SIVs are indigenous viral agents of African nonhuman primate species and are enzootic in many populations. Prevalence varies by species and geographical region although it can be quite high in some populations ([@bib271]). Other than in rare instances, these viruses do not cause disease in their natural hosts and only manifest as an immunodeficiency syndrome when transferred to a different species. Over 40 different SIV isolates from various African species have been recognized. Viral strains are designated by a three-letter suffix to indicate the common name of the species from which they were originally isolated (e.g., SIVcpz from chimpanzees). When distinct viruses have been isolated from different host subspecies, the subspecies is designated with a second suffix (SIVcpz*Ptt* from *P. troglodytes troglodytes* and SIVcpz*Pts* from *P. troglodytes schweinfurthii*). The relatedness of SIV isolates correlates most closely with speciation of the host ([@bib217]). Phylogenetic analysis reveals that isolates from each nonhuman primate species form monophyletic lineages. While this suggests that there has been significant co-speciation of virus and host, there are also numerous instances of cross-species transmission and viral recombination. With the continued survey of African primates and discovery of novel SIVs, further genetic characterization of these isolates will only add to the complexity of the phylogenetic classification. Currently the monophyletic lineages can be grouped into seven major lineages or clades ([Table 1.9](#t0050){ref-type="table"} ).TABLE 1.9Major Simian Immunodeficiency Virus LineagesLineageRepresentative IsolatesNonhuman Primate SpeciesChimpanzee groupSIVcpz*PttPan troglodytes troglodytes*SIVcpz*PtsP. troglodytes schweinfurthii*SIVgor*Gorilla gorilla*Arboreal guenon groupSIVsyk*Cercopithecus albogularis*SIVdeb*Cercopithecus neglectus*SIVgsn*Cercopithecus nictitans*SIVmon*Cercopithecus mona*SIVmus-1 and SIVmus-2*Cercopithecus cephus*SIVery*Cercopithecus erythotis*SIVden*Cercopithecus denti*SIVblu*Cercopithecus mitis*SIVasc*Cercopithecus ascanius*SIVtal*Miopithecus ogouensis*Red-capped mangabey groupSIVrcm*Cercocebus torquatus*Sooty mangabey groupSIVsmm*Cercocebus atys*SIVmac*Macaca mulatta*[a](#tbl9fna){ref-type="table-fn"}SIVmne*M. nemestrina*^a^SIVstm*M. arctoides*^a^African green monkey groupSIVagm*Ver*Chlorocebus pygerythrusSIVagm*GriChlorocebus aethiops*SIVagm*TanChlorocebus tantalus*SIVagm*SabChlorocebus sabaeus*L'Hoest and mandrill groupSIVlho*Cercopithecus lhoesti*SIVsun*Cercopithecus solatus*SIVpre*Cercopithecus preussi*SIVmnd-1*Mandrillus sphinx*SIVwrc*PbbPiliocolobus badius badius*SIVwrc*PbtPiliocolobus badius temminckii*Mantled colobus groupSIVcol*Colobus guereza*[^3]

The chimpanzee group contains SIVcpz*Ptt*, SIVcpz*Pts*, and SIVgor, the simian viruses most closely related to HIV-1 ([@bib554]). Similarities in the viral genomes combined with opportunities for geographic comingling and exposure via hunting provides strong evidence that the emergence of HIV-1 resulted from at least three cross-species transmission events between apes and man ([@bib155], [@bib230] *;* [@bib262]). HIV-1 isolates are organized into three major groups, M--O. Viruses in group M have spread globally thereby causing the HIV-1 pandemic. Viruses from groups N and O have remained confined to patients living in Cameroon and surrounding regions. The origins of HIV-1 groupings M and N have been traced to troops of *Pan troglodytes troglodytes* residing in southeastern and south central Cameroon where the prevalence of infection in apes can range as high as 35% ([@bib358]). A divergent SIVcpz*Ptt* lineage is thought to have given rise to SIVgor which shares closest homology to HIV-1 group O. Evidence suggests two possibilities for a source of HIV-1 group O: independent transmission events resulting in transfer of virus from *Pan troglodytes troglodyes* to both gorillas and humans or, alternatively, western lowland gorillas serving as an intermediate host and transmitting virus directly to humans ([@bib744], [@bib705]). As of yet there is no known human counterpart to the SIV harbored by *P. troglodytes schweinfurthii*. *P. troglodytes versus* and *P. troglodytes vellerosus* have not been found to harbor SIV. The origin of SIVcpz is thought to be the result of a recombination event involving viruses from two distinct lineages; an ancestor of SIVrcm of red-capped mangabeys and an ancestor of the arboreal guenon clade ([@bib28]). Chimpanzees exposed to these primate species through hunting likely contracted both SIVrcm and SIVgsn ancestral viruses which led to recombination within the chimpanzee host and subsequent emergence of SIVcpz.

The arboreal guenon clade contains viruses isolated from the *Cercopithecus* genus and represents the group with the largest number of nonhuman primate species known to be infected with SIV. Viral sequences have been detected from at least ten species including the Sykes's monkey (SIVsyk; *Cercopithecus albogularis*), DeBrazza's monkey (SIVdeb; *C. neglectus*), greater spot-nosed guenon (SIVgsn; *C. nictitans*), Mona money (SIVmon; *C. mona*), mustached monkey (SIVmus; *C. cephus*), red-eared guenon (SIVery; *C. erythrotis*), Dent's mona monkey (SIVden; *C. denti*), Blue monkey (SIVblu; *C. mitis*), Schmidt's guenon (SIVasc; *C. ascanius*) and talopin monkeys (SIVtal; *Miopithecus ogouensis*) ([@bib187], [@bib54], [@bib747], [@bib421]). Two co-circulating variants have been described in mustached monkeys ranging over a small region of Cameroon indicating that it is not necessarily geographic separation that results in divergent viral variants ([@bib4]). Four viruses in this group (SIVgsn, SIVmon, SIVmus, and SIVden) have a *vpu* gene. This accessory gene encodes a protein thought to enhance virion release and viral pathogenicity ([@bib688]). Originally it was believed that only HIV-1 and SIVcpz strains encoded a *vpu* gene. Identification of the *vpu* gene in SIVs of the arboreal guenon lineage provides further evidence that one of these viruses contributed the 3' segment to the SIVcpz genome during an ancient recombination event ([@bib130], [@bib31]).

The red-capped mangabey group currently contains one isolate found circulating in populations of the group's namesake ([@bib49]). The red-capped mangabey is closely related to sooty mangabeys, and viruses from both species contain a *vpx* gene. This would suggest that these viruses should cluster together. However, the pattern of clustering depends on the region of the SIVrcm genome examined. This genomic mosaicism indicates that the SIVrcm strain arose from multiple recombination events. The virus has thus been designated its own lineage. As mentioned previously, SIVcpz resulted from a recombination event between a SIVrcm-like virus and a guenon virus. SIVrcm uses the CCR2b co-receptor for viral entry rather than the more commonly used co-receptor CCR5.

The sooty mangabey group is the group from which the highest numbers of SIV isolates have been made ([@bib226]). These isolates demonstrate a high degree of diversity and are the simian strains most closely related to HIV-2. As with SIVcpz and HIV-1, several cross-species transmission events between sooty mangabeys and man are thought to have contributed to the emergence of HIV-2 ([@bib286], [@bib231]). HIV-2 isolates are arranged in groups A--H with groups A and B representing epidemic strains. Sooty mangabeys from the Ivory Coast harbor SIVs related to HIV-2 groups A and B while those from Sierra Leone and Liberia harbor SIVs related to groups C--H ([@bib622]). Like HIV-2, representatives from the sooty mangabey group have genomes containing a *vpx* gene. SIVsmm is ancestral to SIVmac from rhesus macaques, SIVmne from pig-tailed macaques, and SIVstm from stump-tailed macaques ([@bib141], [@bib50], [@bib505], [@bib436], [@bib18]). With a prevalence of disease close to 60%, sooty mangabeys represent a substantial reservoir of SIV ([@bib225], [@bib622]).

The African green monkey group contains four related viruses recognized in the four African green species including vervets (SIVagm*Ver*; *Chlorocebus pygerythrus*), grivets (SIVagm*Gri*; *C. aethiops*), tantalus species (SIVagm*Tan*; *C. tantalus*), and sabaeus species (SIVagm*Sab*, *C. sabaeus*) ([@bib532]). There are multiple variants of each virus. While prevalence of infection in wild African populations can range as high as 60%, African green monkeys residing in the Caribbean islands demonstrate 0% prevalence ([@bib142], [@bib562], [@bib335]). This founder effect is likely due to the transport of uninfected animals captured at a young age to these locales.

The L'Hoest and mandrill group contains isolates from a variety of unrelated nonhuman primate species including three *Cercopithecus* species, the L'Hoest's monkey (SIVlho; *C. l'hoesti*), the sun-tailed monkey (SIVsun; *C. solatus*), and the Preuss's monkey (SIVpre, *C. preussi*). L'Hoest's monkeys have a 57% prevalence of SIV representing a significant reservoir ([@bib48]). Western red colobus (SIVwrc*Pbb*; *Piliocolobus badius badius* and SIVwrc*Pbt*; *P. badius temminckii*) and olive colobus (SIVolc; *Procolobus verus*) isolates align with the L'Hoest lineage when examining homology across the entire viral genome although certain regions of the genome such as the *gag* and 5' end of the *pol* sequences cluster with the Colobus lineage ([@bib430], [@bib422]). SIVmnd-1 isolated from mandrills (*Mandrillus sphinx*) residing in central and southern Gabon also clusters with the L'Hoest lineage ([@bib732], [@bib679]). Interestingly, a second, highly divergent isolate (SIVmnd-2) has been identified in mandrills from northern and western Gabon. SIVmnd-2, unlike SIVmnd-1, has a *vpx* gene. SIVmnd-2 shares some homology with SIVrcm suggesting that a recombination event between SIVrcm and SIVmnd-1 may have given rise to SIVmnd-2 ([@bib679]). SIVdrl from drills (*Mandrillus leucophaeus*) also shows homology to SIVmnd-2 ([@bib298]).

The colobus lineage contains one strain: SIVcol from the mantled guereza (*Colobus guereza*). This is one of the most divergent of SIV isolates with an average amino acid identity to other known SIV isolates of 40% for the *gag* encoded proteins, 50% for the *pol* encoded proteins, and 28% for the *env* encoded proteins ([@bib129])**.** SIVcol was the first isolate to be discovered from the Colobinae family. The SIV infection status of Asian Colobinae species is not known.

Natural SIV infection of New World nonhuman primates has not been identified. Common marmosets and cotton-top tamarins were susceptible to experimental infection with HIV-2 ([@bib471]). Although animals seroconverted and remained healthy, HIV-specific nucelotide sequences could be demonstrated in tamarin peripheral blood lymphocytes by PCR for extended periods. It is likely that host restriction factors prevent viral infection from progressing.

The lentivirus genome is approximately 10 kb in length and is diploid with two identical positive-sense RNA genomes contained within each viral core. The open reading frames include three genes encoding structural proteins (*gag*, *pol*, and *env*), two genes encoding regulatory proteins (*tat*, *rev*), and the genes encoding accessory proteins (*vif*, *nef*, *vpr*, *vpu*, *vpx*). The compliment of accessory genes varies by the viral isolate. The function of the viral proteins and process of lentiviral replication have been extensively reviewed and will only be discussed briefly here ([@bib220], [@bib754]). The three structural protein genes are each expressed as a polyprotein that is subsequently cleaved into multiple functional proteins. The SIV *gag* gene encodes the p55 precursor protein that is cleaved into the capsid (p27 protein homologous to the HIV major core protein p24), matrix (p17), nucleocapsid (p8), and p6 proteins. These proteins not only make up the viral capsid but are also integral to viral assembly. The *pol* gene encodes the viral enzymes protease, reverse transcriptase, and integrase. The protease enzyme is involved in cleaving precursor peptides, the reverse transcriptase enzyme catalyzes the conversion of the RNA genome to a double-stranded DNA copy, and the integrase enzyme catalyzes the insertion of the viral DNA into the host cell chromosome. Each of these enzymes is a target for antiretroviral therapeutics. The *env* gene encodes two viral glycoproteins: the surface glycoprotein gp120 and the transmembrane glycoprotein gp41. The gp41 anchors gp120 and is involved in mediating fusion of the virus with host cell membranes during viral entry. The gp120 interacts with the CD4 molecule and a coreceptor to bind virus to the target cell and induces a conformational change in gp41 that promotes fusion of the virion envelope and the host cell plasma membrane. Most SIVs utilize the β-chemokine receptor CCR5 as the co-receptor for viral entry ([@bib806]).

All SIV genomes contain two regulatory genes: *tat* and *rev*. *tat* is the transactivator of SIV gene expression. It is comprised of two exons encoding a protein that binds to the transactivation response region (TAR) of the viral genome to initiate and increase the rate of transcription. *rev* encodes a highly conserved protein that binds to the *rev* response element (RRE) on unspliced or partially spliced viral mRNAs to promote their export from the nucleus to the cytoplasm. There are two additional accessory proteins commonly present in complex retroviruses. The *vif* gene encodes the viral infectivity factor that aborts the antiviral action of the host APOBEC protein system. The *nef* gene encodes a 27-kDa protein termed "negative factor." This protein has a variety of functions including downregulation of the CD3--T cell receptor (CD3--TCR) complex and MHC class I expression at the host cell surface thus impairing the ability of cytotoxic T cells to recognize infected cells.

The remaining accessory genes are variably present depending on the SIV isolate. Three types of genomes are recognized: the *vpr* bearing, the *vpr*-*vpx* bearing, and the *vpr*-*vpu* bearing. HIV-1, SIVcpz, and certain members of the arboreal guenon lineage have the *vpu* gene. HIV-2, SIVsmm, SIVrcm, SIVmnd-2, and SIVdrl have the *vpx* gene. The *vpr* encoded protein (viral protein R) is involved in nuclear import of preintegration complexes and modulation of host cell functions. The *vpx* gene is the result of a duplication of the *vpr* gene. The function of this gene product is not yet fully elucidated. The *vpu* product (viral protein U) promotes degradation of CD4 and enhancement of virion release.

#### Epizootiology {#s1540}

SIV infection in natural hosts likely occurs in both a horizontal and a vertical fashion. Epidemiologic assessment of SIVagm in Ethiopian grivet monkeys (*Cercopithecus aethiops aethiops*) suggests that sexual transmission is a significant mode of transmission in wild populations ([@bib562]). The infection rate increases with sexual maturity in both captive and wild sooty mangabeys, further supporting this route as a major mechanism in the propagation of the virus in nonhuman primate populations ([@bib225], [@bib113]). Transmission via wounding is also likely a significant mode of transmission. Microsatellite analysis of isolates from sooty mangabey dams and infants confirms that vertical transmission does occur although this is not thought to be a major contributor to transmission ([@bib622]).

History has shown that inadvertent transmission of virus from a natural host species to a susceptible species within the research setting is also a potential mode of SIV transmission. Retrospective analysis of tissues achieved from outbreaks of opportunistic infections and malignant lymphoma in captive macaques that occurred in the late 1960s and early 1970s demonstrated underlying SIV infection ([@bib142], [@bib436], [@bib445], [@bib446]). The close homology between one of the isolates (SIVstm) and SIVsmm suggested the source was sooty mangabeys. The virus was propagated within the captive macaque populations and resulted in significant morbidity and mortality. In another instance, macaques were inadvertently infected when inoculated with sooty mangabey-derived tissue containing *Mycobacterium leprae* ([@bib241]). Xenobiotic inoculation or transplantation of tissue carries the risk of introducing unsuspected or unknown agents into the recipient animal. Although such protocols clearly play an important role in biomedical research, and in this case led to the serendipitous establishment of the SIV model of HIV/AIDS, they should only be undertaken with realization of the potential risks involved. Recipient animals should be housed in an appropriate fashion to prevent the further transmission of such agents.

#### Pathogenesis and Pathology {#s1545}

Simian immunodeficiency viruses have marked tropism for cells that express the CD4 molecule on their surface. These cells include the helper--inducer subset of T lymphocytes, monocyte macrophages, and antigen-presenting dendritic cells ([@bib682]). Viruses enter these permissive cells through an interaction between the viral envelope glycoprotein gp120, the CD4 molecule, and the CCR5 co-receptor. Once inside the cell, the single-stranded viral RNA is transcribed via reverse transcriptase into DNA copies of itself, which ultimately become integrated into the host cell DNA. Transcription of this proviral DNA results in the production of progeny virus that buds primarily from the surface of infected lymphocytes.

The most common presentation in African nonhuman primates is a persistent, nonpathogenic SIV infection. In contrast, macaque monkeys with naturally acquired or experimentally induced SIV infection demonstrate a profound depletion of CD4+ T lymphocytes that leads to severe immune dysfunction and death from opportunistic infections or viral-induced syndromes. The pathogenesis and clinical presentation of SIV infection in African and Asian nonhuman primate species will each be discussed separately below.

##### SIV in African Species {#s1550}

Understanding how natural hosts maintain chronic SIV infection without disease progression is of great interest to scientists and may give insight to disease processes in man. The pathophysiology of SIV infection in African species, most thoroughly studied in African green monkeys, sooty mangabeys, and mandrills, has recently been the subject of several review articles ([@bib650], [@bib549], [@bib545], [@bib675]). Aspects of the course of disease in these species will be presented here.

Despite a high prevalence of SIV infection in African species, other than in a few reported instances, these animals do not develop immunodeficiency or the accompanying spectrum of pathology observed following SIV infection of Asian macaques. The acute phase of infection in African species is similar in many respects to that observed in macaques. Peak virus production occurs within 1--3 weeks post-inoculation, innate and adaptive immune responses are initiated, and a partial control of viral replication enables achievement of the set point of viral replication. Virus replicates to high titer in both Asian and African species targeting the gut and lymphoid tissue and resulting in a depletion of CD4+ T cells at mucosal sites ([@bib240], [@bib550]). Asian species demonstrate peak viral loads of 10^7^--10^9^ RNA copies/ml of plasma in line with or higher than those observed in normal rhesus macaque progression profiles ([@bib79], [@bib293], [@bib547], [@bib545]). In both species, acute infection is accompanied by modest declines in CD4+ T cell counts ([@bib583]). Humoral and cell-mediated immune responses of African primates appear to be comparable if not slightly diminished when compared to macaques ([@bib803]). From acute infection onward, distinct differences in pathophysiology between Asian and African species begin to emerge. In African species, CD4+ T cell numbers remain stable throughout chronic infection despite continued elevations in viral load that result in high set points of 10^4^--10^6^ RNA copies/ml of plasma. Further loss of mucosal T cell populations does not occur in African species and mucosal immunity is preserved. In contrast, loss of both circulating and mucosal CD4+ T cells is progressive in rhesus macaques.

There are a number of mechanisms suspected to enable African species to maintain disease resistance in the face of high viral loads. A key factor may be the fact that there is a marked reduction in the degree of immune activation following transition from the acute to the chronic phase of infection. Activation of CD4+ and CD8+ T cells resulting in apoptosis of uninfected, bystander cells is believed to contribute substantially to the observed depletion of uninfected CD4+ and CD8+ T cells occurring with HIV/SIV progression to AIDS ([@bib273], [@bib274], [@bib150], [@bib289]). By maintaining an anti-inflammatory phenotype, SIV-infected African species experience reduced activation-induced cell death and preservation of T cell homeostasis ([@bib383], [@bib133], [@bib484]). The ability of the nef product of SIVsmm and SIVagm to more efficiently down-regulate the CD3-TCR from the surface of infected CD4+ T cells may contribute to reductions in immune activation ([@bib75]). An additional contributing factor to the maintenance of CD4+ T cell counts in African species is the preservation of T cell regenerative capacity of bone marrow, thymus, and lymphoid compartments.

On rare occasions progression to simian acquired immunodeficiency syndrome (SAIDS) has been reported in African monkeys. A classic SAIDS presentation was observed in a sooty mangabey naturally infected with SIVsmm for 18 years ([@bib426]). During the final year of life, this animal developed a 100-fold increase in viral load, progressive CD4+ T cell decline, and disseminated B cell lymphoma. Similar cases of increased viral load and CD4+ T cell loss have been reported in mandrills and African greens with longstanding SIV infection ([@bib548]). Reports such as this illustrate that, given a long enough incubation period, host or environmental factors may influence disease occurrence in these species.

Recent findings suggest that SIVcpz infection in chimpanzees may be associated with disease ([@bib357]). Over a 9-year observation period, a 10--16-fold increase in death rate was observed in SIV-infected chimpanzees in two Tanzanian communities. Spleen and lymph node samples collected from a subset of animals demonstrated CD4+ T cell depletion and high levels of viral replication. Histopathological findings consistent with SAIDS were observed in one female. It is suggested that co-evolution of host and virus has allowed for development of a state of disease resistance in African hosts. The more recent SIVcpz emergence on an evolutionary time scale may not have allowed for sufficient virus-host adaptation.

##### SIV in Asian Species of Macaques {#s1555}

In contrast to the phenomena observed in African hosts, SIV infection of macaques commonly results in a progressive loss of CD4+ T cells and onset of SAIDS. The disease phenotype replicates the clinical course of HIV/AIDS in man enabling the SIV-inoculated macaque to serve as an animal model critical for elucidating aspects of HIV pathogenesis and prevention. Primary infection occurs 1--3 weeks post-inoculation and is characterized by viremia, transient leukopenia, and prodromal signs such as fever, lymphadenopathy, diarrhea, rash, anorexia, and malaise. It is during this phase that the SIV-specific antibody response develops. The asymptomatic phase of infection is characterized by a stabilization of viral load, termed the viral set point ([@bib423]). Circulating CD4+ T cell numbers rebound slightly followed by a gradual and progressive decline. SAIDS, the final phase of infection, is characterized by profound CD4+ T cell depletion and onset of opportunistic infections and SAIDS-associated pathologies.

There are three infection profiles: the normal progression profile observed in 75% of animals, the rapid progression profile observed in 20% of animals, and the elite controller profile observed in 5% of animals. Normal progression is characterized by a peak viral load of approximately 10^7^  RNA copies/ml of plasma at 2 weeks post-inoculation. The humoral and cellular immune responses control viral replication to a set point of approximately 10^5^  RNA copies/ml. The disease course averages about 18 months at which point CD4+ T cell counts typically drop below 300 cells/mm^3^ and opportunistic infections develop. Elite controllers have a vigorous cell-mediated and humoral immune response and are able to limit viral replication. Viral load in these animals peaks at approximately 10^5^  RNA copies/ml. During chronic infection viral replication remains below the level of detection and CD4+ T cell counts are within normal limits. In contrast, rapid progressors have high viral loads that peak at 10^8^  RNA copies/ml and remain high throughout the course of infection. These animals demonstrate a reduced antibody response and a survival of only 3--4 months.

A combination of host, viral, and environmental factors likely influence the progression profile observed in a given animal. Host factors include species or subspecies, age, and genotype. Cynomolgus macaques inoculated with SIVmac251 have lower viral loads, higher CD4+ T cell counts, stronger virus-specific immune responses, and prolonged survival when compared to similarly inoculated rhesus macaques ([@bib579]). Likewise, Chinese origin rhesus macaques demonstrate significantly lower viral loads, less prominent depletion of intestinal lymphocyte populations, stronger antibody response, and prolonged survival when compared to similarly inoculated Indian origin rhesus macaques ([@bib427], [@bib726]). Genotype also plays a significant role. The major histocompatibility complex (MHC) class I and II gene products are cell surface glycoproteins involved in the presentation of peptides to CD8+ and CD4+ T cells, respectively. The rhesus macaque MHC region, designated by the prefix *Mamu*, demonstrates significant diversity due to the expression of multiple genes per haplotype ([@bib542]). Certain MHC class I alleles such as *Mamu*-A∗01, *Mamu*-B∗17, and *Mamu*-B∗08 have been associated with slower SIV disease progression, lower viral set points, or an increased likelihood of expressing an elite controller phenotype ([@bib628]). Additional genetic polymorphisms are an area of scientific interest. Particular alleles encoding the cytoplasmic tripartite motif protein 5α (*TRIM5α*) are associated with a reduced efficiency of binding to viral capsid in vitro and a significant lower viral load set points in vivo ([@bib425]). Polymorphisms in genes coding for chemokine receptors (*CCR5*, *CXCR6*, *GPR15*), chemokine receptor ligands (*RANTES*), proteins serving as disruptors to viral life cycle (*APOBEC3* family), and cytokines (IL-10, TNFα) have also been investigated as potential host factors ([@bib799], [@bib766]).

Viral factors may also attenuate, accelerate or alter disease phenotype. SIVsmm and SIVmac strains vary from those that are minimally to highly pathogenic in macaque species ([@bib285]). Viral factors include source, strain, and tissue culture passage history. Uncloned isolates tend to be more pathogenic than molecularly cloned viruses. There are exceptions; the molecularly cloned SIVmac239 is highly pathogenic in rhesus macaques. Modification of certain regions of the viral genome can result in variable virulence. Deletion of *nef* reduces the pathogenic potential of SIVmac239 in rhesus macaques as evidenced by decreased viral load, a strong and persistent antibody response, and decreased risk of SAIDS ([@bib361]). Deletion of the *vif* sequence has also been shown to result in significant attenuation of virulence ([@bib156]). Targeted mutation of the viral genome to produce attenuated strains represents an important avenue of investigation in the search for a HIV vaccine.

Lastly, environmental factors may influence viral pathogenicity. The presence of opportunistic infections, abuse of alcohol or illicit drug use, and stress have all been shown to negatively influence HIV outcome in humans and have been modeled using the SIV-infected macaque ([@bib808], [@bib27], [@bib90]). Diet composition may also impact SIV progression. Macaques fed a high-fat/high-cholesterol diet prior to infection with SIVmac239 demonstrated a significantly increased risk of SIV-related death relative to those animals receiving a standard primate diet ([@bib444]).

The mechanism(s) by which CD4+ T cell depletion occurs in context of SIV infection is not fully understood but likely includes a combination of the following: (1) accumulation of toxic quantities of viral nucleic acids or structural proteins in the cytoplasm of infected cells; (2) lysis of CD4+ T lymphocytes bearing viral-encoded antigens on their surface by virus-specific cytotoxic T-lymphocytes or natural killer cells; (3) lysis of infected CD4+ T lymphocytes by an antibody-dependent cellular cytotoxicity reaction; (4) enhancement of apoptosis of CD4+ T lymphocytes (activation induced cell death, AICD); and (5) destruction of lymph node and thymic architecture leading to reduced regenerative capacity ([@bib474]). In contrast, infected macrophages, in which viral assembly occurs primarily within cytoplasmic vacuoles rather than on the surface of infected cells, are seemingly resistant to lysis and in fact may be responsible for dissemination of the virus to nonlymphoid tissue such as the brain.

Simian AIDS is characterized by the development of opportunistic infections with viral, bacterial, and parasitic pathogens. These agents are described elsewhere within this volume. In addition to these characteristic opportunistic infections, SAIDS may be accompanied by a number of viral induced lesions in a variety of organ systems including the skin and gastrointestinal, cardiopulmonary, nervous, renal, and lymphoid systems. These syndromes will be discussed here.

###### Lymphoid System {#s1560}

Not unexpectedly, lymphoid tissues are a major target of viral infection and six distinct microscopic patterns of change have been recognized: (1) normal morphology; (2) follicular hyperplasia; (3) follicular involution with normal or expanded paracortical regions; (4) depletion of follicular and paracortical regions; (5) distinctive granulomatous (giant cell) lymphadenitis; and (6) a generalized lymphoproliferative syndrome. These morphologic criteria are not mutually exclusive and various patterns may coexist in different lymphoid tissues within the animal at any one time. In situ hybridization demonstrates large numbers of infected cells within the first week after experimental inoculation. These positive cells may temporarily disappear with the emergence of an appropriate immunologic response, only to reappear with progressive CD4+ T lymphocyte depletion and viral destruction of follicular dendritic cells.

Giant cell disease is a relatively common manifestation of SIV infection. A survey of cynomolgus macaques inoculated with SIVsmm revealed a 48% prevalence ([@bib420]). Large multinucleate syncytial cells are observed in multiple organs including lymphoid tissue, lungs, liver, intestine, and central nervous system. Presence of lesions correlates with degree of immunosuppression ([@bib420]). Expression of the cell surface marker CD68 indicates that these cells are of the macrophage/monocyte lineage. The expression of viral *env* glycoproteins on the surface of infected cells leads to fusion with adjacent CD4-expressing cells. Alterations in the *env* gene may alter syncytium inducing capacity and impact strain pathogenicity ([@bib195]).

###### Nervous System {#s1565}

SIV-inoculated macaques may develop a characteristic meningoencephalitis that resembles the encephalopathy of human patients with AIDS. SIV encephalitis affects the gray and white matter of the spinal cord and brain and is composed of multifocal perivascular aggregates of giant cells and histiocytes with smaller numbers of lymphocytes and rare neutrophils. Surrounding these foci are evidence of myelin degeneration and the formation of scattered glial nodules. In situ hybridization shows that giant cells and histiocytes contain large amounts of replicating virus. Evidence shows that the CNS becomes uniformly infected during primary infection with pathogenic strains of SIVmac and yet only a small percentage of animals develop SIV encephalitis in the chronic phase of the disease ([@bib393]). The reason for this paradox is unknown, however, alterations in brain endothelium are likely critical because (1) SIV encephalitis is associated with an increased expression of VCAM-1 on brain endothelium and (2) inoculation of "endothelial tropic" viral strains accelerate and promote the occurrence of lesions within the CNS ([@bib626], [@bib625], [@bib443]). Pathogenesis involves the recruitment and activation of SIV-infected macrophages to the CNS. These cells elaborate mediators of neuroinflammation resulting in neuronal apoptosis and loss.

Peripheral neuropathy is the most frequent neurologic complication associated with HIV. A ganglionitis has been described in the trigeminal ganglion and the myenteric plexus of SIV infected macaques ([@bib389], [@bib536]). This lesion is characterized by the presence of multifocal mononuclear infiltrates, primarily macrophages and lesser numbers of lymphocytes, accompanied by neuronophagia and neuronal loss. Nageotte nodules are typically present and represent replacement of neurons with satellite cells and infiltrating inflammatory cells. The presence of trigeminal ganglionitis is not necessarily associated with concurrent encephalitis ([@bib389]). Ganglionitis of the myenteric plexus may compromise intestinal innervation and contribute to the pathogenesis of SIV/HIV enteropathy ([@bib536]). Additional contributors to virus-associated peripheral neuropathies in HIV patients include toxic neuropathy from antiretroviral drugs, a diffuse infiltrative lymphocytosis syndrome (DILS), and inflammatory polyneuropathies associated with OI.

###### Gastrointestinal System {#s1570}

Chronic diarrhea and wasting are the most common clinical signs in SIV-infected macaques ([@bib40]). Although several opportunistic infections such as *Mycobacterium avium*, *Cryptosporidium parvum*, *Entamoeba* spp., *Enterocytozoon bieneusi*, and cytomegalovirus may be responsible, in many instances secondary opportunistic agents are lacking. In these cases symptoms are attributed to a direct SIV enteropathy equivalent to AIDS enteropathy in humans. Experimental evidence now indicates that the gastrointestinal tract is a major target organ during primary infection due in large part to the number of CCR5+ CD4+ T lymphocytes that are normally present in mucosal tissue. These cells are rapidly depleted during primary infection resulting in compromise of mucosal immunity ([@bib746]). CD4+ T cell loss, as well as loss of intestinal epithelial cells, appears to result from apoptosis during the first 7--14 days post-inoculation ([@bib419]). Lesions are characterized by villous blunting and atrophy, crypt hyperplasia, and presence of infiltrating macrophages. Compromise of the intestinal mucosa is thought to result in microbial translocation which may then enhance the systemic immune activation observed to correlate with SIV/HIV progression ([@bib76]).

A distinct SIV isolate, SIVmacPbj, induces a fulminant necrohemorrhagic gastroenteritis when inoculated into pig-tailed macaques ([@bib227]). Death results within 7--9 days. Similarly, a molecular clone of SIVmac239 (designated SIVmac239YE) produces nearly identical lesions and differs from its parent strain by two amino acids within the *nef* gene product ([@bib807]). These changes apparently affect a tyrosine kinase that indiscriminately causes activation of infected macrophages and lymphocytes and the elaboration of a host of cytokines. The outcome of SIV infection of the gastrointestinal tract (i.e., fulminant, chronic, or asymptomatic infection) likely involves an interplay between host and viral factors, much as is seen in the CNS.

###### Cardiopulmonary System {#s1575}

Simian immunodeficiency virus arteriopathy is a unique lesion of unknown etiology described in macaques experimentally inoculated with SIVmac ([@bib105]). Histologically the lesion resembles a chronic obliterative arteriopathy induced by the virus of malignant catarrhal fever in cattle. It is characterized by extensive medial and intimal proliferation of medium- and large-sized pulmonary arteries. The lesion is often associated with thrombosis of vessels and hemorrhage, consolidation, and infarction of pulmonary parenchyma. The vessels are infiltrated by moderate numbers of CD68+ macrophages and rare CD2+ lymphocytes. Although CMV antigen can rarely be localized to the lesion, it is unknown whether the arteriopathy is the direct result of SIV infection or another agent. Lesions are not limited to the pulmonary tissue. Disseminated lesions have been reported in the kidney, liver, pancreas, intestine, heart, lymphoid tissue, and testis ([@bib797]).

SIV-associated myocarditis has been reported ([@bib798]) and consists of multifocal cardiomyocyte degeneration and necrosis with infiltrating mononuclear inflammatory cells. SIV viral protein can be demonstrated although it is present within macrophages and not cardiomyocytes.

Lymphocytic interstitial pneumonia is a common sequela of pediatric HIV infection and consists of peribronchial and interstitial lymphoplasmacytic infiltrates accompanied by hyperplasia of bronchial lymphoid tissue. The syndrome in SIV rhesus macaques differs in that macrophages are a significant contributor to inflammatory populations ([@bib442]). Multinucleated giant cells are frequently observed. Alveolar septae are expanded with infiltrating mononuclear cells and, in severe cases, alveolar spaces may be filled with fibrin, inflammatory infiltrates, and cellular debris ([@bib39]).

###### Skin {#s1580}

As with many systemic viral infections, a disseminated cutaneous eruption occurs in macaques inoculated with pathogenic strains of SIVmac ([@bib590]). The rash generally appears within 1--2 weeks following inoculation involving the trunk, groin, medial thighs, and face. Complete resolution is apparent within 1--7 weeks. Histologically the exanthema is characterized by a nondescript, superficial, and perivascular lymphocytic dermatitis with variable swelling and degeneration of the epidermis. Immunohistochemistry has revealed these inflammatory cells to be predominantly CD8+ lymphocytes and cytotoxic activity directed at epidermal Langerhans cells.

###### Urinary System {#s1585}

HIV nephropathy is characterized by a focal segmental glomerulosclerosis accompanied by a variable interstitial nephritis. HIV can be demonstrated in renal epithelial cells. Similar lesions have been described in 5--20% of rhesus macaques infected with SIV depending on the strain ([@bib12], [@bib689]). Inoculation with macrophage tropic strains results in a high incidence ([@bib689]). Lesions consist of a focal segmental to global glomerulosclerosis with infiltrating macrophages. Viral protein can be demonstrated within glomerular epithelial cells. Mild tubulointerstitial inflammation may be present. Crescentric glomerulonephritis characterized by hypercellular glomeruli, expansion of the mesangial matrix, and immunoglobulin deposition has also been reported ([@bib68]). Azotemia and proteinuria may be observed clinically.

#### Prevention and Control {#s1590}

Asian macaques should not be allowed direct contact with African species or their tissue products. Control of host-adapted enzootic SIV strains is more problematic. In contrast to Asian macaques in which natural infection is usually followed by seroconversion, African species may harbor the virus and not seroconvert.

#### Zoonotic Potential {#s1595}

SIVmac is a known zoonotic agent but has not yet been associated with disease in humans ([@bib98], [@bib99], [@bib363], [@bib362]). In at least two instances, accidental exposure of humans to the virus has resulted in seroconversion and/or infection. Following a needle stick injury, one individual seroconverted, but the virus could not be isolated or demonstrated by PCR techniques ([@bib363]). In the second instance, the virus was isolated and could be demonstrated by PCR in the seropositive individual ([@bib362]). This laboratory worker had a history of working with the virus without gloves while receiving corticosteroids for dermatitis. Whether exposure occurred at this time is unknown. In both instances CD4+ T cell counts remained stable suggesting non-progressive disease. Seroconversion of a laboratory worker was also discovered during an anonymous serologic survey ([@bib98]). Whether this represents a third instance of SIV transmission to a human being or retesting of sera from one of the previously mentioned individuals is unknown.

The most likely route of exposure is through the parenteral route as a bloodborne pathogen. Facilities housing potentially infected animals should develop a prevention and control plan based on the bloodborne pathogen standards published by the US Occupational Safety and Health Administration (OSHA). This plan should include: (1) implementation of universal precautions; (2) medical surveillance; (3) use of personal protective equipment; (4) provision of appropriate training; (5) implementation of a sharps injury prevention plan including annual review of safety devices; and (6) development of a post exposure plan that is based on risk assessment and stratification. Evaluation of SIV-associated exposures should be performed by a physician experienced in HIV/SIV risk assessment, and, when indicated, post exposure prophylaxis should be provided. First aid kits should be close at hand in the event of an exposure to allow for immediate cleansing of wounds. Strategies for exposure avoidance should be based on eliminating or reducing the use of needles and other sharps whenever possible, utilizing safety equipment such as retractable needles, and training employees on safe work practices.

Spumaretrovirinae {#s1600}
-----------------

### Simian Foamy Viruses {#s1605}

Simian foamy viruses (SFV) of the genus *Spumavirus* are, in many respects, typical of complex retroviruses. They share a similar genomic organization having *gag*, *pol*, and *env* sequences flanked by LTRs. However, a key difference lies in the timing of reverse transcription. Foamy virus reverse transcription occurs during viral assembly or budding such that the process is complete before the virus infects new cells. Subsequently, the functional nucleic acid of SFV consists of double-stranded linear DNA rather than single-stranded RNA ([@bib493], [@bib800]). SFV also have two unique nonstructural proteins; Tas is a transcriptional activator, and Bet is involved in latency regulation.

SFV have been isolated from a number of Old and New World nonhuman primate species ([@bib613], [@bib294], [@bib516], [@bib716]). Originally classified by serotype, viruses are currently named according to the host species of origin (i.e. SFVcpz). Phylogenetics demonstrates significant co-evolution of virus and host species ([@bib701]). Prevalence in all nonhuman primate species is high and, depending on the species, colony, or habitat, often approaches 100% ([@bib63], [@bib314], [@bib429]). Proviral DNA can be isolated from most organs and peripheral blood mononuclear cells indicating widespread latent infection ([@bib197]). In contrast, viral RNA is produced at high levels primarily in tissues of the oropharynx suggesting that this is the major site of SFV replication ([@bib510], [@bib509]). Shedding of virus at high levels within saliva is thought to contribute to efficient transmission.

The virus appears to be nonpathogenic in nonhuman primates. However, these viruses can replicate in a wide variety of cultured cells and may serve as a significant confounder in certain experimental protocols. In cell culture, SFV infection produces CPE characterized by vacuolization of cytoplasm and syncytia formation and superficially may resemble other retroviruses. SFV-free animals should be used for long-term culture of macrophages derived from bronchoalveolar lavage fluid or peripheral blood mononuclear cells.

There is no human-specific foamy virus. To date all human isolates have originated from nonhuman primates and, despite the apathogenic nature of infection, SFV should be considered a significant zoonotic organism. Previously described human foamy virus is genetically identical to SFV-6 isolated from chimpanzees. Reported prevalence of SFV in humans occupationally exposed to nonhuman primates ranges from 1--5% with many subjects reporting a history of sustaining bite wounds ([@bib278], [@bib700]). Investigators continue to search for associations with naturally occurring diseases in humans. Foamy viruses have been proposed as vectors for gene transfer due to the stable integration into host cells, wide cellular tropism, lack of pre-existing immunity in most patients, and presumptive apathogenicity ([@bib43]).

Nonenveloped RNA-Containing Viruses {#s1610}
===================================

Reoviridae {#s1615}
----------

### Rotavirus {#s1620}

#### Introduction {#s1625}

Rotaviruses are a common cause of contagious enteritis in young children, piglets, calves, and lambs. Rotaviruses have been isolated from macaques, but their association with disease is less clear.

#### Etiology {#s1630}

Rotaviruses are of the family *Reoviridae*, subfamily *Sedoreovirinae*, and genus *Rotavirus*. These nonenveloped viruses have an icosahedral capsid that is arranged in three layers with a core containing an 11-segmented, double-stranded RNA genome. Rotaviruses are divided into seven groups (A--G) based on antigenic differences of the inner capsid protein VP6. Viruses may be further characterized into P and G serotypes based on the spike protein VP4 and the major surface glycoprotein, respectively. Viruses may also be classified according to genotype.

Type A viruses are most often associated with disease in humans. Despite the ubiquitous nature of these viruses, relatively few simian isolates have been well characterized. SA11 and rhesus rotavirus are two identified nonhuman primate strains. More recently identified strains include PTRV isolated from a pig-tailed macaque with diarrhea, YK-1 also isolated from a pig-tailed macaque with chronic diarrhea, and TUCH (for the Tulane University and Cincinnati Children's Hospital isolate) isolated from an asymptomatic rhesus macaque ([@bib475], [@bib297], [@bib770]). Phylogenetic analysis of these isolates by Matthijnssens and colleagues indicates that the PTRV genome is of bovine origin ([@bib458]). The rhesus rotavirus and TUCH genomes are of canine or feline origin although they also demonstrate evidence of reassortment with bovine, human, or other rotavirus strains. SA11 shares little genetic similarity to the other identified simian strains ([@bib458]).

#### Epizootiology {#s1635}

The virus is transmitted by the fecal--oral route. Infant and juvenile rhesus macaques are susceptible to inoculation with human and/or simian rotavirus isolates ([@bib793], [@bib108], [@bib475]). There has been less work documenting the extent and clinical importance of spontaneous rotavirus infection in nonhuman primates. Screening of captive macaque colonies with evidence of diarrhea demonstrates a 0% to 88% infection rate ([@bib328], [@bib759]). Although surveys such as this do not establish a causal relationship, experience from other species suggests that rotaviruses may be a common cause of mild, self-limiting diarrhea during infancy. Maternal antibody is thought to be protective ([@bib771]). No carrier state has been identified. In fact, shedding of virus following experimental infection usually resolves within 14 days ([@bib475]). However, the virus will survive in the environment for extended periods.

#### Pathogenesis and Pathology {#s1640}

Virus entry occurs via binding of the outer capsid proteins to cell surface molecules followed by endocytosis and decapsidation of the virion. The virus replicates in the epithelium of the distal one-third of the intestinal villus tip, resulting in epithelial cell necrosis and villous atrophy. Defects caused by epithelial cell loss are closed within hours by reconstitution; however, full repair may take several days and require maturation of newly formed enterocytes. Villous atrophy is associated with diarrhea, which peaks 72 h after infection.

#### Clinical Findings {#s1645}

Following a short incubation period of 24--48 h, viral infection causes profuse watery diarrhea, which persists for several days. Infection is usually self-limiting and usually does not require clinical attention.

#### Laboratory Findings {#s1650}

Although antibodies to SA11 were demonstrated in 15 of 16 species of New and Old World nonhuman primates studied, electron microscopy did not reveal SAll viral particles in 123 random fecal samples from baboons, macaques, squirrel monkeys, and capuchin monkeys ([@bib350], [@bib346]). The virus may be identified in diarrheic stool following ultracentrifugation by negative-staining electron microscopy. Commercially available ELISA and latex agglutination kits can also be used to detect type A rotaviruses within stool samples. Immunoelectron microscopy techniques utilizing antisera against rotaviruses will increase the sensitivity of viral visualization considerably. Molecular techniques may be utilized as well.

#### Treatment and Prevention {#s1655}

The ubiquitous nature of rotaviruses makes their prevention difficult. Therapy in most cases is not required.

### Orthoreovirus {#s1660}

Baboon orthoreovirus, of the family *Reoviridae* and subfamily *Spinareovirinae,* was identified as the cause of a nonsuppurative meningoencephalomyelitis in eight captive-housed baboons that demonstrated evidence of acute, progressive hemiparesis and paresis ([@bib171], [@bib170], [@bib408]). Histopathologic examination revealed lymphoplasmacytic perivascular cuffing, microglial nodules, demyelination, and axonal degeneration. Certain species within the Reoviridae family are fusogenic, including baboon orthoreovirus, representing the only nonenveloped viruses capable of inducing syncytium formation in cell culture.

Picornaviridae {#s1665}
--------------

Picornaviruses (pico = small, rna = ribonucleic acid) are small, single-stranded, nonenveloped RNA-containing viruses. The family Picornaviridae contains many viruses of importance to human medicine and agriculture, including members of the *Hepatovirus*, *Enterovirus*, *Apthovirus*, and *Cardiovirus* genera. Picornoviruses reported in nonhuman primates are listed in [Table 1.10](#t0055){ref-type="table"} .TABLE 1.10PicornaviridaeGenusVirus*Hepatovirus*Hepatitis A virus*Cardiovirus*Encephalomyocarditis virus*Enterovirus*PoliovirusCoxsackievirus A and BSimian enteroviruses*Sapelovirus*SV2

### Hepatitis A Virus {#s1670}

#### Introduction {#s1675}

Hepatitis A virus (HAV) is classified as a member of the *Hepatovirus* genus within the family Picornaviridae. It is responsible for a self-limiting viral hepatitis in human beings and may be transmitted by the fecal--oral route during acute infection or by the ingestion of uncooked contaminated shellfish. The availability of vaccination programs within the United States has resulted in a 92% decline in reported cases between 1995 and 2007 ([@bib143]). The virus does remain endemic within many developing countries and poses a risk for travelers to these regions. It is well accepted that chimpanzees, tamarins, cynomolgus macaques, and owl monkeys are susceptible to HAV. Serologic evidence exists for the infection of rhesus macaques, stump-tailed macaques, Celebes black macaques, baboons, African green monkeys, capuchins (*Cebus albifrons*), marmosets, spider monkeys (*Ateles geoffroyi*)*,* gibbons (*Hylobates lar*), mandrills, and patas monkeys with the same or similar viruses ([@bib184], [@bib16]; Brack, 1987a; [@bib403], [@bib644], [@bib565]).

#### Etiology {#s1680}

The hepatitis A virus is a small, 25- to 30-nm-diameter RNA virus with a dodecahedral configuration composed of 12 pentamers. The 7.4-kb genome consists of a single open reading frame encoding a large polypeptide that is post-translationally cleaved into 11 functional proteins. Six HAV genotypes are recognized with genotypes I--III containing primarily human isolates and genotypes IV--VI containing simian isolates. A variety of nonhuman primates may be infected experimentally with human HAV isolates ([@bib563], [@bib13]). A great wealth of information exists on the experimental infection of tamarins. These animals have served as an important animal model of the human disease and were critical in the initial characterization of the virus and subsequent vaccine development.

#### Epizootiology {#s1685}

Transmission likely occurs by the fecal--oral route. Serologic evidence of infection has been demonstrated in both wild-caught and captive nonhuman primates. In several instances, seroconversion has occurred during the initial period of captivity, suggesting that the combination of stress and environmental factors at this time may promote transmission of the virus. Most experimental work indicates that animals shed virus and are contagious for only short periods ([@bib126]). A single report suggests that under some circumstances animals may remain viremic and shed virus for extended periods ([@bib404]).

#### Pathogenesis and Pathology {#s1690}

Pathogenesis and histopathology are similar in all species studied to date. Following fecal--oral transmission there is a prolonged incubation of 20--50 days. Abnormalities of liver enzymes may be noted at this time. Virus is shed in feces for 10--30 days and onset of this shedding usually precedes detectable clinicopathologic alterations.

Hepatocellular injury is mediated by cytotoxic CD8+ T lymphocytes and is not the direct cytolytic effect of the virus itself. Characteristic histopathologic changes are the activation of sinusoidal cells, focal hepatocellular necrosis, and portal, nonsuppurative inflammatory cell infiltrates. Hyperplasia of bile ducts and bile duct epithelial cell necrosis have been described in chimpanzees. The occurrence of these findings closely parallels elevations in liver enzymes ([@bib161]).

#### Clinical Findings {#s1695}

Clinical signs are uncommon and nonspecific. Anorexia and diarrhea have been noted in some chimpanzees infected with HAV ([@bib71]).

#### Laboratory Findings {#s1700}

Elevations of alanine aminotransferase and aspartate aminotransferase 2--10 times above normal, as well as mild increases in bilirubin, have been documented and coincide with the development of humoral and cellular immunity. Anti-HAV IgM and anti-HAV IgG increase and may be used to confirm infection. Although the disease associated with HAV is often mild, infection with this virus in several instances has interfered with the interpretation of clinicopathologic data collected during toxicology studies ([@bib403], [@bib661]).

The hepatitis A virus is difficult to grow in cell culture and serologic evidence is often utilized in clinical diagnosis. Commercially available immunoassays have been used in a number of Old and New World primate species and may demonstrate acute-phase IgM or convalescent-phase IgG anti-HAV antibodies ([@bib184], [@bib403]).

#### Treatment {#s1705}

In most nonhuman primates, infection is usually self-limiting. Previous infection with HAV is protective.

#### Zoonotic Potential {#s1710}

Numerous cases of human HAV infection contracted from nonhuman primates have been documented ([@bib71]). The vast majority of these cases have been transmitted from recently imported chimpanzees. Hepatitis A virus infection of human beings is often asymptomatic in young children while a majority of adults present with a febrile prodome associated with non-specific gastrointestinal symptoms followed by self-limiting acute hepatitis. Fulminant fatal hepatitis is a rare outcome. In contrast to hepatitis B virus, chronic infection and carrier states are not seen.

### Encephalomyocarditis Viruses {#s1715}

#### Introduction {#s1720}

Encephalomyocarditis viruses (EMCV) are a group of closely related viruses 30 nm in diameter with a genome characteristic of Picornaviridae. They are members of the genus *Cardiovirus*. The protype strain, EMCV Rueckert, was isolated in 1945 from a chimpanzee with fatal myocarditis ([@bib277]). As with other members of the Picornaviridae, they are relatively resistant to a number of environmental factors, including desiccation and freezing.

#### Epizootiology {#s1725}

Encephalomyocarditis viruses infect a variety of wild rodents and have been infrequently implicated in causing disease in rhesus macaques, marmosets, owl monkeys, squirrel monkeys, mandrills, and chimpanzees ([@bib229], [@bib61], [@bib37], [@bib576], [@bib88]). Several epizootics have been recognized in baboons, suggesting a unique susceptibility ([@bib301]). Animals likely become infected when rodents contaminate food or other surfaces with feces. Although mice represent the natural reservoir host, rats are often implicated in transmission of the virus to nonhuman primates and swine. Horizontal intraspecies transmission has been documented in swine and rodents and such transmission in primates is suspected.

#### Pathogenesis and Pathology {#s1730}

Clinical disease is due primarily to the destructive effect of viral replication and host immunologic response within the myocardium. Ultrastructurally, viral particles may be found within myocytes and endothelium. At necropsy, pulmonary congestion, pericardial effusion, and mottling of the myocardium may be noted. Histologically, there is a multifocal to coalescing, necrotizing, nonsuppurative myocarditis ([@bib713], [@bib301]). Neurologic lesions may additionally be observed and consist of perivascular lymphohistiocytic infiltrates within the cerebrum and cerebral cortex. Pathologic findings may be suggestive, but definitive diagnosis requires viral isolation. Differential diagnosis should include other agents such as coxsackie virus, toxoplasmosis, and trypanosomiasis (Chagas' disease) ([Figure 1.22](#f0115){ref-type="fig"} ).FIGURE 1.22Encephalomyocarditis virus (EMCV).EMCV may cause a multifocal necrotizing myocarditis (A and B) and be associated with dystrophic mineralizing of cardiomyocytes (C).

#### Clinical Findings {#s1735}

Affected nonhuman primates are usually found dead with no premonitory clinical signs. Following experimental inoculation, time to death in squirrel and African green monkeys was highly variable, ranging from 4 to 41 days ([@bib61]). In less peracute cases, tachypnea, dyspnea, and frothing from the nostrils have been recorded. In a large biomedical research colony of baboons, placental infection and increased fetal loss were observed ([@bib301]).

#### Treatment and Prevention {#s1740}

No treatment is available. Prevention and control should center on the elimination of reservoir rodent hosts. This may be difficult in outdoor housing, and the virus may persist in the environment for extended periods.

### Simian Enteroviruses {#s1745}

The genus *Enterovirus* contains a large number of viruses pathogenic for humans. Species within the genus recognized by the ICTV include human enterovirus A--D, human rhinovirus A--C, and simian enterovirus A. Simian isolates are found within the human enterovirus species as well as within the species simian enterovirus A. For instance, SV19, SV43, SV46, and baboon enterovirus are members of the species human enterovirus A while SA5 is a member of the species human enterovirus B. The species simian enterovirus A includes the isolates SA4, SV4, and SV28 ([@bib527]). SV2, the first isolated simian enterovirus, has recently been designated a member of the tentative genus *Sapelovirus* ([@bib526], [@bib752]). Greater than 200 serotypes within these species have been described and, since 1969, have been numbered sequentially. For instance, EV92 indicates the 92^nd^ enterovirus isolate while SV19 indicates the 19^th^ simian isolate. Other designations include CV indicating coxsackievirus isolates. Some isolates apparently lack strict species specificity, and the possibility that infection of an inappropriate host (including humans) may be associated with a more virulent disease should be considered.

As a group, these viruses are resistant to a variety of chemical disinfectants, including ammonia compounds and deoxycholate. They are, however, susceptible to UV light and dehydration. The pathogenesis of all enterovirus infections share certain features: (1) entry through the gastrointestinal tract; (2) a brief period of viremia associated with minimal clinical disease in the majority of those infected; (3) gastrointestinal shedding of the virus; (4) frequent antigenic mutation; and (5) infrequent dissemination of virus from the gastrointestinal tract to distant target organs. In humans, enteroviruses are associated with a number of clinical entities, including encephalomyelitis, meningitis, myocarditis, cutaneous exanthemas, respiratory disease, congenital malformations, acute hemorrhagic conjunctivitis, and diabetes mellitus. These serious sequelae are rare, and, in general, the vast majority of human beings infected have minimal clinical signs.

Because of the widespread nature of enteroviruses and the frequent asymptomatic infection of most individuals, it is often difficult to establish an etiologic relationship between a specific enterovirus and disease occurrence. The following criteria have been recommended: (1) a high rate of viral isolation from individuals with disease versus individuals without disease; (2) seroconversion during the course of illness; (3) a lack of evidence of concurrent infectious agent; and (4) virus present in significant concentrations in body fluids. While subgroups of enteroviruses are clearly associated with disease (polioviruses and coxsackieviruses) in nonhuman primates, numerous "simian" enterovirus serotypes have also been identified and their association with disease is less clear.

Species from which enteroviruses have been isolated include chimpanzees, macaques, vervet monkeys, African green monkeys, baboons, langurs, and marmosets. Many isolates have been made from animals with no clinical signs or mild diarrhea ([@bib520]). An outbreak of myocarditis and meningoencephalitis in the fall of 1970 at the Lawrenceville facility of the Centers for Disease Control and Prevention illustrates the difficulty in making the association between disease and an enteroviral agent ([@bib352]). This outbreak was associated with high morbidity and mortality in rhesus macaques and African green monkeys. Most of the rhesus macaques were found dead without clinical signs whereas others had dysentery and experienced convulsions on handling. Lesions in these animals were inconsistent and composed of increased numbers of mononuclear cells within the cerebrospinal fluid and scattered perivascular hemorrhages. An enterovirus (simian agent 16) was cultured from four of ten brains. African green monkeys died with chronic-active myocarditis and a nonsuppurative encephalitis. Simian agent 16 is a common isolate from macaques, and this virus did not produce clinical disease when inoculated into rhesus monkeys.

Coxsackieviruses are enteroviruses that have been associated with cardiac fatalities in nonhuman primates ([@bib491], [@bib275]). Multifocal lymphocytic infiltrates extending from the endocardium to the pericardium were accompanied by varying degrees of myocyte degeneration, necrosis, and fibrosis. Immunohistochemistry and molecular techniques were used to identify the virus within the cardiac tissue.

### Poliovirus {#s1750}

#### Introduction {#s1755}

The epidemic form of human poliomyelitis has occurred since antiquity. Asian macaques have served as an important experimental model of this disease and have been critical in vaccine development and safety testing ([@bib616]). The experimental susceptibility of macaques was first demonstrated in 1908. In the 1950s, approximately 200 000 nonhuman primates were imported annually to support this research ([@bib751]). Human vaccination programs have been highly successful, reducing the 350 000 cases reported in 1988 to less than 2000 in 2007. However, the virus continues to circulate in countries such as Afghanistan, Pakistan, Nigeria, and India posing a risk for continued transmission ([@bib210]).

#### Etiology {#s1760}

Three distinct serotypes of wild-type poliovirus are recognized. Individual isolates may vary in their virulence and invasiveness.

#### Epizootiology {#s1765}

Natural infection of the chimpanzee, gorilla, and orangutan has been demonstrated. These occurrences are exceedingly rare since the advent of widespread vaccination of human populations. The gastrointestinal tract becomes infected and animals may shed virus in feces.

#### Pathogenesis and Pathology {#s1770}

Prior to the vaccine era, polio was a disease of the young and immunosuppressed. In the face of an appropriate immune response or maternally acquired neutralizing antibodies, infection is eliminated or limited to the gastrointestinal tract. In cases in which the immune response is deficient, the virus disseminates to the central nervous system and is capable of infecting and destroying neurons.

The poliovirus infects specialized enterocytes (M cells) and initially replicates in gut-associated lymphoid tissue. The major determinant of viral tropism is the poliovirus receptor CD155. Polymorphisms in the gene encoding for this protein contribute to the host range restriction of poliovirus infection ([@bib316]). New World primates and rhesus macaques are not susceptible to infection via oral inoculation. Cynomolgus macaques and chimpanzees can be infected via oral routes although with reduced efficiency relative to humans ([@bib320]). Cell lines from tamarins and marmosets demonstrate reduced virus--receptor interaction, suggesting that a reduced ability of the CD155 receptor to bind virus contributes to this variation in infectivity by a natural route of exposure ([@bib364]).

Lesions are found scattered throughout the gray matter of the central nervous system with a propensity to affect the spinal cord, cerebellar nuclei, and diencephalon. The initial inflammatory response consists of polymorphonuclear cells that are rapidly replaced by lymphocytes and plasma cells forming perivascular aggregates and infiltrating the meninges. Neuronal necrosis and glial nodules may be evident.

Rhesus macaques are experimentally susceptible to poliovirus infection and the development of the encephalomyelitis if inoculated with poliovirus parenterally (usually intracranially). Natural poliovirus infection has not been diagnosed in rhesus macaques and rhesus appear to have a specific block in the translocation of poliovirus from M cells in the gut. This block is absent in cynomolgus macaques which are susceptible oral poliovirus infection.

#### Clinical Findings {#s1775}

In many cases, no clinical signs are evident. Disseminated infection to the spinal cord may lead to paresis, paraplegia, and death. Skeletal biometric changes have been documented in Gombe chimpanzees as a long-term sequela to poliomyelitis and deinnervation atrophy of skeletal muscle.

#### Zoonotic Potential {#s1780}

Although possible, transmission from nonhuman primates to humans has not been demonstrated.

#### Prevention {#s1785}

The Sabin modified-live oral polio vaccine has reportedly been used to vaccinate and protect Gombe chimpanzees and a variety of great apes ([@bib11], [@bib501]). Caution is advised in using any modified-live vaccine in species in which proper testing of efficacy and biosafety have not been conducted.

Caliciviridae {#s1790}
-------------

### Primate *Calicivirus Pan paniscus* Type 1: PCV-Pan 1 {#s1795}

A calicivirus was isolated from a Pygmy chimpanzee with a mild vesicular stomatitis resembling herpes simplex infection ([@bib665]). The virus was isolated on two separate occasions 6 months apart and while contact chimpanzees were seropositive, none showed clinical signs. PCV-Pan 1 had characteristic morphologic features ultrastructurally and was subsequently shown to have a high degree of genetic identity to feline calicivirus, thus placing the simian isolate in the *Vesivirus* genus of the *Caliciviridae* family ([@bib589]). This virus has also been isolated from a silver leaf langur (*Presbytis cristata*), lowland gorilla, spider monkey, and douc langur (*Pygathrix nemaeus*) ([@bib663], [@bib664]).

### Norovirus {#s1800}

The *Norovirus* genus, of which Norwalk virus is the prototype strain, is a common cause of viral gastroenteritis in humans. While infection is self-limiting, transmission of the virus is often problematic for schools, hospitals, and the military. The virus is resistant to disinfection and is spread via ingestion of contaminated food and water. Members of the Norovirus genus have a 7.5-kb genome and are organized into five genogroups designated GI--GV. Serosurveys in mangabeys, macaques, and chimpanzees have demonstrated a high prevalence of antibodies directed against the GI and GII genogroups ([@bib328]). Presence of antibody was not associated with clinical disease. Rhesus macaques and chimpanzees were susceptible to experimental infection and, although viral shedding and seroconversion occurred, animals did not develop gastroenteritis ([@bib792], [@bib600]). In contrast, experimental infection of pig-tailed macaque infants resulted in a self-limiting diarrheal illness and transfer of infection to the dam ([@bib695]).

### Recovirus {#s1805}

Using degenerate PCR primers, a previously uncharacterized calicivirus was detected in the stool of juvenile rhesus macaques housed at the Tulane National Primate Research Center ([@bib199]). The virus named Tulane virus (TV) has a genome 6.7 kb in length with a poly-A tail. Based on phylogenetic relatedness to other members of the Caliciviridae, the virus is provisionally assigned to the novel genus *Recovirus* (named for *r*hesus *e*nteric *c*alicivirus). Because TV was detected in stool of animals both with and without diarrhea, an association with clinical disease could not be made.

Coronaviridae {#s1810}
-------------

Coronaviruses have a large, positive-sense RNA genome that is approximately 28--30 kb in length. The enveloped virions are characterized by a helical nucleocapsid and large spike (S) glycoproteins. These glycoproteins form projections of the surface of the virus contributing to the classic crown- or halo-like ultrastuctral appearance from which the virus name is derived.

### Coronavirus-Like Particles {#s1815}

Coronavirus-like particles have been detected using electron microscopy in the feces of common marmosets, cotton-topped tamarins, macaque species, baboons, and chimpanzees ([@bib669], [@bib612]). These particles were identified in up to 43% of samples examined. A link to a diarrheal illness could not be established.

### SARS Coronavirus {#s1820}

The severe acute respiratory syndrome (SARS) resulted in \>8000 probable cases of pneumonitis and an associated 10% mortality rate between November 2002 and July 2003 ([@bib555]). The fulfillment of Koch's postulates via experimental infection of nonhuman primates enabled establishment of a link between the SARS coronavirus (SARS-CoV) and this severe respiratory epidemic ([@bib385]). Inoculation of rhesus macaques via intranasal or intratracheal routes resulted in evidence of diffuse alveolar damage characterized by the accumulation of edema, fibrin, and cellular debris within alveolar spaces and accompanied by epithelial desquamation, type 2 pneumocyte hyperplasia, hyaline membrane formation, and syncytial cells ([@bib385]). Despite the characteristic appearance of the described lesions, most experimental infections in nonhuman primates do not reach the level of severity observed in human patients succumbing to respiratory failure ([@bib464]). A more recent report suggests that infection of aged macaques resulted in a stronger innate immune response and thus was associated with lesions of greater severity ([@bib674]). Common marmosets also have demonstrated utility as an animal model of SARS-CoV ([@bib255]). Intratracheally inoculated marmosets developed a multifocal to coalescing pneumonitis with multinucleate syncytia and type 2 hyperplasia. Diffuse alveolar damage was not observed. Infected animals also demonstrated a multifocal hepatitis and mild diffuse colitis sharing features of extrapulmonary disease reported in human patients.

Hepeviridae {#s1825}
-----------

### Hepatitis E Virus {#s1830}

#### Introduction {#s1835}

The hepatitis E virus (HEV) is an important etiologic agent of self-limiting hepatitis (non-A, non-B). Although only occasionally detected in industrialized nations, HEV may reach epidemic proportions in developing countries. Outbreaks usually occur following heavy rainfall and have been associated with sewage contamination of drinking water.

#### Etiology {#s1840}

The agent is a single-stranded RNA virus assigned to the *Hepevirus* genus of the family *Hepeviridae*. It is 34--37 nm in diameter and has a genome of approximately 7.2 kb in length. There are four major genotypes with GI found primarily in Asia and Africa, G2 in Mexico, and G3--G4 in the United States, Europe, and Asia.

#### Epizootiology {#s1845}

Humans become infected by the fecal--oral route. IgG antibody responses have been reported in wild-caught macaque species suggesting that natural infections can occur ([@bib19], [@bib283], [@bib795]). A number of species are susceptible to experimental infection with HEV including owl monkeys, cynomolgus monkeys, rhesus macaques, moustached tamarins, African green monkeys, and chimpanzees ([@bib72], [@bib565], [@bib718]).

#### Pathogenesis and Pathology {#s1850}

Cynomolgus monkeys appear to be the species most susceptible to experimental inoculation. Similar to HAV infection in this species, minimal clinical signs were associated with HEV infection. Viral antigen was detected in the liver 30--37 days postinoculation and was associated with elevations in liver enzymes, a mild nonsuppurative portal hepatitis, and the appearance of an antibody response. Virus was shed in the feces through bile and was identified by electron microscopy.

#### Zoonotic Potential {#s1855}

Swine and rodent species are suspected reservoirs of infection and sources of zoonotic transmission. Given this, potential for transmission from nonhuman primates to man is possible.

[^1]: Tentative species within the genus.

[^2]: From [@bib391].

[^3]: These animals are not natural hosts and demonstrate progressive disease with viral inoculation.
